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A b s tr a c t
Pneumonia in young ruminants, caused by the Gram-negative bacterium Pasteurella multocida, 
world-wide is an infectious respiratory disease of major economic and welfare importance. P. 
multocida infection is on the increase, for unknown reasons, as the serotype A:3 that causes the 
majority of pneumonic disease has not been fully characterised. Greater knowledge of P multocida 
A:3 may reveal the underlying mechanisms of pathogenesis that have not yet been elucidated. The 
aim of the work presented in this thesis was to expand knowledge of P. multocida, specifically with 
respect to serotype A:3. There are several published attempts to develop a suitable animal model of 
P multocida infection but prior to this investigation none were reliable, reproducible or closely 
mimicked the field disease. As a consequence, progress towards a vaccine has been slow and there 
is currently no vaccine available to protect against disease caused by P. multocida A:3.
In these studies the lipopolysaccharide (LPS) from P multocida A:3, a potentially important 
virulence factor, was characterised and found to be of the rough form, indicating loss of the O- 
antigen responsible for variation in the bacterial isolates. This discovery may facilitate the 
development of vaccines targeted against LPS. Pulsed-field gel electrophoresis of DNA cut by 
enzymes with infrequently predicted restriction sites revealed the potential for much genetic 
diversity. An experimental model of pneumonic pasteureiiosis caused by P. multocida A:3 was 
established to help determine mechanisms of pathogenesis. In this model, 300 ml of PBS 
containing lO’ cfu of P. multocida produced progressive clinical and pathological responses 
comparable to those observed in field cases providing for the first time a model suitable for future 
experimental studies (Dowling et al., 2002). Furthermore haptoglobin and serum amyloid-A were 
found to be useful markers for the disease. Subsequent work confirmed the reliability and 
reproducibility of the model in terms of the clinical and pathological responses. Host-pathogen 
interactions at various stages of disease were assessed by 2-dimensional electrophoresis of 
bronchoalveolar lavage fluid isolated from calves infected with live P multocida A:3 which 
revealed changes in antimicrobial peptides, annexins, antioxidant protein and apolipoprotein-1 
precursor.
Host responses to both live and killed P. multocida A:3 challenge were compared. Calves received 
either formalin killed P. multocida or saline, followed, at day 21, by challenge with live P. 
multocida. There were marked changes in both clinical scores and acute phase protein 
concentrations in responses to both treatments, with the highest values associated with formalin- 
killed P. multocida. Calves given formalin-killed P. multocida appeared to cope well with the 
bacterin challenge indicating a possible method for generating protection against exposure to a
Abstract_______________________________________________________________________
homologous challenge. The responses in calves given homologous live challenge after exposure to 
the bacterin were more severe than those calves given only the homologous challenge, suggesting 
that the bacterin compromised the animals’ defences rather than enhancing protection.
The in vitro interaction of macrophages with P. multocida was shown to be independent of 
opsonisation and the pathogen could survive in these cells for up to 1 hour, possibly by disabling 
the bactericidal function of the macrophage which may he significant to pathogenesis in the host.
The work reported in this thesis led to a successful, progressive and reproducible animal model that 
has provided a detailed picture of the clinical and pathological responses following R multocida 
infection. This study has provided a better understanding of the disease process and the host 
interaction with R multocida A; 3 and from these novel findings more informed approaches to 
vaccine development should be possible.
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Chapter 1. G eneral Introduction
Pneumonic pasteurellosis is an infectious bacterial disease of great economic importance and 
welfare and affects young ruminants. The disease is often initiated by a predisposing infection or 
stress, and the bacterial species isolated from clinical cases are Pasteurella multocida and 
Mannheimia haemolytica serotypes A. Historically, M. haemolytica was the predominant isolate 
from cases of pneumonic pasteurellosis and consequently much research was focused on this 
organism. This has led to well defined animal models (Panciera et al., 1984a, Jones et al., 1989, 
Porter et al., 1995, Highlander et al., 2000) describing the host response, subsequently assisting 
breakthroughs in vaccine technology (Gilmour et al., 1991, Sreevatasan et al., 1996, Kraabel et al., 
1998, Hodgins and Shewen., 2000). However, more recently, official figures retrieved from 
Veterinary Investigation Diagnosis Analysis (VIDA), collated within the UK, for the period 1992 to 
2001 show that the incidence of P. multocida A:3 is on the increase and is now as or more 
important than M. haemolytica in causing disease. Whereas much is known regarding M. 
haemolytica much less information is available on the pathogenic process o f pasteurellosis initiated 
by P. multocida. Several attempts have been made to develop a suitable animal model o f P. 
multocida infection but there is no reliable, reproducible model that mimics closely the field 
situation. As a consequence, progress towards a vaccine has been slow and there is currently no 
vaccine available against a P. multocida infection.
This general introduction seeks to review what is known about P. multocida A:3, and to address the 
gaps in our knowledge on host-bacterial interactions and a reliable and realistic disease model to 
assist vaccine development and characterisation of the organism itself. The introduction will be 
divided into two parts, the first part will discuss the organism and the second will focus on the host 
response to infection with P. multocida, with specific reference to bovine pneumonic pasteurellosis.
1.1. P asteu rella  m u ltocida
1.1.1, History and nomenclature
p. multocida is an opportunistic pathogen in wild and domesticated animals, as well as in man, and 
has been recognised as an important pathogen by the veterinary profession for over a century. 
Pasteurellosis caused by this organism was described initially in the bovine by Bollinger in 1878
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and P. multocida was first isolated a year later by Toussaint (M utters et al., 1989). The organism 
has been given many names beginning with Micrococcus gallicidus designated by Burrill in 1883.
In 1887 the generic name, Pasteurella, was assigned by Trevisan who wanted to commemorate 
Louis Pasteur's discovery o f P. multocida as the causative agent o f fowl cholera in turkeys (Mutters 
e ta l ,  1985).
For a period, organisms with a variety of species names were assigned to the Pasteurella genus on 
the basis of bipolar staining or on the host species from which the organism was isolated, for 
example P. bovicida. Other names are listed in Index Bergeyana (Buchanan et al., 1966). After 
approximately 40 years of nomenclature changes for Pasteurella spp., Rosenbach and M erchant in 
1939 proposed the epithet, multocida (Rosenbach and Merchant, 1939). Until 1932, the genus 
Pasteurella consisted only o f P. multocida, a situation that changed when the genus expanded to 
include Pasteurella haemolytica, on the basis of a lengthy classification study of 114 isolates. This 
study showed the presence of two distinct types of organism differing in their phenotypic 
characteristics and warranted their classification into separate species, as suggested by Newsom 
and Cross, (1931) who gave the species name Pasteurella haemolytica to the atypical, avirulent 
group composed of strains o f bovine and ovine origin, leading to the separation of the closely 
related P. multocida in the typical group (Newsom and Cross, 1931).
1.1.2. Determination and classifîcation of P, multocida.
p. multocida  represents a heterogeneous taxon consisting of a single species and subspecies, and is 
associated with a range of diseases in a variety of hosts (Mohan and Pawandiwa, 2000). Phenotypic 
and genotypic methods have been employed to differentiate P. multocida  from closely related 
species. Among the phenotypic methods used are colony morphology, biotyping, capsular and 
somatic typing and these allow us to determine bacterial antigens or biochemical properties that 
may identify biochemical varieties (Blackall et a l ,  1995 and Aye et al., 2001). Genotyping 
currently involves pulsed-field gel electrophoresis (PFGE) (Lainson et al., 2002) and polymerase 
chain reaction (PCR) (Townsend et al., 2000, 2001 and Rocke et al., 2002) providing a more rapid, 
reproducible and sensitive means of strain differentiation. The three subspecies within P. multocida 
(P. multocida  subsp. multocida, P. multocida subsp. septica and P. multocida  subsp. gallicida) were 
assigned to the genus Pasteurella sensu stricto by DNA-DNA hybridisation studies that determined 
the genetic relationships amongst species and their positions within the family Pasteurellaceae 
Pohl 1981 (Mutters et al., 1985).
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L I.2.1, Phenotypic Methods
1.1.2.1.1 Colony morphology and capsular antigen.
P. multocida is a small, non-motile, nonspore-forming, Gram-negative rod or coccobacillus 0.2-0.4 
X 0.6-2.5 |im , which exhibits a typical bipolar staining with Leishman or methylene blue stain in 
fresh cultures and animal tissues. Cells are arranged singly or in pairs and occasionally as chains or 
filaments if cultures are grown under unfavourable conditions. When P. multocida is grown on 
blood agar at 37°C the colony shape and size may vary considerably, ranging from circular, 
convex, discrete colonies (1 to 2 mm) to large mucoid colonies (3 to 5 mm) which are translucent 
and greyish in colour with a mucoid appearance characteristic of capsular type A P. multocida. 
(Rimler and Rhoades, 1989). Variation in colony morphology is due to differences in the size and 
chemical composition of the capsule, which is primarily composed of carbohydrate with some 
hyaluronic acid and is somewhat hydrophilic (Carter, 1972).
Colonies of P. multocida capsular groups B and E may also vary in size depending on the degree of 
capsulation. They can range from large greyish colonies when freshly cultured to small smooth 
colonies that give a yellowish-or bluish-green iridescence when viewed in transmitted light. 
Capsular type D and F strains may also produce mucoid colonies that are generally smooth in 
appearance and display a pearl-like iridescence in oblique transmitted light. The capsular material 
o f serogroups D and F was identified by the action of glycosidases and subsequent decapsulation as 
heparin or chondroitin, respectively (DeAngelis et al., 2002).
Rough colonies, with a circular, slightly dry appearance, are often produced by old cultures, due to 
the loss of capsular material, a process known as dissociation. The capsule can be regained by 
passaging these rough cultures through the natural host or through laboratory animals such as mice.
Colony morphology is related to virulence, while dissociation is related to the loss of virulence and 
antigenicity. This was shown in a study whereby acapsular bacteria were readily taken up by 
murine peritoneal macrophages while capsular P. multocida were significantly resistant to 
phagocytosis (Boyce and Adler, 2000). Encapsulated cultures have been associated with the 
production of effective vaccines, as the capsule contains an array of antigens that can stimulate the 
production of an efficient immune response against these foreign invaders (Adler et al., 1999). 
However, the relationship between capsule and virulence is not absolute as an acapsular B:2 strain 
of P. multocida  was still able to stimulate protective immunity against a P. multocida challenge 
(Boyce and Adler, 2001), indicating that some noncapsulated strains have the ability to be virulent.
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L l.2 .1 .2  Capsular typing
To study the pathogenesis and epidemiology of disease agents it is essential that isolates are 
classified in order to arrive at a concise diagnosis. This is of particular importance when applied to 
R multocida organisms that have the ability to infect a broad spectrum of hosts (Brogden and 
Packer, 1979). Serotyping of P. multocida using an indirect haemagglutination (IHA) test was able 
to identify four serological groups (A, B, D and E) based on capsular antigens (Carter, 1967 and 
Rimler and Rhoades, 1987). The IHA test was based upon the agglutination of human ‘O ’ red blood 
cells (RBCs) sensitised by capsular antigen from bacterial cultures. The capsular antigen was 
prepared by heating suspensions of the bacteria at 56°C for 30 m and removing cells by 
centrifugation. Over the years the IHA test has been modified and now uses fresh sheep RBCs 
(Sawada et a i ,  1982). Using this modified IHA, further P. multocida type was consistently isolated 
from turkeys and could not be placed in the existing serogroups, leading to the assignation of a 
serogroup F (Rimler and Rhoades, 1987). It is worth noting that a disadvantage of capsular typing 
is the difficulty of inducing antibodies to the specific antigen and, moreover, cross reactions may 
occur between antibodies against the serogroup antigens.
1.1.2.1.3 Somatic typing
Two systems exist currently for somatic antigen typing of P. multocida; Namioka’s system based 
upon tube agglutination tests (Namioka and Murata, 1961a; Namioka and Murata, 1961b) and 
Heddleston’s system based upon a gel diffusion precipitin test (Heddleston et al., 1972). The 
Namioka tube agglutination test is based on release of core or somatic bacterial components by 
agglutinating HCl-treated cells with rabbit antiserum. Using this method, 11 somatic types were 
characterised. A disadvantage of this typing system is that some isolates undergo autoagglutination 
following HCl treatment and cannot be typed (Rimler and Rhoades, 1989). The Heddleston gel 
diffusion precipitin test uses the supernatant o f culture suspensions heated at 100°C for 1 h as the 
antigen (Heddleston et al., 1972). Antiserum are prepared in chickens because they respond better 
to the type specific antigen after a short course of immunisation with a bacterin (Rimler and 
Rhoades, 1989). This method was able to differentiate 16 somatic types (Heddleston et al., 1972), 
Brogden and Packer (1979) attempted to equate serotypes among different typing systems and 
found any correlation unreliable due to the antigenic complexity of P. multocida  and the type of 
antigen used in each test.
The most widely accepted and current serotype designation system is a combination of Carter 
capsular typing and Heddleston somatic typing, whereby the capsular type is expressed first, 
followed by the somatic type. Using this method the Haemorrhagic Septicaemia (HS) serotypes 
from Asia and Africa have been designated B;2 and E:2, respectively. This system has consistently 
identified serogroups that cause diseases of economic significance.
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1.1.2.1.4 Non-serological typing
A particular limitation of serological typing of P. multocida is the inability o f serogroups A, D and 
F to agglutinate with homologous sera (Rimler, 1994), This phenomenon is associated with a 
component of the bacterial capsule, namely hyaluronic acid in serogroups A and a 
mucopolysaccharide, similar to hyaluronic acid, in serogroup D strains. Alternative tests include 
the addition of acriflavine to concentrated broth cultures, whereby a positive reaction is determined 
by production of a flocculent precipitate (Carter and Subronto, 1973). This test is used primarily to 
differentiate D strains of P. multocida from other types but some serogroup F strains also react 
positively. Furthermore, tests based on enzymic removal of capsule using a disc diffusion technique 
constitute a non-serological means of disease diagnosis. Addition of staphylococcal hyaluronidase 
to mucoid serogroup A strains causes depolymerisation of hyaluronic acid present in the bacterial 
capsule resulting in the loss of capsule. The decapsulation of D strains is mediated by the addition 
of chondroitinase AC and heparinase III; F strains were decapsulated by chondroitinase AC and 
were unaffected by the other enzymes (Rimler, 1994). It is worth noting that these tests are often 
used to complement the serological tests rather than replace them.
1.1.2.1.5 Biochemical characteristics o f  P. multocida
Classification of P. multocida isolates into biotypes based on fermentation reaction patterns has 
been reported and is associated with isolates from a particular host species (Fegan et al., 1995). P. 
multocida can be differentiated from closely-related bacteria on the basis of the following: 
fermentative growth, positive reaction for oxidase, catalase and indole, negative reaction with 
urease, lack of growth on MacConkey agar, acid production from hexoses (glucose, mannose, 
galactose, fructose) and variable fermentation with disaccharides positive for sucrose and negative 
for maltose and lactose. The subspecies of P. multocida can be differentiated by the following 
reactions: P. multocida subsp. gallicida  ferments arabinose, whereas subsp. septica and subsp. 
multocida cannot. P. multocida subsp. multocida  and subsp. gallicida  ferment sorbitol, whereas 
subsp. septica does not.
1.1.2.2. G eno typ ic  characterisa tion
With the advent of molecular biology techniques it has been possible to characterise isolates 
according to their most fundamental and stable property, their genetic information (Hunt et al.,
2000), and to identify bacterial pathogens that otherwise would be untypable. These techniques 
provide a more precise and rapid mode of grouping strains than phenotyping methods (Hunt et a i ,  
2000).
Recently the differentiation of strains of a similar serotype has been achieved using a variety of 
genotyping methods these include restriction endonuclease analysis (REA) which uses restriction
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enzyme digestion of genomic DNA and agarose gel electrophoresis for DNA fragment separation 
(Zhao et al., 1992 and Rubies et al., 2002), and ribotyping based on REA except that only 
restriction fragment length polymorphisms are highlighted (Hunt et al., 2000). These techniques are 
often applied in conjunction with one another, for example to differentiate avian (Blackall et al., 
1995) and porcine (Zhao et al., 1992) strains that exhibit considerable genomic heterogeneity. 
PFGE is a specialised form of REA producing a digest with fewer but larger fragments (Blackall 
and M iflin, 2000) and which demonstrates greater discrimination than ribotyping for the 
differentiation and identification of bacterial strains (Kodjo et al., 1999). PFGE has shown the 
potential to discriminate closely related strains (Lainson et al., 2002) although two limitations exist, 
the DNA extraction procedure is rather time consuming and the technique requires specialised and 
expensive equipment which is difficult to acquire in diagnostic laboratories.
Several studies have shown the benefit o f PCR fingerprinting for the differentiation of P. multocida 
isolates (Townsend et al., 1997, 1998). Arbitrarily primed PCR (AP-PCR) was effective in the 
discrimination of post-vaccination P. multocida isolates from turkeys (Hopkins et al., 1998) and 
was used to detect DNA fragments that distinguish serotype 1, the causative agent of avian cholera 
in wild waterfowl, from the other 15 serotypes of P. multocida (Rocke et al., 2002). Repetitive 
extragenic palindromic PCR (REP-PCR) exhibits a high degree of discrimination as shown in a 
recent study of the epidemiological relatedness of avian and swine P. multocida  isolates, wherein 
REP-PCR compared favourably with PFGE (Gunawardana et al., 2000; Amonsin et al., 2002). 
Furthermore, a PCR assay using primers derived from the 23S rRNA gene sequence of P. 
multocida has been developed and applied to the rapid identification of 144 P. multocida isolates of 
avian and porcine origin (Miflin and Blackall, 2001).
PCR assays amplify target sites of the organism’s genome that may be responsible for their genetic 
diversity or similarity and are sensitive, rapid and reproducible with a high level o f differentiation. 
Following the identification and sequence analysis o f the capsular biosynthetic loci which are 
highly specific for each P. multocida capsular serogroup, a multiplex PCR assay has been designed 
to identify serological differences between strains (Townsend et al., 2001). This assay provides an 
alternative to the present capsular serotyping system which tends to be rather laborious and often 
unable to produce definitive results. However, for accuracy and reliability, newly developed 
molecular typing techniques should be used in conjunction with other conventional methodologies 
with at least two distinct typing methods incorporated in any epidemiological study.
1.1.3. Virulence factors of R multocida
p. multocida, in common with other pathogens, has the potential to colonise, invade the mucosal 
surface, proliferate within host tissues and evade the host defence system resulting in ineversible
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damage to the host (Brown and Williams, 1985). Key virulence factors include lipopolysaccharide 
(LPS), capsule, fimbriae and outer membrane proteins (OMP) (Fig 1.1) and these factors, in 
combination with cellular and secreted host components, contribute to the characteristic clinical 
and histopathological changes associated with pneumonic disease (Confer, 1993). However, a 
better understanding of the chemical determinants of pathogenicity responsible for adherence, 
colonisation, invasion, and virulence in various hosts is required for the development of novel 
methods for treatment and control (Rimler and Rhoades, 1989).
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1.1.3.1, Lipopolysaccharide
LPS is an integral component of the outer membrane of Gram-negative bacteria. It forms a 
hydrophobic barrier which restricts the entry of digestive enzymes and certain antibiotics, and 
enables the bacteria to evade many innate host defence factors including complement, lysozyme 
and cationic proteins (Luderitz e ta l ,  1983; Brogden, 2000).
The structure of LPS is shown in diagrammatic form in Fig. 1.2. The outermost part of the LPS 
molecule consists o f repeat units o f covalently linked oligosaccharides, called O-antigen, that are 
structurally and antigenically diverse and play a major role in the serotypic classification system of 
P. multocida (Adler et a l ,  1999). Internal to the 0-side chains is the core oligosaccharide region 
that is structurally similar in common Gram-negative bacteria. To the core portion is linked a 
highly conserved lipid region. Lipid A that is embedded in the outer membrane of the bacterium 
and which is responsible for the toxicity o f LPS, but which exerts its lethal effects only when the 
bacteria lyse. This general structure is typical of the smooth or S-form chemotype LPS and is 
typical of Escherichia co ll When S-form LPS is analysed by polyacrylamide gel electrophoresis 
and stained with silver a ladder pattern appears, with the number of rungs denoting the number of 
repeat O-antigen units. Mutants that have lost the ability to synthesise an 0-side chain are 
described as rough (R-form chemotype) (Poxton, 1995).
1.1.3.1,1 Lipid A and 0-side chains are determinants o f virulence
An intact O polysaccharide is involved in the expression of virulence by a number of possible 
mechanisms. For instance the presence of an 0-chain  allows bacteria to adhere to certain tissues, 
resist serum killing and provide protection against damaging reactions with antibodies and 
complement. When rough forms are exposed to antibody, interaction with antigens in the core 
region enables complement to lyse the bacteria and contributes to a loss o f virulence, as observed 
with rough P. multocida A:3 isolates (Confer, 1993). However many rough strains of bacteria can 
be protected from the lytic action of serum due to the presence of capsular polysaccharides 
(Poxton, 1995)
LPS plays a vital role in the interaction of the pathogen with its host; for example LPS may be 
involved in adherence leading to colonisation, resistance to phagocytosis, or antigenic shifts that 
determine the course and outcome of infection (Adler et a l ,  1996). The injection of purified lipid A 
into experimental animals mimics the effects o f LPS, causing an array o f non-specific 
physiological reactions such as fever, intravascular coagulation, hypotension, shock and death 
(Cullor, 1992). Thus lipid A is the toxic factor and is able to act when released from the outer 
membrane during growth or following cell lysis as a result o f killing by phagocytes, attack by the 
membrane attack complex of complement or by antibiotics such as tetracycline.
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LPS released into the blood stream interacts with phagocytes to trigger the complement and 
coagulation cascade and release inflammatory cytokines, which constitute an integral part of the 
host defence against invaders.
P. multocida  LPS has shown to be antigenic in birds and is essential for the development of an 
immune response against P. multocida infection in turkeys. However, exposure of cattle or rabbits 
to LPS from P. multocida has failed to confer protection against experimental exposure with P. 
multocida (Adler et al., 1999). Nevertheless, an investigation using a bactericidal monoclonal 
antibody against LPS was found to completely protect mice against a homologous challenge of live 
P. multocida (Wijewardana et al., 1990), though only partial protection was observed in mice using 
opsonic monoclonal antibodies to LPS (Ramdani and Adler, 1991).
The range and role of LPS chemotypes present in P. multocida have not been defined for both 
healthy and diseased animals. It is unknown whether P. multocida adopts the rough or smooth form 
of LPS, whereas the rough form of M. haemolytica LPS has shown to be more virulent than the 
smooth form on in vitro phagocytosis by ovine alveolar macrophages (Hodgson et al., 2000). Such 
studies will elucidate the mechanisms of pathogenesis and assist vaccine development.
1,1.3.2. Capsule
The capsule of Gram-negative bacteria is located outside the outer membrane and is composed of 
hydrated polyanionic polysaccharides. Bacterial capsule plays a significant role in preventing the 
entry of particular molecules through the membrane, resists dehydration and mediates adherence of 
the bacteria to epithelial surfaces. In addition capsule promotes the survival and subsequent 
proliferation of the pathogen by interfering with opsonisation and phagocytosis and reducing 
complement-mediated killing (Boyce et al., 2000). These observations indicate that capsule is 
likely to be a virulence determinant, and studies have shown that capsulated isolates o f P. multocida 
in mice and piglets are more virulent than non capsulated isolates (Jacques et al., 1993). However, 
capsulated P. multocida strains were unable to adhere to respiratory tract mucus in vitro because the 
capsule may have masked any surface components (adhesins) involved in adherence. It has been 
demonstrated that capsules of most P. multocida strains express sialic acid units on their surfaces to 
mimic the sialyl-mucin layer coating epithelial cells, which is believed to have a nutritional 
function and which may be responsible for the ability of P. multocida to colonise and invade 
mucosal surfaces (Mizan et al., 2000, Vimr and Lichtensteiger, 2002).
Growth conditions may also influence capsule production, as P. multocida grown under iron- 
depleted conditions in vitro or in vivo produces significantly less capsule and expresses a greater 
affinity for the respiratory tract mucus than cells grown in iron-replete conditions (Jacques et al.,
1994). n
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Aside from its association with virulence, capsule structure has been used to distinguish the 
serogroups of P. multocida for epidemiological studies (Rimler, 1994). Capsules are poor
immunogens but once recognised by the host can provide an effective target for antibodies, thereby
contributing to protection.
1,1.33. Fimbriae
Colonisation of host cell surfaces by Gram-negative bacteria is mediated by numerous adhesins, 
such as polymeric filamentous appendages known as type 4 fimbriae (Strom and Lory, 1993 and 
Abraham et al., 1998). Type 4 fimbriae have been identified and characterised in serogroups A, B 
and D of P. multocida (Ruffolo et al., 1997). An increase in expression of fimbriae in P. multocida 
was observed under the microaerophilic conditions that bacteria colonising the mucosal surfaces 
generally encounter (Ruffolo et al., 1997). The ability of fimbriae to exist in large numbers tends to 
facilitate cell-cell or cell-substrate adhesion. The ability of fimbriated P. multocida serogroup A 
strains to adhere to host epithelial cells has been reported in rabbits (Glorioso et al., 1982; Al- 
Haddawi eta l., 2000).
A type 4 subunit protein (PtfA) from P. multocida A:1 strain was isolated and characterised 
(Ruffolo et al., 1997) and the ptfA  gene has subsequently been cloned which may lead to work 
exploring its role as a candidate vaccine antigen (Doughty et al., 2000).
1.1.3.4. Outer Membrane Proteins
OMPs of P. multocida can elicit protective immunity in experimental animal models (Confer,
1993). This has been demonstrated in rabbits whereby antibody responses were detected against 5 
P. multocida OMPs (Lu et al., 1988), Furthermore, rabbits were protected against homologous 
challenge following vaccination with P. multocida outer membranes and an antibody response was 
raised against OMPs (Lu et al., 1988). A monoclonal antibody prepared against 37.5 kDa OmpH, 
protected both mice and rabbits against a live P. multocida challenge (Lu et al., 1991a; Lu et al., 
1991b). However, Abdullahi et al., (1990) found no correlation between protection in mice exposed 
to either a homologous challenge or to a 37.5 kDa OMP antigen from bovine isolates of P. 
multocida
The OmpH of P. multocida was identified as a porin (Chevalier et al., 1993) and its potential to 
confer protection, as an immunogen was shown experimentally (Luo et a l ,  1999). A study to 
characterise the effects o f a major P. multocida porin on bovine neutrophils demonstrated an 
increase in functional activity of the cells as assessed by stimulation o f chemotaxis and oxidative 
burst measurement (Galdiero et al., 1998).
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Several different OMPs of P. multocida type A :3 may stimulate an antibody response against the 
organism in cattle (Confer et al., 1996) and OMP from serotype B:2 protected buffalo calves 
against a homologous challenge and could be used in vaccines against haemorrhagic septicaemia 
(Pati et al., 1996). Vaccination studies in chickens showed that a cyclic synthetic peptide was able 
to mimic a region of the P. multocida OmpH and induce partial homologous protection (Luo et al., 
1999).
Following the construction of a genomic library for P. multocida A:1 and screening with rabbit 
anti serum against whole membrane preparation, a gene encoding the Oma87 OMP was cloned 
(Ruffolo and Adler, 1996) and exhibited 75 % amino acid identity with D15 protective OMP of H. 
influenzae (Flack et al., 1995). Subsequently, Oma87 was found to be present in all 16 LPS 
serotypes of P. multocida and Oma87 homologues were found in a number of Gram-negative 
bacteria. The protective properties of Oma87 were demonstrated, whereby mice passively 
immunised with rabbit antiserum raised against recombinant Oma87 were protected against a lethal 
challenge dose of the homologous A:1 strain (Adler et al., 1999; Hunt et al., 2000). However, no 
protection was observed against a heterologous strain A:3 due possibly to the large amount of 
capsule in this strain masking Gma87 from antibody (Adler et a l ,  1999). Recent findings have 
demonstrated also a lack of protection in chickens against challenge with a virulent P. multocida 
serotype A following vaccination with a GST-Oma87 fusion protein (Mitchison et al., 2000). 
Further work is required to determine the expression of the protective epitopes of Oma87 and its 
role in immunity to pasteurellosis.
1.1.3.5. Iron-regulated proteins
Iron is an essential nutrient for most organisms through its central role in the metabolic electron 
transport pathways (Faustian et a l ,  2001). However, in vivo the free ionic concentration of iron is 
too low to support microbial growth due to the presence of iron-binding glycoproteins such as 
transferrin and lactoferrin. Bacteria have addressed this problem by developing a mechanism of 
sequestering iron from these protein carriers (Ruffolo et a l ,  1998). The first such system was 
identified in the supernatant o f P. multocida A;3 grown in iron-depleted conditions and involved a 
growth-enhancing factor called multocidln that functioned as a siderophore, and acted as a low 
molecular weight iron chelating agent (Hu et a l ,  1986). It was later shown that the same organism 
expressed high molecular weight iron-regulated OMP (ÏRQMP) when grown under iron-restricted 
conditions (Ikeda and Hirsh, 1988). It was demonstrated that these IROMP, with a molecular mass 
ranging from 52 kDa to 99 kDa, were also expressed by bacteria grown in vivo, suggesting a 
possible role for linking the multocidin complex with the organism (Keumhwa et a l ,  1991).
13
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These novel antigens can raise an antibody response against both homologous and heterologous 
serotypes of P. multocida, a possible role for these antigens in cross-protective immunity (Choi et 
a l ,  1989). Expressed OMP were later identified as the receptor proteins involved in the uptake and 
transport of the iron-siderophore complex across both outer and cytoplasmic membranes. It was 
reported recently that IR-OMP could induce cross-protective immunity in mice whereas OMP 
grown in iron surplus conditions induced protection only to a homologous challenge (Ruffolo et a l ,  
1998).
Finally, a mechanism of sequestering iron, independent of siderophore, has been identified and 
recently reviewed, (Ogunnariwo and Schryvers, 2001) and which involves the expression of a b i­
partite receptor composed of two proteins TbpA and TbpB. Both proteins exist in most bacterial 
species; they are surface exposed, iron-regulated and bind transferrin (Ogunnariwo et a l ,  1991). 
TbpB is a lipoprotein that binds directly to transferrin and TbpA is a member o f a family of TonB- 
dependent transporters that removes iron from transferrin at the cell surface, where it then migrates 
into the cytosol o f the Gram-negative bacteria (Zhao et a l ,  1998). Previous studies have 
documented the presence o f transferrin receptors in bovine P. multocida strains isolated from cases 
of pneumonia and haemorrhagic septicaemia (Ogunnariwo et a l ,  1991; Veken et a l ,  1996). A 
single novel receptor protein has been isolated from R multocida strains with immobilised bovine 
transferrin (TbpA) that is able to acquire iron from bovine transferrin without the need for a second 
receptor protein (TbpB) (Ogunnariwo and Schryvers, 2001).
The surface proteins involved in the acquisition of host iron have the potential to make effective 
vaccine candidates as they are essential to the bacteria for overcoming the iron-limiting conditions 
and are accessible at the cell surface, facilitating the production of antibodies to these antigens. 
Since the discovery of in vivo expressed genes by Hu et a l ,  (1986), iron-regulated proteins (IRP) 
grown in vitro have been the major component of a successful vaccine against M. haemolytica 
infection in lambs (Gilmour et a l ,  1991). A similar approach may be adopted for calves against F. 
multocida infection, except that with the development of genetic tools, certain genes controlling 
iron levels within the bacteria could be manipulated to disadvantage the pathogen.
1.1.3,6. Gene products associated with P. multocida virulence
Since the sequencing of the P. multocida genome (May et a l ,  2001) it is now possible to identify 
genes that may play an indirect role in the pathogenesis o f disease caused by this organism. Genes 
of particular interest with respect to a live attenuated vaccine strategy are galE, recA, aroA, fur, 
exbB, exbD, tonB and hgbA, all of which (except galE, recA and aroA) regulate intracellular iron 
concentration in the pathogen.
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The galE  gene product catalyses metabolism of galactose, located within the O-antigen of LPS, to 
glucose (Robertson et a i ,  1993). Mutants of the gene grown in glucose were unable to produce 
wild-type LPS, indicating a role for this gene in the virulence of R  multocida. Reduced virulence 
was observed following intraperitoneal inoculation of mice with R. multocida galE  mutants and led 
to the development of live attenuated vaccines to protect susceptible animals (Fernandez de 
Henestrosa er aZ., 1997).
Studies on the recA gene have failed to confirm a specific role in the virulence of P. multocida, 
although a recA mutation led to delays in proliferation, which slowed the process of infection and 
thus reduced virulence (Cardenas et al., 2001). There is potential for use of this recA mutant in the 
development of safe live attenuated vaccines, along similar lines with an aroA mutant which has 
shown to protect mice against an artificial infection of Haemorrhagic Septicaemia (HS) (Tabatabaei 
et al., 2002). These mutants have shown to be more effective than inactivated vaccines.
In addition to iron, zinc is also required by bacteria (Ratledge and Dover, 2000) and a zinc-uptake 
system comprising znuACB  genes has been identified and cloned in P. multocida (Garrido et al., 
2003). These genes have found to be under the control o f the ferrlc-uptake regulator (/hr) gene and 
are required for virulence of P. iiiultocida in a mouse model (G am do et ah, 2003). Moreover, P. 
multocida exbB, exbD and tonB genes regulate the uptake and transport o f iron or haem from 
haemoglobin into the cytoplasm of the organism. These genes are transcribed independently, but all 
three are required for the organism to cause infection (Bosch et al., 2002a). Finally, a gene product 
reported to bind haemoglobin in vitro was identified and the gene designated hgbA. This gene is 
regulated by iron and is present in all P. multocida strains irrespective of their origin or serotype 
(Bosch et al., 2002b).
The positive association of these gene products with P. multocida virulence suggests their potential 
as targets for the development of safe vaccines and a better understanding of iron uptake and 
transport mechanisms.
1.2. Bovine pneumonic pasteurellosis
p. multocida is a pathogen affecting a wide range of species, causing serious diseases in man, 
animals and birds. The bacterium is the primary agent of a disease in cattle known as pneumonic 
pasteurellosis and which is of great economic significance in Britain and North America, where it 
has caused losses to the livestock industry for over a century (Dalgleish, 1990). Currently, the 
associated loss to beef and dairy industries caused by bovine pneumonic pasteurellosis (BPP) in the 
USA is over one billion dollars per annum (Weekley et ah, 1998) and in the UK the annual losses 
due to BPP and other respiratory infections amounts to over £30 million (Dalgleish, 1989). In the
_
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UK pneumonic pasteurellosis is associated primarily with newly weaned calves after housing or 
transport to a new herd or premises and the peak incidence of BPP occurs between September and 
December when the bulk of the calf sales takes place (Dalgleish, 1990). BPP forms the main topic 
of this thesis and is discussed in detail below.
The primary isolates from clinical cases of BPP are M. haemolytica A:1 and P. multocida A:3. A 
decade ago M. haemolytica was considered the aetiological agent o f BPP while P. multocida was 
isolated only occasionally (Frank, 1989). However, the latest data retrieved from Veterinary 
Investigation Diagnosis Analysis (VIDA, UK) for the period 1992-2001 indicate that the number of 
reported cases of BPP attributable to P. multocida  was 35 % in 1994, with an increase from 42 to 
51 % during 1998 to 2001. This data highlights the increasing prevalence of P. multocida in the 
development of BPP compared to that o f M. haemolytica (Veterinary Laboratories Agency (VLA) 
2001). Bennett et al. (1999) collated data from published and unpublished sources with regard to 
the occurrence of BPP and suggested that 10 to 15 % of all finishing beef cattle are at risk at any 
given time in the UK.
P. multocida is part o f the commensal flora of the respiratory tract but is prevented from causing 
disease by the host’s immune system, with a variety o f defence mechanisms coming into play. The 
relationship between host and bacteria is stable in a healthy animal, however this stability can be 
altered by changing circumstances, such as a predisposing infection with a viral, parainfluenza 
virus-3 (PI-3) or bacterial agent {Haemophilus somnus) or stressful circumstances such as transport 
and environmental stimuli, that compromise the integrity of the antimicrobial barrier (Griffin,
1997). It is believed that once the immune system becomes compromised, P. multocida, along with 
other bacteria of its genera, may proliferate rapidly within the nasopharynx, migrate to the lung in 
aerosolised droplets and colonise to an unfavourable degree, causing bronchopneumonia. To date in 
the literature no distinction has been made between commensal and virulent strains and their 
involvement in the pathogenesis o f disease. There is however, in the case of M. haemolytica A; 1 
evidence for the emergence of a more virulent population than a predominant less virulent M. 
haemolytica A:2 strain (Gonzalez and Maheswaran, 1993). It would be of interest to investigate if a 
phenotypic switch between commensal and pathogen could take place, from an identical genetic 
background resulting in the development o f pneumonic pasteurellosis.
The clinical features of BPP include sudden dullness, pyrexia (up to 41.2°C), anorexia and laboured 
breathing often accompanied by adventitious respiratory sounds that may be heard on auscultation 
of the anterior pulmonary region. A mucosal discharge from the nostrils, mouth and eyes may be 
present. Calves that recover remain dull and anorexic for a period after recovery, causing 
significant economic losses due to retarded growth rates (Gibbs et al., 1984).
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At post-mortem (PM) the pulmonary lesion is an acute exudative fibrinous pneumonia confined to 
the anterior lobes, though in severe cases the pathology may be more extensive and may affect the 
caudal lobes (Jubb et al., 1993). Areas of affected lung are dark red or purple in colour, 
consolidated, with areas of fibrinous pleurisy. Histopathologically there is an acute inflammatory 
reaction where the alveoli become inundated with neutrophils, macrophages and oedema. 
Subsequently, these pulmonary lesions became walled off by fibrous tissue and became infiltrated 
by plasma cells and lymphocytes. The interlobular septa are often enlarged with fibrinous exudates 
and inflammatory cells (Allan e ta l., 1985).
Current methods of control in regions affected by BPP include managemental and prophylactic 
schemes. M anagement procedures involve minimising imposed stress, with weaning, vaccination 
and castration in place ahead of transportation to the market. Prophylactic schemes practiced by 
farmers in North America include the in-feed and in-water use of antimicrobials along with 
immunomodulators on cattle purchased from market (Gibbs, 2001). However, the practice of 
dosing cattle with antimicrobials as a preventative measure is controversial because of the 
perceived danger of the emergence of resistant Pasteurella spp. strains (Post et al., 1991). Research 
on this matter is scant and is essential when considering the increase in prevalence of P. multocida. 
Furthermore, evidence for the reduced efficacy of antimicrobials has been demonstrated with 
oxytetracycline and ampicillin which were unable to remove M. haemolytica from the nasopharynx 
of 20 clinically healthy calves (Shoo et at., 1990). A similar situation has not been demonstrated 
with P. multocida.
In the UK the prophylactic use of antimicrobials in an outbreak of respiratory disease is restricted 
to housed, in-contact at risk calves and aims to arrest the spread of infection. A study conducted by 
Jenkins (1985) found that antimicrobials were effective against actively dividing or pathogenic 
Pasteurella spp., indicating the merits of administering antibiotics at the earliest onset of disease. 
Treatment for BPP recommended by veterinary practitioners is oxy tetracycline in conjunction with 
an anti-inflammatory drug flunixin meglumine.
The mixed success of antimicrobials in controlling BPP has focused research interests on 
vaccination. New vaccines against the disease caused by M. haemolytica A; 1 and A;2 are based on 
inducing antibodies to IRP and these have been successful in providing an acceptable level of 
protection in sheep (Gilmour et al., 1991). Surprisingly, there are no equivalent vaccines available 
currently for P. multocida-induced bovine pneumonic infection. Following intensified research over 
the past five years, progress in understanding the pathogenesis o f pneumonic pasteurellosis caused 
by P. multocida has been made. The use of bronchoalveolar lavage to recover the cells involved in 
the first line o f defence in the lower respiratory tract (Caldow et al., 2001) has allowed preliminary 
studies of the interaction between P. multocida  and the host defence system to be examined in vitro
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(Mathy et al., 2002). It is anticipated that these advances will provide the incentive to produce an 
effective vaccine targeted against P. multocida infection in cattle.
1.2.1. Host response to bovine pneumonic pasteurellosis
A successful pathogen possesses a variety of virulent characteristics that can either interfere with or 
even evade the host defence mechanisms. For us to understand the survival strategies of the 
bacterium we must increase our knowledge of the host protection system and this review will focus 
on the innate immune system that is relevant to the age of experimental animals used in this thesis.
The innate immune system of the lung comprises a hierarchical system of defence for the 
recognition, rapid removal and killing, of foreign agents. Each component of the system has a 
distinct role in the elimination of micro-organisms and in maintaining a sterile lung environment 
(Bienenstock, 1984). These defences include epithelial barriers, enzymes within saliva and tears, 
aerodynamic filtration by the nasal cavities, mucociliary apparatus, cough reflex and the 
inflammatory response that leads to fever, a mechanism by which the immune system inhibits the 
growth of the pathogen. These are highly effective first line defence mechanisms and prevent the 
colonisation of pathogens in the upper respiratory tract (URT) and their subsequent entry into the 
lower respiratory tract (LRT). Bacterial components such as LPS interact with host cells and trigger 
the release of cytokines and chemokines, which then orchestrate the innate cellular responses of the 
lung that include complement-mediated lysis, cytotoxicity, and phagocytosis (Tizard, 2000). An 
array of such responses communicating with each other will stabilise the antimicrobial responses 
against invading pathogens. Research has shown that these mechanisms are often responsible for 
the development of host tissue damage if they are not controlled in a co-ordinated manner.
1.2.1.1. H o st defences o f  the upper resp ira tory tract.
The URT includes the nasal sinuses, pharynx, larynx, trachea and bronchi. Inhaled air encounters 
resistance to flow in the nasal cavity and induces a turbulent flow pattern. This phenomenon 
deflects and traps aerosolised particles larger than 1 0  pm in the inhaled air, against the nasal 
mucosal lining and these particles are eliminated subsequently by swallowing (Boyton and 
Openshaw, 2002). Foreign bodies greater than 5 pm but less than 10 pm  often escape the defences 
of the nasal cavity and are deposited on a ciliated epithelial layer that extends from the nasal 
turbinate to the terminal bronchioles. Within this epithelial layer are glandular cells that are 
responsible for the release of mucus when stimulated by a turbulent flow of secretion, and trap the 
inhaled foreign material (Boyton and Openshaw, 2002). Cilia impede the adherence and entry of 
foreign agents into the LRT by beating in a co-ordinated fashion to propel the inhaled material 
towards the buccal cavity for swallowing (Zhang et al., 2000).
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For bacteria to overcome these host defences and cause tissue damage, attachment to host epithelial 
cells is vital and this is considered the first step in the production of disease. Recent findings have 
shown that R multocida attaches to microvilli and the mucus layer of respiratory epithelium 
through fimbriae (Al-Haddawi et al., 2000). Following attachment, it is thought that R multocida 
and its toxic secretions rupture the cilia membrane resulting in the deciliation of epithelial cells. 
This decreases bacterial clearance, promotes colonisation and growth and the progression of 
disease (Al-Haddawi et al., 1999).
1.2.1.1.] M olectdar responses to colonisation o f  the upper respiratoiy tract
Once the functional integrity of the epithelial layer has been surpassed by disruption and 
inflammation, the immunological barrier is unable to stem the infection. Additional defence 
mechanisms are required to maintain lung sterility and to prevent access o f pathogens to the LRT. 
Surface secretions from the epithelium act to halt microbial activity and proliferation. These 
secretions include immunoglobulins (IgA being the most prevalent in the URT), proteases, 
defensins, cathelicidins, lysozyme, lactoferrin, surfactant proteins (SP-A and D) and 
lactoperoxidase which generates superoxide free radicals to kill bacteria (Ganz and Weiss, 1997). 
These antimicrobial factors have a beneficial role in the pathogenesis o f pneumonic pasteurellosis 
and their response to epithelial compromise and microbial invasion will be discussed in this 
section.
Recent evidence has shown the expression of antibiotic peptides in epithelial cells, and suggests a 
role in host defence of mucosal surfaces. During a pneumonic episode two antimicrobial peptides 
belonging to the (3-defensin family (Tracheal antimicrobial peptide (TAP) and lingual antimicrobial 
peptide (LAP) are produced by epithelial cells in the URT. TAP is expressed in the ciliated 
epithelium of the bovine trachea and was the first member of the P-defensin family to be 
discovered (Diamond et at., 1991). Upon stimulation of tracheal epithelial cells (TEC) with 
bacterial LPS, TAP messenger ribonucleic acid (mRNA) levels increase dramatically. LAP has 
been isolated from squamous epithelial cells o f the bovine tongue and its mRNA expression is 
elevated as a result o f tissue injury and inflammation. The mechanism o f antimicrobial activity of 
TAP and LAP is via selective membrane disruption of the pathogen (Russell et al., 1996). 
Alterations in the expression or biological activity of these defensins can predispose the host to a 
microbial infection (Russell et al., 1996).
Cathelicidins along with the defensins are members of the antimicrobial peptide family. They are 
located in epithelial cells and kill bacteria by permeating the LPS membrane (Brogden et al., 2001).
Surfactant proteins are a family of collagenous carbohydrate binding proteins. SP-A-and-D are 
members of this family and they bind to carbohydrate and lipid moieties of pathogens. This
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facilitates the removal of the pathogen from the URT by inhibiting adherence to epithelial lining, 
enhancing phagocytosis and killing. Lactoferrin is a glycoprotein that sequesters iron from the 
environment and is secreted from serous cells as well as from polymorphonuclear neutrophils 
(PMN). It functions by inhibiting bacterial growth by promoting iron-restricted conditions and 
agglutinating the bacteria (Skerrett, 1994). R multocida has shown to be well equipped for 
overcoming the effects o f lactoferrin and actually utilises this glycoprotein as a source of iron 
(Sparling, 1983). Lysozyme is present in serous cells o f tracheal epithelium and inhibits bacterial 
survival by digesting the peptidoglycan membrane of the bacteria (Coonrod, 1986).
Immunoglobulins are present in respiratory secretions with IgA confined to the URT while IgG is 
more prevalent in the alveoli following a M. haemolytica infection (M cBride et a i ,  1999). This has 
not been demonstrated for R multocida. IgA masks inhaled foreign material and protects the 
mucosa by preventing epithelial adherence, infiltration and by augmenting toxin neutralisation, 
which is reinforced by non-specific defence mechanisms. Specific IgG acts as an opsonin to 
promote the uptake of R multocida by alveolar macrophages (Reynolds, 1991).
IgA may be destroyed by enzymatic degradation. Recent findings have reported the production of 
proteases by R multocida  from human pulmonary fluid and these exhibits a high affinity for the 
cleavage of the heavy chain of human IgA outside the hinge region. Moreover, this protease differs 
from those that cut at the hinge region, as seen with Haemophilus influenzae and Streptococcus 
pneumoniae, and suggests the discovery of a new virulence determinant specific for P. multocida 
(Pouedras et al., 1992). The secretion o f these proteases from P. multocida  into culture medium has 
been found in isolates from sheep, cattle, pig and chicken (Negrete-Abascal et al., 1999). These 
proteases exhibit properties identical to that of neutral metalloproteases, in that they show optimal 
activity at both pH 6  and 7, while their activity is inhibited by EDTA and reactivated by calcium 
(Negrete-Abascal e ta l., 1999).
Evolution of proteases appears to be advantageous to pathogens as it enables them to avoid 
destruction and opsonisation by IgA and IgG by degrading these immunoglobulins. Research has 
been directed to other functions o f proteases other than the cleavage of immunoglobulin molecules, 
to implicate their involvement in the pathogenesis of respiratory disease (Ohbayashi, 2002). Matrix 
metalloproteases (MMP) are a group of endopeptidases, dependent on zinc as a cofactor, able to 
degrade the extracellular matrix of lung tissue. Recent evidence has shown a role for macrophage- 
derived M MP (MMP-2) in the pathogenesis o f pulmonary sarcoidosis (John et al., 2002). 
Furthermore macrophages were found to secrete MMP-9 in a dose-dependent manner in response 
to a mycobacterial infection in vitro and the immunoregulatory cytokines interferon-gamma (IFN- 
Y), interleukin (IL) -4 and IL-10 suppressed the bacterial-induced M M P production by reducing the 
amount of tumour necrosis factor-a (TN F-a) available to the macrophages (Quiding-Jarbrink et al.,
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2001). The precise mechanisms of lung injury caused by M MP are still unknown but it is believed 
that M MP facilitate the migration o f inflammatoi-y cells and extracellular matrix remodelling 
(Ohbayashi, 2002). Much attention is being directed towards possible methods of inhibiting such 
functions of MMP.
1.2,1.2. H o st de fences o f  the lo w er resp ira tory tract
The LRT consists o f the bronchioles and alveoli suspended in connective tissue. Particles less than 
5 pm  can penetrate to the LRT, as discussed previously. In most cases, invading bacteria are cleared 
from the alveoli efficiently and quickly, but when the host is immunocompromised the ability of 
foreign invaders to colonise and proliferate within the URT highlights the importance o f the LRT to 
acquire its own defence mechanisms to contain the spread of such foreign material and minimise 
the irreversible damage to lung tissue. The extent of pathogenesis is highly dependent on the 
location and amount of deposited virulent particles. Study of the progression of events within a 
diseased lung of an experimental animal may lead to a better understanding of host-microbial 
interaction and improved methods of control (Bienenstock., 1984).
1.2.1.2.1 Cell recruitment following lung mjury
Once the bacteria have reached the stage of invasive growth within the lung, the host initiates a 
cascade of events constituting the inflammatory response. This disrupts the physiological and 
metabolic equilibrium and causes behavioural and pathological changes (Kushner and 
MacKiewicz, 1987). Inflammation can be injurious to the host and is subject to multiple levels of 
control involving a diverse array of cells including vascular endothelial cells, neutrophils, alveolar 
macrophages, pulmonary intravascular macrophages, airway epithelial cells and soluble mediators 
such as IL-1, IL - 6  and TN F-a.
Within minutes after tissue injury, as may occur during pneumonic pasteurellosis, vasodilation of 
the microcirculation within the affected region occurs while neutrophils and monocytes attach 
themselves to the endothelial cells lining the small blood vessels before migrating out o f the blood 
into the tissue spaces. Adhesion molecules expressed by endothelial cells are, to a large extent, 
responsible for assisting neutrophils to migrate to loci o f inflammation. This expression is triggered 
by products of Gram-negative bacteria, including P. multocida, such as LPS, that activates 
monocytes in the circulation to attract neutrophils by forming a complex with LPS binding protein 
(LBP). This complex binds to a G D I4 membrane receptor on the surface of the phagocyte and 
initiates a signal for the release of T N F-a through a Toll-like receptor 4 (Tlr4) (Beutler et al.,
2001). Other products include molecules produced as a result of damaged tissue, such as thrombin, 
histamine and IL-1. The cytokines cause endothelial cells to express the adhesion molecule, E-
21
Chapter 1__________________________________________________________________
selectin, while thrombin and histamine are responsible for the enhanced expression o f P-selectin 
(Kerr, 1999).
Mucins, such as L-selectin, are expressed on the surface of circulating neutrophils and aid the 
transient binding of neutrophils to endothelial cells via attachment to P-selectins (Crockett-Torabi,
1998). This initial adherence is relatively unstable, but it attracts and slows the inflammatory cells 
so that they begin to roll along the endothelium in the direction of blood flow. A second phase of 
adhesion then occurs when chemoattractants, such as IL-8 , platelet activating factor (PAF) 
prostaglandins, leukotrienes and other cytokines are released and act upon the neutrophils, 
releasing a G-protein-mediated transduction signal that enhances the expression of and initiates a 
conformational change in the integrin C D lla/C D 18 on the surface o f the leukocyte (Ackermann 
and Brogden, 2000). This conformational change results in increased affinity for its ligand ICAM-2 
expressed on endothelial cells, making the neutrophils stop and bind firmly to the endothelial cells 
(Coomber et al., 2001). Once tight adherence has been achieved the cells cross the vascular basal 
lamina and infiltrate the tissue affected, for example the alveoli. This process is called diapedesis 
and is mediated by platelet endothelial cell adhesion molecule-1 (PECAM-1), which is expressed at 
intercellular junctions of endothelial cells (Furie and Randolph, 1995). The respiratory epithelial 
cells lining the bronchioles express ICAM-1 and this mediates the final stage o f neutrophil 
infiltration (Radi et al., 1999).
Paradoxically, neutrophils contribute to tissue damage by releasing elastase, hydrolases, cytokines, 
oxidative free radicals and chemokines, which are required for the phagocytic killing of pathogens 
by neutrophils. However, neutrophils can become apoptotic and have shown to play a vital role in 
the resolution of inflammation induced by M. haemolytica by limiting the autotoxic potential of the 
neutrophil (Chin et a l ,  2000). To date these is no evidence for the beneficial effects o f apoptotic 
neutrophils in the resolution of inflammation induced by P. multocida.
1.2.1.2.2 Phagocytes
The phagocytic cells of mammals belong to two complementary systems: the myeloid system 
consisting of cells that act rapidly but are unable to sustain their effort, for example PMN and the 
mononuclear-phagocytic system that includes monocytes/macrophages which acts slowly but is 
more sustained. Granulocytes of the myeloid system have characteristic lobulated, irregular nuclei 
and fall into three types; neutrophils, basophils and eosinophils, according to the staining of their 
cytoplasmic granules, lysosomes which contain an array of lytic enzymes and other proteins. 
Neutrophils are the major cell o f the myeloid system and the granulated cytoplasm takes up neither 
basic nor acidic dyes. They arise in the bone marrow and are continuously released into the blood 
at a specific stage of maturity, where they will circulate for 7-10 h. Cattle tend to have a lower 
percentage of neutrophils, approximately 20 to 30 % in the peripheral blood, compared to 50-70 %
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found in other species. They are cells with a short life span of 3 days once they have migrated into 
tissues, with a multi-lobed nucleus that distinguishes them morphologically from other 
granulocytes, and possess an array of cytoplasmic granules, which store a variety of chemicals for 
the degradation of ingested material. The neutrophil granules are o f two types: a primary granule 
contains lysozyme, myeloperoxidase, elastase and cathepsin B and a secondary specific granule 
contains lactoferrin, lysozyme and collagenase. A unique trait o f ruminant neutrophils is the 
presence of a third type of cytoplasmic granule, larger than the primary granule that is known to 
contain cationic antibacterial peptides. These peptides possess bactericidal properties for specific 
bacteria, for example indolicidin has antimicrobial activity for E. coli and S. aureus (Selsted et al.,
1992). However, the selectivity of these peptides for P. multocida remains unknown. Furthermore, 
bovine neutrophils are unusual when compared to other species; for example they have Fc 
receptors (FcR) for IgM that can act as an effective opsonin. They are chemotactically attracted to 
certain products of complement activation (C3b). Neutrophils also contain an abundance of 
glycogen granules, used to supply glucose during glycolysis, enabling the cell to function in 
anaerobic conditions.
The second type of phagocytic cell, the macrophage belongs to the mononuclear cell lineage, 
characterised by a single rounded nucleus, and is capable of sustained phagocytic activity. While 
some remain motile as circulating monocytes in the blood, others migrate into particular tissues and 
differentiate into tissue specific macrophages. Those located within alveoli are alveolar 
macrophages and they act as a first line of defence for the removal of foreign material. They 
process the antigen or inhaled foreign material for presentation to T-cells in association with major 
histocompatibility complex (MHC II) molecules. In addition they relay signals to other cells in 
response to foreign agents by the release o f an array of cytokines including IL-1, IL -6  and TN F-a. 
Furthermore, they repair tissue damage by removing dead or damaged tissue and thereby assist the 
healing process (Tizard, 2000).
1.2.1.2.3 Phagocyte recognition o f  pathogen
For phagocytosis to occur binding between phagocyte and pathogen must occur and there are two 
basic mechanisms that are either opsonin-independent or opsonin-dependent. In the absence of 
opsonins, Ofek et al., (1995) summarised three modes of recognition between the pathogen and the 
phagocytic cell that would result in phagocytosis.
1.2.1.2.3.1. Opsonin-independent phagocytosis
The first process o f phagocytosis occurs by hydrophobic interactions between molecules on the 
surfaces of the pathogen and phagocytic cells. The second form involves protein-protein 
interactions through a tripeptide motif, RGD (arginine-glycine-aspartic acid) located in micro­
organisms more often associated with Yersinia sp. invasin and Bordetella pertussis filamentous
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hemagglutinin. This RGD m otif promotes these bacteria to associate with macrophage adhesion 
molecules ICAM-1, leading to phagocytosis (Saukkonen et al., 1991). The final form of opsonin- 
independent mediated phagocytosis is lectinophagocytosis, which involves recognition between 
bacterial surface lectins and carbohydrates on the host cell (Ofek and Sharon, 1988).
Fimbriae type 4 identified in all capsule types of P. multocida is an example o f a bacterial protein 
lectin that facilitates the binding of bacteria to phagocytes by attaching to sugar residues on the host 
cell surface (Al-Haddawi et al., 2000). A further example of a lectin is the mannose receptor, 
specific for all tissue macrophages examined, including alveolar and hepatic macrophages. It is a 
type-I transmembrane glycoprotein consisting of a single subunit, a short cytoplasmic tail and 8  
carbohydrate-binding domains. This receptor expresses a high affinity for oligosaccharides located 
on the surface of microbes, such as K. pneumoniae  (K21a), that express capsular polysaccharides 
presenting the following sequence, M an-a2/3-M an. This form o f recognition of encapsulated 
bacteria inevitably results in endocytosis o f pathogen and stimulation of respiratory burst (Keisari 
et al., 1997). Protein lectins are thought to play a major role in the host response against infection 
and the development of innate immunity. Even though they facilitate the engulfment of pathogens, 
this may be beneficial for the microbe. For example the fungus Cryptococcus neoformans survives 
and grows readily after phagocytosis by human macrophages but is killed by the chymotrypsin-like 
cationic proteins and oxygen-dependent system of human polymorphs (Chaturvedi et al., 1996).
Studies on lectinophagocytosis (Ofek and Sharon, 1988) have shown its inefficiency in bacterial 
recognition when compared to opsonin mediated phagocytosis. This mode of phagocytosis could 
have evolved as a result o f bacteria evading the lectin mediated interactions. Varieties of opsonins 
exist within serum and lymph fluid and include naturally or acquired immunoglobulins, 
complement components, acute phase proteins (AFP) and pulmonary surfactant proteins.
1.2.1.2.3.2. Opsonin-dependent phagocytosis
When host cell and pathogen are suspended in milieu they tend to have a negative charge due to the 
presence o f surface polymers such as oligosaccharides, lipids and protein, and will tend to repel 
each other (Patrick and Larkin, 1995). Therefore, for binding to occur it is essential that the 
negative charge on the bacterium is neutralised by a positively charged protein. Examples of such 
positively charged proteins include pulmonary surfactant protein-A (SP-A), APP, LBP and 
mannose-binding protein (MBP), all o f which opsonise the polysaccharide surface of bacteria 
providing it contains mannose in the O-antigenic region of LPS. For example. Salmonella enterica 
group B, D l, D2 and E l contain an O-antigen with a repeating unit of 1-galactose and 4-mannose 
residues (Curd et al., 1998).
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However, antibodies are by far the major proteins of the immune system and are the most effective 
opsonins, coating bacteria and linking them to the CD32 (FcyRII) receptor located on the surface of 
neutrophils and macrophages. Bovine macrophages possess a unique Fc-R called Fcy2R which 
binds bacteria coated with IgG2. FcyR I, II, III bind to the Fc portion of IgG and this ligand binding 
between pathogen and host cell induces receptor cross-linking, stimulating the src family kinases to 
phosphorylate tyrosine residues within the immunoglobulin tyrosine activation motif (Nakamura et 
al., 2 0 0 2 ).
Another opsonin of great importance is C3b, the third component o f the complement system. 
Complement activation is triggered by the presence of antigen-antibody complexes on cell surfaces 
and leads to the proteolytic cleavage of complement components. The complement receptor CD35 
(C R I) is common to both macrophages and neutrophils, but an additional GDI lb/CD  18 (CR3) 
complement receptor is expressed by macrophages. These receptors are able to recognise the 
corresponding complement molecule present on microbes that have reduced surface charge 
facilitating attachment to the negatively charged phagocytes (Carroll, 1998). However, the binding 
of opsonised bacteria to receptors CRI and CR3 fails to trigger the respiratory burst and is a 
preferred route for the bacteria and are able to thrive within a phagocytic cell. This may explain in 
part the observation that M. haeinolytica can survive in alveolar macrophages for a limited period 
in vitro (Hodgson et ah, 2002). At present, there is no information available with regard to the 
ability of P. multocida to survive phagocytosis.
1.2.1.2.4 Uptake o f  the pathogen
Adherence of the pathogen stimulates the phagocyte pseudopodia to fuse and enclose the bacterium 
within a membrane bound vacuole called a phagosome (Tizard, 2000). This process is thought to 
occur by the polymerisation o f actin and is followed by a signalling cascade initiated by 
phosphorylation of tyrosine residues and mediated by protein kinase-C (PK-C). A major substrate 
of PK-C is a membrane-associated protein called myristoylated alanine-rich C kinase (MARCKS) 
that regulates the structure of the actin filaments at the membrane anchored to a skeleton of 
microtubules in the cytoplasm by cross-linking with F-actin and Myosin-I (Allen and Aderem, 
1995).
Once the pathogen has progressed towards the interior of the phagocyte and fused with the 
lysosome granules to form a phagolysosome, the lysosome granules release their destructive 
agents, such as oxygen free radicals, hydrogen peroxide, lysozyme, hydrolytic enzymes and 
peroxidase into the vacuole. In addition, carbohydrate, phosphate or sulphate groups removed from 
molecules fuse with the phagosome and the pH becomes more acidic, activating the acid 
hydrolases. It is fortunate that hydrolases are only active at pH 5 because if they were to leak out 
into the cytoplasm of the host cell which has a pH of 7.2, they would be likely to damage the cell. A
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hydrogen ion ATPase is found in the membrane of the lysosome to maintain the acidic 
environment. Once the granules release their reactive intermediates the oxygen-dependent and 
independent killing may commence.
1.2,1,2.5 Oxygen-dependent killing mechanisms
There are two oxidative-generating pathways, one found in macrophages and the other in 
neutrophils, that facilitate bacterial clearance and which could result in lung injury if uncontrolled. 
These pathways are slightly different with respect to the toxic agents produced.
1.2.1.2.5.1. The macrophage-associated nitric oxide mechanism
Production of O2' allows for its intercalation with the nitric oxide (NO) pathway. LPS, TN F-a, IL-1 
and IFN-y bind to macrophages, triggering transcriptional induction of inducible NO synthase 
(iNOS) through Tlr. This event occurs only within alveolar macrophages or type II epithelial cells. 
The enzyme iNOS mediates the conversion of L-arginine into NO and citrulline. At this point O2' 
facilitates the conversion of NO into an array of reactive nitrogen intermediates (RNI) possessing 
potent antimicrobial activity, and which can lead to acute lung injury. Evidence for this was 
forthcoming when experimental rats were given an intravenous injection of LPS in order to 
produce acute endotoxemia. A time-dependent increase in expression of iNOS mRNA was induced 
in the lung and reached a peak 24h p.c, (Wizemann et a l ,  1994).
An experiment was carried out to assess M. haeinolytica LPS induced NO production, its role in 
BPP and to reduce lung injury by blocking the action o f TN F-a, IL-1, IFN-y and L-NMMA, in vivo 
(Han Sang Yoo et al., 1996). This investigation showed that the antimicrobial activity of NO in 
alveolar macrophages was better than other RNI. There is evidence that Mycobacterium avium  can 
survive attack by NO because it is able to produce superoxide dismutase with manganese as a 
cofactor. To investigate the bacterium ’s mode of survival, synthetic manganese containing a 
superoxide dismutase mimetic (SODm) M40403 has been designed for the specific removal of O2’ 
(Salvemini et al,, 2001). To date, no information exists with regard to the ability for P. multocida to 
survive attack by host reactive intermediates.
1.2.1.2.5.2. Respiratory burst associated with neutrophils
Once the phagocytes have been exposed to a foreign stimulus they consume a large amount of 
oxygen as they generate the respiratory burst. This accompanies the capture of the pathogen and is 
required for killing rather than the process of phagocytosis (Mims, 1982). The oxygen is consumed 
by the phagocyte in the end reaction of glucose oxidation through the hexose monophosphate 
shunt, during which the addition of a single electron to oxygen, mediated by the activation of
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plasma membrane-bound NADPH oxidase, results in the production of superoxide anions (O2') 
(Lohmann-Matthes et a l ,  1994).
O2 + NADPH -> (NADPH oxidase) O2 + NADP+ + H+
Oxide radicals may be produced also by other routes not involving NADPH oxidase (Wang et a l ,  
2000).
The catalytic activity of superoxide dismutase generates hydrogen peroxide (H2O2), from which 
potent oxidant species may be produced by either of two methods. The first involves an enzyme 
myeloperoxidase (MPO), which is released after phagocytosis into the phagolysosme forming a 
complex with H2O2 and which has the potential to react with chloride ions. This oxidation reaction 
will produce an array of toxic, longer lasting antimicrobial agents such as hypochlorous acid that 
either attack directly the pathogen or react with nitrogen intermediates to form highly reactive 
compounds such as chloramines (Shepherd, 1986).
The second method for the conversion of O2' into toxic free radicals adopts a non-enzymatic 
approach and occurs in macrophages, neutrophils and monocytes. O2' reduces Fe^ "^  in ferritin 
compartments to create Fe^ "^ , which is highly reactive and catalyses the conversion of H2O 2 into a 
hydroxyl radical, at the same time regenerating Fe^^. Individuals suffering from chronic 
granulomatous disease have defective reactive oxygen intermediate producing systems and are 
more prone to bacterial infections. Anti-oxidants such as glutathione, vitamins E and C, catalase 
and (3 carotene protect the phagocyte from attack by free hydroxyl radicals by scavenging these 
radicals or reducing them to water.
The respiratory burst is abolished by the action of macrophage deactivating factor (MDF) or 
transforming growth factor-(3 (TGF-|3). MDF suppresses the respiratory burst by 50 % and the 
suppression remains at this level regardless of any attempt to trigger it artificially, for example by 
the use of phorbol myristate acetate (PMA) (Li et a l ,  2000) or LPS (Jian et a l ,  1995). Treatment 
with factors TGF-(3l and TGF-(32 produces a result similar to that o f MDF except that the 
suppressive effect can be eliminated by IFN-y or T N F-a (Nathan, 1991). The mechanism of 
deactivation of the respiratory burst by MDF or TGF-P remains elusive but research has been 
directed on changes in the levels and translocation of NADPH oxidase components.
Quantification of the respiratory burst in lung phagocytes using luminol-dependent 
chemiluminescence (LDCL) has been used to examine the effects in vivo and in vitro o f exposure 
of lung cells to PI-3 or M. haemolytica. Ovine alveolar macrophages challenged with either PI-3 or 
M. haemolytica exhibited an increase in light emission in this system indicating an increased
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activity in respiratory burst (Hodgson et al., 2002). The highest chemiluminescence (CL) responses 
were recorded from lambs exposed to M. haemolytica 6  days after PI-3 exposure, the group of 
lambs that had the poorest pulmonary clearance. Overall, CL responses were higher in lambs where 
bacterial proliferation occurred than in those lambs that controlled the infection (Davies et at., 
1986). Similar phagocytic studies are needed with P. multocida to determine the efficiency of 
phagocytosis and the relationship with BPP caused by this pathogen.
1.2.1.2.6 Oxygen-independent killing mechanisms
There are a number of possible mechanisms for the killing and digestion of microbes that do not 
require the presence of oxygen. Immediately after phagocytosis the pH level within the phagosome 
decreases to approximately 3, and creating a hostile, unfavourable environment for the pathogen. 
During the phagolysosome generation pathway a number of granules located within the cytoplasm 
of neutrophils and macrophages fuse with the phagosome and release their antimicrobial contents 
into the vacuole (Spitznagel and Shafer, 1985).
Lactoferrin and transferrin are examples of iron chelators found in specific granules of polymorphs 
and serum, respectively, that restrict the growth of bacteria and facilitate rapid destruction (Jacques 
et al., 1994). However, some bacteria have developed ways of obtaining iron from such chelating 
agents. One such microbe is Listeria monocytogenes which produces a reductant that reduces Fe^^ 
in lactoferrin and transferrin to Fe^ "^ , thereby releasing the sequestered iron (Patrick and Larkin,
1995).
It has become clear over the past decade that cationic peptides form a significant part of the 
oxygen-independent antibacterial system in phagocytes. Defensins ( a  and P) and cathelicidins are 
two important cysteine-rich peptides that contribute to innate immunity and anti-microbial defence 
by binding to the bacterial cell membrane and neutralising the virulent effects o f the bacteria (Yang 
et al., 2001). These peptides have been subjected to crystallisation and nuclear magnetic resonance 
and exhibit distinct hydrophobic and charged regions that allow them to permeate the phospholipid 
membrane and stimulate bacteriolysis. This property is attributed to 6  cysteines of each peptide that 
form a circular molecule, stabilised by intramolecular disulphide bonds and creating ion-permeable 
channels in the membrane (Patrick and Larkin, 1995). Their broad-spectrum bactericidal effects are 
non-specific and apply to Gram-negative and Gram-positive bacteria as well as some enveloped 
viruses. These effector molecules have been implicated also in the release of chemokines (IL-8 ) 
and degranulation of mast cells, providing evidence for their involvement in the inflammatory 
response.
Resistance to the antimicrobial effects of defensins has developed in some Gram-negative bacteria, 
for example Salmonella typhimurium  is able to survive and replicate within host cells through the
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expression of PhoQ, a sensor kinase that responds to changes in pH, ion concentration and 
osmolarity (Gunn and Miller, 1996).
1.2.1.2.7 Bacterial evasion o f  phagocytosis and survival
Pathogens such as Neisseria spp. have developed strategies of surface antigenic variation to avoid 
recognition by antibodies and to avoid phagocytosis via the FcyR. Another way that bacteria can 
avoid phagocytosis is to alter the Fc region of IgG and preventing the protein from interacting with 
the bacteria. This phenomenon has been identified in Staphylococcus aureus (Celli and Finlay,
2002). Although, neither survival mechanism has been demonstrated for P. multocida.
Reports have suggested that organisms, including N. meningitidis and S. aureus, are able to 
interfere with complement deposition, thus preventing phagocytosis. For example, capsule made 
from surface polysaccharide may protect against complement-induced bacterial killing by 
preventing complement from binding to the bacterial membrane. In addition, bacteria expressing 
smooth LPS can also deter complement-mediated lysis o f bacterial cell membrane (Lindahl et al., 
2000).
In addition to surviving within phagocytes, some bacteria have developed the ability to escape from 
the phagocytic vacuole into the cytoplasm or to prevent phagolysosomal fusion. The former has 
been discussed above with reference to S. typhimurium  and resistance to cationic antimicrobial 
peptides. L monocytogenes, Shigella flexneri and Rickettsia conorii, but not P. multocida, are able 
to polymerise actin into a tail-like structure in order to allow them to migrate out of the 
phagolysosome and into the cytosol o f infected phagocytes (Gouin et al., 1999 and Goebel and 
Kuhn, 2000). It is assumed that all bacteria that gain access to the cytosol are able to survive and 
replicate.
Bacteria are able to flourish intracellularly by preventing phagolysosomal fusion; this protects them 
from reactive oxygen intermediates and some oxygen-independent compounds. Mycobacterium  
tuberculosis is often coated with antibody to entice phagocytosis which prevents phagolysosomal 
fusion from occurring, allowing bacteria to multiply. It is believed that some mycobacterial 
products, such as sulphatides, interact with the lysosomal membrane, reducing its mobility within 
the cytoplasm and thus reducing the chance o f phagosome and lysosome combining (Britton et al.,
1994). In contrast, molecules present in the wall o f Chlamydia psittaci interfere with the 
phagosome membrane and prevent fusion (Moulder, 1991). Although information is lacking on P. 
multocida, Haemophilus somniis, an organism with similar attributes to P. multocida, is able to 
survive within bovine macrophages and neutrophils by removing H 2O2, and inhibiting the 
respiratory burst. In addition, it is capable of resisting nitric oxide mediated killing (Gomis et al., 
1997) although the mechanism for this has not been identified.
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L 2 .L 2 .8  Systemic acute phase response and molecular components o f  the lower respiratory 
tract
This phase o f the host response following a bacterial infection is associated with pain, fever, 
endocrine and metabolic changes and alterations in serum protein concentrations, characterised by 
production of liver derived APP such as haptoglobin (Hp), serum amyloid A (SAA), «i-acid 
glycoprotein (AGP). Cytokines, namely IL-1, IL - 6  and T N F -a produced by monocytes and 
macrophages activated by bacterial products, are responsible for mounting the systemic acute phase 
response (APR).
The APR is a beneficial reaction designed to prevent further damage to the site o f injury. It acts to 
restrict the growth of and aids elimination of the infective agent, and to remove damaged tissue and 
activate the repair process, thus re-establishing homeostasis. The APR is essentially a non-specific 
immune response, and is succeeded by a specific immune response (Hirvonen, et al., 1999). Under 
the influence of IL-1 and T N F-a and in particular IL-6 , hepatocytes increase the synthesis o f APP, 
a group of plasma glycoproteins, the concentration of which increases by greater than 25 % in 
response to tissue damage. The rate of increase depends on the protein and also varies among 
species. APP can function as either mediators, inhibitors, modulators, scavengers and 
immunomodulators during inflammation.
Plasma APP profiles differ between animal species. The major bovine APP associated with 
different pathological conditions include Hp and SAA, while AGP is a moderately responding APP. 
These proteins have shown to be sensitive markers for inflammation in cattle (Horadagoda et al.,
1999). Bremner (1964) was the first to document that the concentration o f Hp, a protein that is 
virtually undetectable in the plasma of healthy calves, can reach approximately 1 mg ml ' during 
inflammation. He also recognised that serum Hp levels could decrease during haemolysis due to an 
increased uptake of Hp-Haemoglobin complexes by the hepatic system where they are 
subsequently recycled, (Tizard, 2000) and that this should be taken into account when interpreting 
serum Hp levels. Spooner and M iller (1971) reported that Hp-Haemoglobin complexes were 
detected in only 0 .6  % o f clinically healthy cattle, but were found in most cows diagnosed with 
bacterial infection. The main antimicrobial property o f Hp is due to this complex formation that 
renders iron present in haemoglobin unavailable for bacterial proliferation. Hp detection, based on 
its ability to bind haemoglobin, is a useful diagnostic test for the detection o f inflammatory 
disorders (Eckersall e ta l., 1999).
Bovine serum amyloid A (b-SAA), a precursor of amyloid protein A, increases 100-fold in cattle 
inoculated experimentally with E. coli LPS (Boosman et a l ,  1989). Other experimental studies 
have measured the SAA response in cattle following inoculation with M. haemolytica or P. 
multocida (Horadogoda et al., 1993, 1994) and after physical stress in calves (Alsemgeest et al.,
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1993). From these studies SAA was judged to be a sensitive APP, reacting faster than Hp following 
a bacterial infection (Gruys et al., 1993; Horadagoda et al., 1994). Serum levels o f b-SAA can be 
determined by ELISA (Boosman et al., 1989; Horadagoda et al., 1993) and, with a commercial 
assay now available, b-SAA is another useful marker of disease in cattle.
Plasma concentrations of AGP, a constitutive plasma protein, rise slowly following tissue injury in 
cattle (Conner et a l ,  1988). Although AGP is an abundant protein, its physiological significance is 
not fully understood. Inhibition of neutrophil function, transport of molecules through the 
endothelial layer and platelet aggregation has been reported, though it is not known to possess any 
immunoregulatory functions (Hochepied et al., 2000). Concentrations of AGP are known to 
increase in several cattle diseases including pneumonia, mastitis, arthritis and following 
subcutaneous inoculation of M. haemolytica in calves (Walker et al., 1994). Bovine AGP is 
quantitatively analysed using a single radial immunodiffusion method (Tamura et al., 1989).
Studies focused on antimicrobial peptides, adhesion molecules and metalloproteases have opened 
prospective avenues for determining the microbicidal activities o f the respiratory tract. Further 
research on host-pathogen interactions is required to enhance our knowledge of the pulmonary host 
defence system against pathogens and to provide novel treatment and control for such microbicidal 
activity.
1.2.2. Experimental ruminant models for the induction of bovine 
pneumonic pasteurellosis
Over the past three decades M. haemolytica has been found to be the most frequent Pasteurella 
spp. isolated from the lungs o f ruminants affected with BPP. Most investigations on the design of 
experimental models have therefore been focused on this species of pasteurella.
Experimental reproduction of pneumonic pasteurellosis in ruminants tends to be expensive, partly 
due to the requirement that animals are free from Pasteurella spp. and is a limiting factor. This was 
shown following a survey into the prevalence of M. haemolytica in sheep, when it was found that 
95 % of the conventionally reared sheep were found to caiTy M. haemolytica in their tonsils and 64 
% carried bacteria in the nasopharynx (Gilmour et a l ,  1979). Most of these animals had either 
passive immunity or immunity as a result o f natural exposure to the organism, with possible 
implications for the consistent reproduction of disease for research purposes. As a result o f these 
findings specific-pathogen free animals have been used for the characterisation of M. haemolytica 
infection and these have been invaluable in the analysis of pathophysiological responses and the 
testing of vaccines specific for this organism in a controlled environment (Sharp et al., 1978; 
Gilmour et al., 1979). The identification of IRPs, as primary and novel antigens produced by the
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bacteria in vivo (Gilmour et ah, 1991) has proven to be a major advance in the search for a vaccine 
against M. haemolytica infection.
In the past decade P. multocida  types A and D have become more frequently associated with 
pneumonic pasteurellosis in ruminants. It is important therefore to develop a suitable, model that 
will reproduce the disease seen in the field, in order to study the pathogenesis o f infection, analyse 
the efficacy of immunisation and to develop new methods of control. Many of the experimental 
models developed at the Moredun Research Institute (MRI) for control o f M. haemolytica infection 
would assist the development o f a calf model for P. multocida.
The choice of method and route of inoculation in experimental studies have major consequences 
for the desired results (Jericho, 1987). Stress factors such as weaning, transportation, dehorning, 
handling, castration and accompanying predisposing agents such as mycoplasmas, viruses and 
bacteria play a major role in the production of pneumonic pasteurellosis and will often exacerbate 
the response.
1.2.2.1. Models using natural routes o f infection
Various investigators have induced experimentally pneumonic pasteurellosis in calves using diverse 
strains o f either P. multocida or P. multocida in conjunction with M. haemolytica or with a virus as 
a predisposing agent.
Pneumonic pasteurellosis in calves aged 2-6 months of age was produced with a combination of 
SF-4 bovine strain of myxovirus parainfluenza-3 and P. multocida. The viral inoculum, 5x10^ 
TCID50, was administered intranasally, a natural route of infection, and involved atomisation of the 
inoculum into the nostrils through a hole in a plastic bag held over the calf’s head, causing the 
forced breathing of the inoculum (Hetrick et a l ,  1963). Two days later, P. multocida at 10^ cfu ml ' 
suspended in 5 ml o f allantoic fluid was administered intratracheally and by day 2 following 
exposure to the organism clinical signs, including changes in demeanour, respiratory distress, 
diarrhoea, anorexia and nasal exudate of varying severity, were found in all calves. These clinical 
signs associated with respiratory illness were observed 11 days post-infection with P. multocida 
when the calves were exposed to the same agents but in reverse order, suggesting that P. multocida 
was only able to multiply following a virus attack, when the host's immune system was 
compromised. When calves were separately given either P. multocida or SF-4 virus only a mild 
form of respiratory disease developed, indicating that calves were able to harbour such infectious 
agents without exhibiting overt clinical signs (Hetrick et a l ,  1963).
A model for pneumonic pasteurellosis was established in goats using P. multocida  types A and D 
harvested from pneumonic lungs of goats and using 4 ml of the bacterial suspension administered
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intratracheally (Zamri-Saad et al., 1996). This model established that type D isolates produce more 
severe lung lesions than do type A strains, a finding in agreement with research that showed that 
type D toxins have been linked with severity of lesion (van Diemen et al., 1994).
Previous work conducted at the MRI (Donachie et al., unpublished), and elsewhere (Ames et al., 
1985; Gourlay et al., 1989), has demonstrated the lower virulence of P. multocida  relative to M. 
haemolytica when the bacteria were administered in small volumes of PBS. Gourlay et a l ,  (1989) 
produced pneumonic pasteurellosis in calves aged 2-6 months with P. multocida serotype A by 
infecting them through either the intratracheal or intravenous route. The inoculum ranged from 1.5 
X lO'' to 1.5 X 10'° cfu. Clinical illness was mild in all calves, with pyrexia and respiratory signs 
being only temporary in the worst affected calves.
Ames et a l ,  (1985) produced pneumonic pasteurellosis in 2 day old calves with either M. 
haemolytica or P. multocida. A  rebreathing bag was used to make the calves hyperpnoeic and, 60 
ml of culture was then injected into the trachea. The degree of clinical signs and the extent of the 
lesions produced were in proportion to the amount of the organism in the inoculum. M oreover he 
concluded that P. multocida alone produced a mild clinical response and that the extent o f lung 
lesions, including pneumonic consolidation, was minimal compared to that caused by M. 
haemolytica. Both experimental approaches however failed to produce overt disease according to 
the criteria put forth by Houghton, (1995). The standard approach used by Donachie and co­
workers when infecting conventional calves with M. haemolytica has been to use 60 ml of bacterial 
suspension. However, more recently, higher volumes (300 ml) o f challenge inoculum have resulted 
in a more reliable and progressive development of the disease, mimicking that seen in the field. A 
similar approach could be applied to P. multocida infection in cattle with the aim of improving our 
understanding of the interactions between the bacteria and the host immune system.
1.3. Other disease caused by P, multocida
p. multocida is the causative agent o f other important diseases such as haemorrhagic septicaemia, 
fowl cholera, atrophic rhinitis and rabbit septicaemia, these are summarised below and listed in 
Table 1.1.
1.3.1. Haemorrhagic Septicaemia
Haemorrhagic septicaemia (HS) is an acute, often fatal septicaemic disease affecting cattle and 
buffaloes, with a wide geographical distribution. In most Asian and African countries HS is 
endemic and is considered to be one of the most economically significant bacterial diseases (Jones
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et a l ,  2002). Following exposure to virulent organisms, clinical signs appear after a short 
incubation period and affected animals develop fever, respiratory distress and profuse mucosal 
discharge from the nostrils and mouth. Within a few days, most cases become recumbent and die 
from septicaemia. Subcutaneous oedema, widespread petechial haemorrhages in submucosal 
tissues, congested lungs and enlarged lymph nodes are observed at PM  (DeAlwis, 1992). In 
endemically infected areas immunisation using adjuvant vaccines provides the most effective 
means of controlling HS (Jones et a l ,  2002).
1,3.2. Fowl cholera
An infectious avian disease of world wide distribution, caused by R multocida  serotypes A :I, A:3 
or A:4 (Rhoades and Rimler 1987). The disease often manifests as the septicaemic acute form with 
high morbidity and mortality. The period of acute illness is very short and consists o f anorexia, 
mucosal discharge from the eyes, mouth and nostrils, increased effort for respiration and bloody 
diarrhoea and death may occur within hours or days. The lesions seen in birds that have died of 
acute illness include small haemorrhages of internal organs and mucous membranes (Blackall and 
Miflin, 2000). The disease is treated with chemotherapeutic agents, primarily sulphonamides and 
antibiotics, and these agents are subjected to in vitro sensitivity testing to ensure maximum efficacy 
against P. multocida  (Blackall and Miflin, 2000). Vaccination is recommended in regions where the 
disease is known to occur though, for P. multocida, 16 serotypes exist and the commercially 
available vaccine contains only the most common serotypes A :l, A:3 and A:4.
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Table 1.1. Specific serotypes associated with livestock disease caused by P. multocida, designated 
by the Carter-.Heddleston method.
C apsu lar Som atic Serotype Disease Host
type type species
A 1 ,3 ,4 A ll, A;3, A:4 Fowl cholera Poultry/
turkeys
5 ,6 A ;5 ,A :6
7 ,8 ,9 ,  10 A:7, A :8 , A;9,
A:10
12, 13, A: 12, A ;13,A :14,
14,15 A:15
16 A:16
3 A:3 Bovine pneumonic pasteurellosis Cattle
Pneumonia Pigs
B 2 B:2 Haemorrhagic Septicaemia in Asia Cattle and
buffalo
D 11 D :ll Atrophic rhinitis Pigs
E 2 E:2 Haemorrhagic Septicaemia in Africa Cattle
F Fowl cholera Turkeys
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1.3.3. Atrophic rhinitis
Atrophic rhinitis is a common disease of swine that is o f worldwide economic importance to the 
pig rearing industry and is characterised clinically by sneezing, coughing, and nasal discharge. The 
resulting inflammation and atrophy of the nasal turbinates causes crooked or shortened snouts 
(Chanter and Rutter, 1989). The disease presents as either a non-progressive mild form caused by 
Bordetella bronchiseptica or a progressive form caused by toxigenic strains of P. multocida (types 
D and A) alone or in combination with B. bronchiseptica. The toxigenic strains of P. multocida 
produce potent cytotoxins and B, bronchiseptica produces a dermonecrotic toxin (Brockmeier et 
al., 2002). Both forms inhibit osteoblastic activity and promote osteoclastic reabsorption in nasal 
bones (Lopez, 2001). Available vaccines use a combination of B. bronchiseptica bacterin with 
toxoids prepared from toxigenic P. multocida strains (Sakano et al., 1997).
1.3.4. Snuffles
p. multocida  A; 12, A;3 and D;1 strains are a major cause of mortality and morbidity in rabbits. The 
predominant syndrome is “snuffles”, which is characterised by conjunctivitis, rhinitis, sinusitis and 
pleuropneumonia. Antibiotics are often prescribed as the first line o f treatment and control, but 
studies have focused on vaccination as a means of control in rabbi tries where pasteurellosis is 
common (Deeb, 2000). Preliminary vaccination studies in rabbits have demonstrated the ability of 
P. multocida IR-OMP administered intranasally to stimulate immunity against experimental 
pneumonic pasteurellosis (Confer et al., 2001).
In addition to these diseases caused by P. multocida  in domestic livestock, the sporadic occurrence 
of P. multocida infection in other species has also been documented in elephants, donkeys and 
horses (Pavri and Apte, 1967), camels (Hassan and Mustafa, 1985), deer (Aalbaek et al., 1999) and 
in a snow leopard (Chaudhuri et al., 1992). Humans may become infected by P. multocida 
following an animal bite. Patients tend to exhibit swelling, cellulitis and some bloody drainage at 
the wound site and infection may move to nearby joints where it can cause swelling and arthritis. 
However, infections unrelated to animal bites have been frequently reported and include 
meningitis, and pneumonia (Klein and Cunha, 1997).
1.4. Aims of the study
The aims of the thesis are as follows: Firstly, commensal and virulent P. multocida isolates amongst 
cattle within the M idlothian region will be characterised by molecular typing and LPS chemotyping
36
Chapter 1__________________________________________________________________
and compared with the M RI-P mwtocida A: 3 used for the production o f pneumonic pasteurellosis 
in this study. Secondly, to produce a progressive and realistic model of pneumonic pasteurellosis 
due to P. multocida, in cattle and by characterising the pathophysiological and biochemical 
responses of the host to either low or high volumes of challenge inocula. It is anticipated that an 
optimal dose and volume will produce disease comparable to that seen in field cases and will assist 
the development of treatment strategies. Thirdly, the reproducibility o f the model will be assessed 
and bronchoalveolar lavage fluid (BALF) will be screened for bacterial and host proteins involved 
in pathogenesis using novel proteomic techniques. Fourthly, the clinical, APP and pathological 
responses attributable to formalin-killed P. multocida will be characterised and compared with 
those recorded after challenge with live formulations of P. multocida. Finally, the mechanisms of 
host-pathogen interactions will be determined by analysing responses of lavaged lung cells to 
formalin-killed P. multocida challenge.
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2.1. Biochemical characterisation of P, multocida
2.1.1. Colony Morphology
Initial characterisation of P. multocida  strains recovered from nasal swabs and lung were 
determined by colony morphology. After overnight incubation at 37°C on 5 % (v/v) sheep blood 
agar (SBA) plates (appendix 1.2.1), one of two colony types was produced by P. multocida', 
smooth, circular greyish colonies 1-2 mm in diameter or greyish mucoid colonies 3-5 mm in 
diameter (Barrow and Feltham, 1993). Mucoid colonies ranged from discrete, circular slightly 
mucous-like to large ‘watery’ mucoid colonies that often coalesced. Growth on SBA produced a 
characteristic odour. Nasal swab and lung isolates with a colony morphology similar to that seen 
with P. multocida were assessed for their oxidase and catalase activity.
2.1.2. Oxidase activity
This was ascertained by Oxoid touch-sticks (Oxoid Ltd, Basingstoke, Hampshire, UK). The 
impregnated end of the stick was touched on to the surface of a well separated colony and rotated 
to remove a mass of cells. The stick was examined after 30 s; if no colour change occurred It was 
examined 3 min later. A deep purple colour indicated a positive reaction consistent with the colony 
being P. multocida.
2.1.3. Catalase activity
Using sterile loops small amounts of growth were transferred from SBA plates onto microscope 
slides and each was mixed with a loopful of catalase reagent (equal volumes of 3 % (v/v) hydrogen 
peroxide and 1 % (w/v) aqueous methylene blue). The enzyme catalase is located within Gram 
negative bacteria and catalyses the conversion of hydrogen peroxide to oxygen. Coverslips were 
placed over the reaction mixtures and if bubbles were produced within 10 s, isolates were 
considered catalase positive. If no bubbles were produced then bacteria were considered catalase 
negative. Field isolates that tested positive for oxidase and catalase were selected for further 
characterisation.
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2.1.4. Urease activity
For each isolate, several colonies were resuspended in 0.5 ml of sterile distilled water in a bijou, 
and a urea disk (BD Biosciences-Life Research, Between Towns Rd, Cowley, Oxford, UK) added 
using sterile forceps and incubated at 37°C for 4 h. A positive reaction was indicated by the disk 
turning pink in colour, and strongly positive isolates were detectable after 1 0  min.
2.1.5. Indole production
A single colony of each isolate was inoculated into 10 ml nutrient broth (NB) and incubated for 48 
h static at 37°C. Following incubation, 2 ml of the broth cultures were transfeiTed to sterile bijoux 
containing 0.1 ml of K ovâcs reagent (bioMerieux, 69280 Marcy F Etoile, France) and mixed well. 
Solutions were incubated for 1 min at room temperature (RT) and the production of indole was 
detected by the development of a deep pink colour at the surface of the broth.
2.1.6. Carbohydrate fermentation tests
Carbohydrate media consisted of 1 % (w/v) solutions of each substrate in peptone water sugar base 
(BD Biosciences-Life Research) (appendix 1.1.1), dispensed in 3 ml volumes. Sugar-free controls 
were also prepared. Bacterial suspensions with McFarland values of 3-4 were prepared using a 
densimat (bioMerieux), from the growth of bacteria on SBA plates resuspended in saline. The 
McFarland values were multiplied by a conversion factor, 3 x 10® and a correction factor of 1.5 
applied, to provide an estimated viable count of 1.4 to 1.9 x lO'' cfu ml"'. The carbohydrate media 
were inoculated with 0 .2  ml of these bacterial suspensions, and incubation was carried out for up to 
14 d at 37°C. Every 2 d the broths were examined for a change of colour from purple to yellowish- 
brown, indicating the production of acid from sugar substrates (Bisgaard et al., 1991).
2.1.7. Detection of P-galactosidase activity (ONPG test)
Bacterial suspensions, prepared as described under section 2.1.6, were inoculated into 0-nitro- 
phenyl-D-galactopyranoside (ONPG) broth (appendix 1.1.2) and incubated for 48 h at 37°C. P- 
galactosidase activity was detected by the development of a yellow colour.
39
Chapter 2__________________________________________________________________
2.1.8. Ornithine decarboxylation
M oeller decarboxylase broth (BD Biosciences-Life Research) was prepared, with and without L- 
ornithine (Sigma, Co. Ltd, Poole, Dorset, UK), according to the manufacturer’s instructions, and 
dispensed aseptically in 3 ml volumes into bijous. Bacterial suspensions, prepared as described 
under section 2.1.6., were inoculated in 0.4 ml volumes into the decarboxylase broths. The cultures 
were then overlaid with 1 ml of sterile mineral oil, and incubated for 7 d at 37°C. Ornithine 
decarboxylation was detected when media changed purple.
2.1.9. Capsule characterisation
Determination of P  multocida  capsular types was performed using hyaluronidase (capsular type A) 
(Carter and Rundell, 1975) and acriflavine tests (capsular type D) (Carter et al, 1973; Rimler 1994). 
The former test identified type A strains by growth restriction due to the depolymerisation of 
capsular hyaluronic acid by hyaluronidase. Tests for enzyme decapsulation activity were carried out 
using a disc diffusion technique, whereby a culture was streaked on to the surface of a dextrose 
starch agar plate, and a sterile filter paper disc placed over the streaked area. A 20 pi volume of 
filter-sterilised hyaluronidase solution (3 units (U) hyaluronidase and 0.02M  PBS pH 7) was added 
to the disc and cultures incubated for 18-24 h at 37°C. Decapsulation was shown by a clear circular 
zone of colony forms that surrounded the disc (Rimler 1994).The latter test identified type D strains 
by the production of a heavy flocculent precipitate following the addition of a 0 .1  % (w/v) aqueous 
solution of acriflavine to a concentrated broth culture (Carter et al, 1973).
2.2. Molecular characterisation of P. multocida
2.2.1. Pulsed-field gel electrophoresis
An initial study was performed to determine the most appropriate restriction endonuclease for 
Pasteurella spp. Apal proved to be more suitable than D ral, producing well-defined profiles of 
bacterial DNA, in agreement with a previously reported observation (Lainson et at., 2002).
Suspensions o f pure cultures were diluted in 1.5 ml phosphate buffered saline (PBS), to a culture 
density of McFarland 2.5 (approximately equivalent to 7.5 x 10® cfu ml"'). Conditions for the 
digestion of chromosomal DNA using Apal were those used by Lainson et al., (2002), with slight 
modifications. Briefly, cells were harvested by centrifugation at 11, 340 x g for 10 min at RT. 
Supernatant fractions were discarded, and bacterial pellets were washed four times with Pett IV
40
Chapter 2__________________________________________________________________
buffer (appendix 1.3.1); subsequently, bacteria were resuspended in 0.5 ml of Pett IV buffer. Cells 
were warmed for 30 min at 40°C and suspensions were mixed with equal volumes of 2 % (w/v) 
low gelling temperature agarose (Promega, Madison WI, USA) (appendix 1.3.10) and dispensed 
into plug moulds (Bio-Rad Laboratories, Hemel Hempstead, UK); 3 plugs were made per strain 
and digested in 5 ml of EC lysis buffer (appendix 1.3.2) containing lysozyme to lyse the bacterial 
cell wall, at 37°C for 24 h. Following proteinase K  (100 p,g ml ' Sigma) digestion of bacterial 
proteins in 3 ml ESP buffer (appendix 1.3.3) at 50°C for 60 h, plugs were incubated at RT for 30 
min in 5 ml of TE buffer (appendix 1.3.4) containing 0.1 M  PM SF (Sigma) (appendix 1.3.5). The 
plugs were then washed with 8  x 5 ml Tris-BDTA (appendix 1.3.8 and 1.3.9) on a shaker at RT for 
15 min each. Four mm sections (inserts) were cut from the plugs and equilibrated in distilled water 
(DW) containing 1 x A pal digestion buffer (Promega) and 10 mg ml ' BSA (Promega) final 
concentrations for 1 h at RT. Subsequently the inserts were digested in equilibration buffer 
containing 20U of Apal (Promega), at 30°C for 48 h. Plugs were then washed in 1 ml of TE bulfer 
(appendix 1.3.4) for 15 min, then loaded onto 1 % (w/v) agarose gels (Promega) (appendix 1.3.11). 
Lambda DNA 340 ladder PFGE markers (New England BioLabs Inc, USA) were included as 
molecular weight standards.
Electrophoresis was carried out in TBE buffer (appendix 1.3.7) on the BioRad CHEF DRII system 
at 14°C and 6 v cm"', with an initial switch time of 1 s increasing to a final switch time of 40 s for a 
duration of 23 h. Gels were then stained at RT using 100 p.1 of 0.25g ml"' ethidium bromide 
(Promega) mixed with 250 ml DW  for 45 min and were washed in DW  for 20 min at RT with 
gentle shaking. Banding patterns were recorded using an Image M aster Video Display System 
(Pharmacia, Amersham Biotech, Buckinghamshire, England).
2.2.2. Identification of P. multocida by PCR
p. multocida in bovine nasal swabs was identified by PCR, using primers specific for the km tl gene 
that encodes a protein involved in the synthesis of capsular polysaccharide. Conditions for the 
detection of P. multocida were those used by Townsend et a i ,  (2001).
2 .2 .2 .1. B acteria l D N A  extraction  f o r  P C R
Loopfuls of bacterial growth taken from  SBA plates, were resuspended in 250 p,l o f nuclease-free 
water, and incubated at 99°C for 10 min to lyse the bacterial cells. The bacterial lysates were 
cooled at -20°C for 5 min and centrifuged at 3, 000 x g for 10 min at RT. A distinct layer was then 
detected containing bacterial genomic DNA which was removed and stored at -20°C or analysed 
directly by PCR.
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2.2 .2 .2 . P C R  cond itions
The P. multocida specific PCR primers, km tlt?  (5’-ATCCGCTATTTACCCAGTGG-3’) and 
km tlspô  (5’-GCTGTAAACGAACTCGCCAC-3'), were designed to amplify a 460bp fragment of 
the km tl gene (Townsend et a l ,  2001). 2.5 pi aliquots of extracted P. multocida DNA were 
resuspended in 25 pi o f PCR amplification mixture, consisting of P. multocida  specific primer at a 
concentration of 1 pM  (Invitrogen Ltd, Inchinnan Business Park, Paisley, UK), with each 
deoxynucleoside triphosphate at a concentration of 200 pM  (Invitrogen), 1 x PCR buffer 
(Promega), 1.5 mM MgCU (Promega), and 1 U of Taq DNA polymerase (Promega). In addition, all 
modifying enzymes (including restriction endonucleases and DNA polymerases) were purchased 
from Promega, unless stated otherwise. All thermal cycling was performed in a Thermo Hybaid 
PCR system Px2 (Thermo Life Sciences, Edison Rd, Hampshire, UK) under the following 
conditions: initial dénaturation at 95°C for 5 min, followed by 30 cycles of dénaturation at 95°C for 
30 s, annealing at 55°C for 30 s, extension at 72°C for 30 s, and a final extension at 72°C for 5 min.
2.3. Characterisation of P. multocida lipopolysaecharide
2.3.1. Phenol-hot water micro-extraction of bacterial LPS
Single P. multocida colonies were inoculated into 10 ml of NB that were incubated statically 
overnight at 37°C. Cells were harvested by centrifugation at 2, 000 x g for 30 min at 20®C. 
Subsequently, cells were washed twice in 20 ml of PBS and resuspended in 500 pi pyrogen-free 
water. Five hundred pi o f 90 % (w/v) aqueous phenol was added to each sample. The mixture was 
vortexed for 10 s, heated in a water bath at 70°C for 10 min, vortexed once, cooled on ice for 2 
min, and then centrifuged at 3, 000 x g for 4 min at RT (Westphal and Jann, 1965). The clear upper 
aqueous layer, containing LPS, was either stored at -20°C or analysed directly by sodium dodecyl 
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot.
2.3.2. SDS-Polyacrylamide LPS Gels
LPS species of different molecular weights were separated by discontinuous SDS-PAGE using 1.0 
mm thick pre-cast 12% (w/v) aery 1 amide /  bis-acrylamide gels (NuPAGE gel system, Invitrogen). 
Smooth LPS extracted from E. coli serotype 055:B 5 (Sigma) was used as a positive control 
alongside molecular weight standards of 3-188 kDa (SeeBluePlus2; Invitrogen), which covered the 
expected range of LPS masses. The pre-stained markers also provided immediate visual 
confirmation of successful immunoblot transfer. Equal volumes of LPS extract and NuPAGE
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sample buffer were mixed, boiled for 5 min and loaded at 3 pi per well. Electrophoresis took place 
at 200V (70-80mA) for approximately 35 min, at RT, until the dye front reached the bottom of the 
gel.
2.3.3. Characterisation of LPS by Silver stain
LPS bands were silver stained (SilverQuest™ silver staining kit, Invitrogen). The methods applied 
for the running and silver staining of LPS polyacrylamide gels are more rapid, reliable and 
reproducible than those described by Uchida and Mizushima, (1987) and Tsai and Frasch, (1982). 
All incubations were performed on a rotary shaker (1 revolution s ') at RT. Volumes were 100 ml 
unless otherwise stated. Gels were submerged in fixative solution (proprietary formulation) for 20 
min, then washed in 30 % (v/v) ethanol for 10 min. Sensitising solution 30 % (v/v) ethanol, 10 % 
(v/v) sensitiser; (proprietaiy formulation) was added for 1 0  min, before gels were washed again in 
30 % (v/v) ethanol followed by DW  for a further 10 min. Staining solution 1 % (v/v) (proprietary 
formulation) was added to gels for 15 min, and, subsequently, gels were washed with ultra pure 
water for 20-60 s. Gels were then incubated in developing solution 10 % (v/v) (proprietary 
formulation), with the duration of incubation being determined by the differential staining intensity 
o f the background and LPS in the gel. Once the desired stain was obtained 10 ml of stopper 
solution (proprietary formulation) was added. LPS bands were designated upwards from 1, 
equivalent to the lowest molecular weight species.
2.3.4. Immunoblotting
Electrophoretically separated LPS species were transferred onto nitrocellulose membranes 
(Schleicher & Schuell, Dassel, Germany) using a Trans blot semi-dry transfer cell system (Bio-Rad 
Laboratories) at 70 mA per gel for 2 h at RT in Tris-glycine buffer (Sigma) (transfer buffer, 
appendix 1.4.1). Conditions for the detection of LPS bands were modified from the method of 
Lacroix et al., 1993. Transfer membranes were immersed in a high salt blocking buffer (0.5 M 
NaCl-PBS pH 7.0, 0.5 % (v/v) Tween-80 [PBS-Tween]) (appendix 1.4.2) for 1 h at RT (Huntley et 
al., 2001). M embrane-bound LPS was probed for 1 h at RT with the following polyclonal antisera 
diluted in blocking buffer: Bovine anti-P multocida  immune serum (1:200), and rabbit anti-P 
multocida immune serum (1:40). After four washes in a high salt blocking buffer, membranes were 
incubated for I h at RT with the appropriate horseradish peroxidase (HRP)-conjugated sheep anti- 
bovine IgG or anti-rabbit IgG (Serotec, Kidlington, Oxford, UK) at a 1/1000 dilution in blocking 
buffer, depending upon the species from which the primary antiserum was derived. Immunoblots 
were then washed four times in blocking buffer and freshly prepared DAB HRP substrate (Sigma)
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(appendix 1.4.5) was added. Once the desired staining was obtained D W  was added to stop the 
colourimetric reaction.
2.4. Preparation of Pasteurella multocida antigens for in 
vitro studies
An isolate of P. multocida (MRI reference 619/90) was retrieved in 1990 from the lung of a calf 
challenged with a mixture of five P. multocida  isolates recovered from  field cases of BPR The 
isolate was passaged through another calf to confirm its virulence and stored in NB at -70°C. This 
freshly passaged isolate (MRI reference 671/90), confirmed by somatic typing (VLA, Edinburgh) 
as P. multocida  A;3, was used as the challenge isolate for this study. PFGE analysis (Kodjo et al., 
1999) was used to compare the DNA content of the challenge isolate with that of bacteria recovered 
from infected tissue.
A 10 ml starter culture of P. multocida M RI-671/90, was prepared by resuscitating a stored culture 
and isolating pure colonies for inoculation in 10 ml of NB. This 10 ml starter culture was incubated 
at 37°C overnight for 16 h and then inoculated into 1, 200 ml of NB. This culture was placed on a 
rotary shaker at 100 rpm  for 4 h 30 min at 37°C to obtain a log phase culture that was then 
centrifuged at 3976 x g, for 30 min at 4°C. Most of the supernatant fraction was poured off and the 
remainder was used to resuspend the cell pellet. The pellet was spun down at 2040 x g, for 30 min 
at 4°C, washed and resuspended twice in PBS, The final cell pellet was resuspended in 20 ml of a 
10 mM Tris solution at pH 7.6 (appendix 1.3.9) containing 200 |il 10 mg ml"' PM SF (in ethanol), as 
a protease inhibitor. The pellet and diluent were stored overnight at 4°C.
The whole cell suspension was sonicated in a glass universal for 5 x 30 s bursts, cooling on ice 
between each burst. This was repeated until the sonicate was clear, whereupon unbroken cells were 
then removed by centrifugation at 2040 x g at 4°C for 30 min. The pellet was discarded and the 
supernatant fraction transferred to 4 x 5 ml 70-Ti ultracentrifuge tubes (Beckman Coulter Life 
Sciences, Fullerton, CA, USA). The supernatant fraction was centrifuged at 82600 x g at 4°C for 1 
h 30 min. The pellets were separated from the supernatant fractions, pooled, washed and 
resuspended in 6  ml of a 10 mM Tris solution. The resuspended preparation was centrifuged at 
191940 X g for 45 min, at 4°C. The supernatant fraction was discarded and the final pellet 
comprising cell envelopes was resuspended in 2 ml of a 10 mM Tris solution at pH 7.6 and stored 
at -20°C.
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2.5. Antiserum production for P. multocida LPS 
characterisation
2.5.1. Generation of rabbit anti-P multocida hyperimmune sera
Rabbits of either sex, between the ages of 4-6 months, bred at MRI, were used to raise 
hyperimmune serum against formalin-killed P. multocida (serotype A:3 isolate 671/90). A stored (- 
70‘^ C) vial of P. multocida (671/90) was plated out onto SBA plates and incubated overnight at 
37°C in a moist chamber. Growth from the plate was harvested with 10 ml of saline using a plastic 
loop and cells centrifuged and washed once in 10 ml of saline. Washed cells were resuspended in 
saline containing 0.3 % (v/v) formalin, and adjusted to give a final concentration of 10'' cfu ml ' 
and stored at 4°C until time of challenge.
Pre-immunisation blood samples were taken from a marginal ear vein of each rabbit, and tested for 
the presence of pre-existing antibodies by immunoblotting and enzyme-linked immunosorbent 
assay (ELISA). Immunisations were carried out according to the schedule in Table 2.1. Three days 
after the last immunisation, rabbits were euthanased with 3 ml (0.6 ml kg ') of Pentobarbitone 
Sodium B.P. (200 mg ml '; Animal Care, Lancaster, UK) intravenously (i.v.), and exsanguinated by 
cardiac puncture. Blood was allowed to clot at RT overnight. Serum was separated by 
centrifugation and stored in 5 ml aliquots at -20°C.
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Table 2.1. Immunisation schedule for the production of hyperimmune serum.
Day Treatment
1 Pre-immunisation blood sample
2 0.5 ml subcutaneously at one site
4 1 .0  ml subcutaneously at one site
7 2 .0  ml subcutaneously at one site
10, 13, 16, 19, 22, 25 2 .0  ml intravenously
32 Trial bleed
35 Exsanguination
2.5.2. Generation of bovine anti-P multocida hyperimmune sera
Bull calves at 8  weeks of age were used to raise hyperimmune serum against live P. multocida 
(serotype A:3 isolate M RI-671/90 challenge strain, Chapter 4). Carriage of, or prior exposure to, P. 
multocida was checked by the culture of nasal swabs on vancomycin (1 mg ml"'. Sigma) SBA 
plates (appendix 1.2.2) and analysis of antibody to P. multocida by ELISA, respectively. Calves 
were challenged intratracheally via a bronchoscope with 300 ml of PBS containing 10^ cfu ml"' of 
P. multocida (section 2.8.4).
Six to fourteen hours after challenge, calves were given 5 ml long-acting tetracycline 
intramuscularly (1 ml 10 kg ': 200 mg ml"') (Intervet UK Ltd, Cambridge, UK) along with 2.5 ml 
o f a non-steroidal anti-inflammatory drug, flunixin meglumine (2.2 mg k g ':  2 ml 45 k g ')  
(Schering-Plough Animal Health, Uxbridge, Middlesex, UK) administered i.v., after antibiotic to 
prevent overt disease and undue suffering to the animals. Blood samples were taken 21 days after 
challenge and ELISA and immunoblot analyses were used to assess titres. Calves were re­
challenged because of low titres and for ethical reasons a lower volume (lO" cfu P. multocida in 60 
ml PBS) was used. At 28 d post re-challenge, the calves were euthanased with 25 ml of 
Pentobarbitone Sodium B.P. (200 mg ml"'; Animal Care), and antisera were collected.
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2.6, Serology
2.6.1. Blood sampling
Jugular vein blood samples (9 ml) were collected into chilled vacutainers (Becton Dickinson, 
Cowley, Oxford, UK) containing 1 ml ethylenediaminetetraacetic acid (EDTA) (appendix 1.9.1) 
from all calves on day of arrival, the day of challenge (day 0), 4 h p.c. and daily thereafter until the 
day of necropsy. Plasma was separated and stored at - 40°C until analysis for APP (Hp, AGP and 
SAA), IgG, and plasma antibody to parainfluenza virus type-3 (PI-3), respiratory syncitial virus 
(RSV), infectious bovine rhinotracheitis virus (IBRV) and bovine viral diarrhea virus (BVDV).
2.6.2. Detection of acute phase proteins
2.6 .2 .1 . H ap tog lob in
Plasma Hp concentrations were determined using the Phase ™ haptoglobin-haemoglobin binding 
assay (Tridelta Ltd, Greystones, Ireland) (Eckersall et al., 1999). This is a non-species specific 
colorimetric assay that uses a peroxidase substrate to prevent non-specific binding between serum 
proteins and haemoglobin (Hb), without altering the binding affinity between Hb and Hp. Unbound 
Hb exhibits peroxidase activity, which is inhibited at a low pH. Hp present in the sample will form 
a complex readily with haemoglobin under these pH conditions. As the amount of Hp rises, amount 
o f Hb-Hp complex is enhanced with a simultaneous increase in peroxidase activity. Hp levels in 
either plasma or serum can therefore be established directly when compared against standards 
prepared from a range of known concentrations of Hp. In duplicate, 7.5 |xl of each prepared 
calibrator (0, 0.5 and 2 mg ml"') along with test specimen was transferred to a fresh microplate. 100 
jul of Reagent 1 (equal volumes of Haemoglobin (v/v) and Haemoglobin diluent (v/v)) was added 
to each well and the plate tapped to ensure that calibrators/specimens and haemoglobin were 
mixed. Shortly after 140 pi of Reagent 2 (Chromagen and substrate mixed in a ratio of 9:5) was 
added to each well and the plate incubated for 5 m at RT and read immediately at 630 nm. A 
calibration curve was generated by plotting absorbance (630 nm) versus Hp concentration (mg ml' 
') to facilitate the calculation of the haptoglobin concentration in test samples. Test values were 
read from the curve and multiplied by an appropriate factor if dilution had been required. The 
normal range of haptoglobin in the bovine is between 0 and 0.5 mg ml ' and the acute range is 
between 0.5 and 3 mg ml"'.
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2.6 .2 .2 . Serum  A m ylo id -A
Plasma concentrations of SAA were determined using the Phase range ELISA SAA kit (Tridelta 
Ltd Greystones, Ireland) that employs a monoclonal antibody specific for SAA coated onto 
microtitre well strips. Diluted test samples or standards of known SAA content (300, 150, 75, 37.5, 
18.8, 0 ng m b') were added to the wells and a second biotinylated anti-SAA monoclonal antibody 
added. The immobilised antibody bound SAA present in the well, where it was detected with the 
conjugate antibody. After washing, to remove unbound material, Streptavidin-HRP conjugate was 
added, the plate incubated for 30 min at RT, in the dark and 3,3,5,5-tetramethylbenzidine solution 
(TMB) substrate solution added. After stopping the reaction with H 2SO4 the absorbance at 450 nm 
was measured and SAA concentration derived by comparison to the standards.
2 .6 .2 3 . Œ} A c id  g lycopro tein
The AGP concentrations in plasma were measured using a radial immunodiffusion kit (Saikin 
Kagaku Institute, Japan). Each test sample (5 pi) was placed in an individual test well. As the 
sample diffused from the well into the agar gel containing specific anti serum to bovine « lA Q  a 
precipitin reaction occurred and a ring was produced, with the radius proportional directly to the 
concentration of a iA G  in the test sample. The concentration was computed by reference to two 
known standard solutions of ajA G  at concentrations of 250 pg ml ' and 1000 pg ml"'.
2.6.3. Detection of serum IgG
ELISA plates were coated with 50 pi per well of P. multocida A :3 envelope at 1/100 dilution in 
carbonate-bicarbonate buffer pH 9.6 (appendix 1.5.1) and left at 4°C overnight. The plate was then 
washed 3 times with ELISA wash buffer (appendix 1.5.2) to remove any unbound envelope protein. 
The plate was blocked with 200 pi per well of a high salt blocking buffer (0.5 M NaCl-PBS, pH 
7.0, in 0.5% (v/v) Tween-80 {Sigma}) (appendix 1.4.2) for 1 h at 37°C (Huntley et a l ,  2001). This 
stage was to prevent subsequent non-specific binding of uniformly diluted antisera to the well 
surface. After washing a further three times with ELISA wash buffer, test and standard sera were 
added to 1 0 0  pi volumes, in duplicate to antigen coated wells, and to one uncoated well to estimate 
the extent of any non-specific antibody binding. The standard positive convalescent and negative 
sera were used at a dilution of 1/ 1 0 0 , while during a preliminary study, the test sera were titrated 
from 1/50 to 1/6400, much variation amongst animals was noted. Therefore an arbitrary dilution of 
1/100 was implemented for the detection of test serum IgG raised to P. multocida A:3. Plates were 
washed with ELISA wash buffer and sheep anti-bovine IgG-HRP conjugate (Serotec, Oxford, UK) 
added (1/1000) to each well before incubation for 1 h at 37°C. After washing, 50 pi of the substrate
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((9-phenylenediamine (OPD) and hydrogen peroxide (H2O2), appendix 1.5.5) was added to each 
well and the plate incubated for 5 min at RT. The reaction was stopped by the addition of 2.5 M 
H2SO4 (appendix 1.5.6) and optical density (O.D) in the wells read at 492 nm.
2,6.4. Detection of respiratory viral antibodies
The measurement o f virus specific IgG levels in bovine plasma used an ELISA combining the 
following viral antigens: PI-3, RSV, BVDV and IBRV in a single test microplate format. All viral 
antigens except for RSV which was isolated from the Rispoval vaccine (Pfizer, UK) originated 
from  local Scottish bovine isolates. Bound antibody was detected subsequently by the reaction of 
an anti-bovine HRP-conjugate followed by the addition of a substrate, either OPD or TMB.
The ELISA method used to test the presence of viral antibodies in experimental samples was 
adopted from Caldow et a l ,  (1988) with slight modifications. The appropriate viral antigens were 
diluted in 0.05 M carbonate buffer (pH 9.6) and 100 pi was added per well to the microtitre plate 
(Greiner bio-one Ltd, Stonehouse, Gloucester, UK) which was incubated overnight at 4°C in a 
humidified chamber. Coated plates stored at 4°C were used up to 5 d after coating with antigen. 
Plates were washed with PBS-Tween (0 .0IM  PBS and 0.1 M EDTA in 0.05 % Tween-20). Plasma 
samples were diluted 1/50 in ELISA diluent (PBST-0.5 % (v/v) ovalbumin (appendix 1.6.1) and 
mixed thoroughly. The control sera were also diluted 1/50 in PB ST- 0.5 % (v/v) ovalbumin ELISA 
diluent. Control and experimental samples were loaded onto the ELISA plate, 4 wells per sample at 
100 pi per well and incubated for 1 h at 37°C in a humidified chamber. After washing, bound 
antibody was detected by the addition of rabbit anti-bovine IgG HRP-conjugate at 1/3000, 1/6000, 
1/2000, 1/4000 dilution for BVDV, IBRV, RSV and PI-3, respectively (Sigma) for 1 h at 37°C in a 
humidified chamber, followed by washing and the addition of the substrate OPD (Sigma) (0.8 mg 
m b') in substrate buffer (appendix 1 .6 .2 ) with 30 % (v/v) H 2O2. The colour reaction was measured 
on a Dynex M RX microplate reader (Dynex technologies, Ashford, Middlesex, UK) at a 
wavelength of 492 nm. The results were expressed in OD units as mentioned earlier and adjusted in 
accordance with a standard curve determined for each test. The ELISA was calibrated so that an 
OD reading > 0 .1  was regarded as specific antibody positive.
2.7. Proteomics-2D-Electrophoresis
All reagents within this section were purchased from Amersham Pharmacia Biotech UK Ltd, 
Buckinghamshire, England, unless stated otherwise.
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2.7.1. BAL sample preparation
A 10 mi volume of supernatant fraction recovered by bronchoalveolar lavage (BAL) (section 
2.9.1), was desalted by placing the sample in 10 cm of snakeskin dialysis tubing (Pierce 
Biotechnology Inc, Rockford, IL, USA) and dialysing against 3 changes of DW for 24 h at 4°C. 
The desalted solution was concentrated down to approximately 1 ml using Spectra/Gel absorbent 
(Spectrum Labs, Medicell, UK). The 1 ml of solution was dried using a freeze dryer (Edwards 12K 
Supermodulyo, Alpha Laboratories Ltd, Hampshire, UK). The lyophilised powder was dissolved in 
200 |xl of rehydration buffer (appendix 1.7.1) and protein content was determined using a 2-D 
Quant protein assay kit.
2.7.2. Quantification of protein in BAL fiuid samples
The PlusOne 2-D Quant Protein assay kit was used to determine the concentration of protein 
present in the sample. The assay was performed according to m anufacturer’s instructions. The 2-D 
Quant kit uses a combination of precipitant and co-precipitant to precipitate quantitatively the 
sample protein. The protein is sedimented by centrifugation and resuspended in a solution of cupric 
ions. These ions bind to the polypeptide backbone of protein and any unbound cupric ions (Cu^^) 
then react with the colourimetric agent (proprietary formulation). The colour density is inversely 
related to the concentration of protein in the sample (PlusOne 2-D Quant Kit protocol). All o f the 
solutions (precipitant, co-precipitant, copper solution, colour reagents A and B) described in this 
procedure were included in the 2-D Quant Kit and all reactions were performed at RT unless stated 
otherwise.
10 juil of protein solution, in rehydration buffer was assayed using the protocol described. The 
absorbance of each sample was read at 490 nm using a microplate reader (Dynex M R X II Endosafe 
Ltd, Kent, UK) and the concentration of protein in each sample was determined from the standard 
curve. From  the results, samples were diluted with rehydration buffer to a concentration of 100 fig 
of protein in 200 pi. Preliminary results suggested that 100 pg of BAL proteins were well 
differentiated by 2-DE when staining with colloidal Coomassie blue stain (Genomics Solutions, 
Ann Arbor, MI, USA).
2.7.3. First dimension electrophoresis; Isoelectric focusing of sample
Prior to isoelectric focusing (lEF), 40 mM dithiothreitol (DTT) and immobilised pH gradient (IPG)
buffer (3-10) (propriety formulation) were added to the samples to give final concentrations of 0.28
% (w/v) and 0.5 % (v/v), respectively. lE F  was used as the first dimension to separate proteins
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according to their isoelectric points (pi) and was performed on an IPGphor lEF system. The 
procedure was as follows: 1 0 0  pg of protein in 2 0 0  pi of rehydration buffer was placed in an 11 cm 
ceramic strip holder and an 11 cm IPG gel strip, pH range 3-10, was placed gel-side down on top of 
the solution. PlusOne dry strip cover fluid was placed over the IPG strip and used to fill the rest of 
the strip holder to prevent the strip from drying out during lEF. The ceramic holders were then 
loaded onto the IPG phor and the strips rehydrated for 12 h at 20°C. They were then subjected to 
lEF by means of a series of increasing voltage steps; 100 V for 2 h, 500 V for 1 h, 1000 V for 1 h, 
2500 V for 1 h and 8000 V up to 38.8 kVh. According to Strahler et al., (1988) the increasing 
voltage gradient allows the separation of samples independent of varying salt concentrations. Once 
the strips were electrofocused they were stored either at -80°C or prepared directly for 2- 
dimensional electrophoresis (2-DE).
2.7.4. Second-dimension electrophoresis; SDS-Polyacrylamide gel 
electrophoresis of the isoelectrically separated sample
The 11 cm strips were equilibrated in 7 ml of equilibration buffer (appendix 1.7.2) containing 70 
mg of DTT for 15 min at RT on a shaker. The solution was decanted and the strips were 
equilibrated for a further 15 min in 7 ml of equilibration buffer containing 280 mg of 
iodoacetamide (Sigma). During equilibration of the IPG strip, the M ultiphor II flatbed system was 
prepared for 2-DE. The temperature was set to 15°C on the MultiTemp III Thermostatic Circulator 
and 2 ml of IPG cover fluid was pipetted onto the Multiphor II cooling plate prior to addition of the 
2-D Gel. The strips were left on a paper towel to remove as much of the equilibration solution as 
possible without over-drying. A 12.5 % (w/v) homogeneous 2D-ExcelGel was used to separate the 
proteins according to their molecular weights with gel buffer strips placed on either side of the gel 
as contacts between the gel and the electrodes. Two 11 cm IPG strips were placed on each Excel 
Gel and a piece of application paper (0.5 x 0.5 cm) containing 15 |xl of molecular weight standards 
(Mark 12 MW: Invitrogen) was placed between the two IPG strips. Electrophoresis was performed 
at 20 mA / 600 V until the bromophenol blue had moved out of the IPG strips after which the IPG 
strips were discarded and the cathode buffer strip moved over to the position previously occupied 
by the IPG strips, and the electrode moved to the new location of the cathode buffer strip. The 
current was increased to 40 mA and the run was continued until the dye front reached the anode 
buffer strip.
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2.7.5. Detection of protein by colloidal Coomassie blue
After electrophoresis, gels were removed from the M ultiphor and fixed in a solution of 40 % (v/v) 
methanol, 10 % (v/v) acetic acid, 50 % DW  for 2 h at RT on a shaker. A staining solution was 
prepared from 320 ml of colloidal Coomassie blue stain (Genomics Solutions) mixed with 80 ml of 
methanol. The fixing solution was drained off and the staining solution was added overnight. 
Coomassie blue binds to the proteins stoichiometrically. A disadvantage of Coomassie staining is 
its relatively insensitive detection limit. This limitation was catered for by ensuring that an 
adequate amount of protein was present during sample preparation. Following colloidal Coomassie 
blue staining, gels were placed in 25 % (v/v) methanol to decrease background staining, and 
destaining was performed twice for 30 m on each occasion or until excess stain had leached out 
from  the gel. Subsequently, gel images were captured using an Image scanner and analysed using 
the ImageMaster 2D Elite software (Amersham Pharmacia). This program provides essential tools 
for automatic protein spot detection, quantification of spot density and allows equivalent spots to 
be matched between different gels.
2.7.6. Protein identification by matrix assisted laser desorption 
ionisation time of flight (MALDI-TOF) mass spectrometry
Following analysis of 2-D gels, spots were excised for further characterisation by MALDI-TOF. 
This is a highly sensitive (femtamole level) technique, performed on a Voyager-DE PRO mass 
spectrometer (Applied Biosystems, CA, USA). It can detect and characterise biomolecules such as 
proteins, peptides, oligosaccharides and oligonucleotides with molecular masses between 400 and 
300,000 Da. Protein identification by this technique is rapid and requires only a small amount of 
sample (less than 1 p mol). The biomolecule is fixed in an UV-light absorbing matrix, oc-cyano-4- 
hydroxycinnamic acid (CHCA), onto a target plate that is placed in the mass spectrometer. A 
nanosecond laser pulse irradiates the sample spot. Most of the laser energy is absorbed by the 
matrix, preventing unwanted fragmentation of the biomolecule. An electrical field confers the same 
kinetic energy on the ionised peptides so that they pass down a field-free flight tube under vacuum 
according to their mass to charge ratio and reach the detector plate at the end of the flight tube at 
proportionately different times. In this way each molecule yields a distinct signal and the 
percentage incidence of each ion will be unique for each trypsin digested protein analysed by 
MALDI mass spectrometry (MS). The masses of the peptides can be determined by reference to 
calibration peptides.
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2 .7.6.1. Trypsin d igestion  o f  p ro te in s  in 2 D E  gels f o r  M A L D I-T O F
Prior to M ALDI-TOF it was necessary to fragment proteins with trypsin (a proteolytic enzyme that 
cleaves proteins after the amino acid lysine to produce peptides) digestion, so that the mass of each 
fragment could then be determined by mass spectrometry. The Moredun Functional Genomics Unit 
provided the protocol for in-gel trypsin digestion of proteins, and all steps were performed at RT 
unless stated otherwise. The spots of interest from 2-D gels were excised manually using a spot 
picking pen (The Gel Company, San Fransisco, CA) which ensured that no excess gel around the 
spot was extracted. Meticulous care was taken to avoid keratin contamination (from skin) by 
cleaning the spot picking pen (The Gel Company) with methanol between each excision and gloves 
were worn throughout the procedure. The excised spots were placed into sterile 1.5 ml siliconised 
microfuge tubes (Anachem Ltd, Luton, UK), covered with 100 mM ammonium bicarbonate / 50 % 
(v/v) acetonitrile, and incubated for 15 min. These destaining and dehydrating reagents 
respectively, were discarded and this step was repeated until the colloidal Coomassie blue stain 
(Genomics Solutions) had been removed from the gel spots. Gel pieces were dehydrated with 100 
% acetonitrile (Sigma) for 10 min and then dried by centrifugal evaporation using a Speed Vac 
(Savant Instruments Inc, Hicksville, NY) for 20 min at RT.
Sequencing grade trypsin (Promega) was dissolved in 25 mM ammonium bicarbonate to a 
concentration of 10 ng jil '. Just enough trypsin solution was added to cover and rehydrate gel 
pieces, which were left to stand for 15 min. Following rehydration, 25 mM ammonium bicarbonate 
was added to the microfuge tubes in order to cover the gel pieces. The tubes were incubated at 
37°C for at least 16 h. Following protein digestion supernatants containing peptides of interest were 
either stored at -20°C  or 0.5 |l i 1 aliquots were taken for analysis by M ALDI-TOF MS.
2.7 .6 .2 . M A L D I-T O F  M S
Equal volumes (0.5 p,l) of peptide digest and 10 mg ml'^ of CHCA matrix (Ciphergen Biosystems, 
Inc, Fremont, CA) suspended in 50 % (v/v) acetonitrile /  0.1 % (v/v) trifluoroacetic acid (TEA) 
were applied to the designated circle on the target plate and left to dry. Standards of a known 
molecular mass were spotted in 0.25 p,l volumes on the top right hand side of the designated circle 
for calibration. The standards were left to dry and then automated MS was performed.
2.7.7. Database search
An online database constructed by a Swiss proteomics company (Swiss-Prot) contains 
“fingerprints” comprising the peptide masses generated by trypsin digestion of known proteins. 
Comparison of the fingerprints obtained from MALDI-TOF MS with the fingerprints on the Swiss-
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Prot database was used to identify proteins of interest detected in the BAL samples. An equivalent 
database with which to identify P. multocida proteins in lung fluid was available following recent 
sequencing of the entire genome of a turkey capsular serotype A strain (Pm70) of P. multocida 
(May et al., 2001).
2.8, Animal experiments
2.8.1. Animals
Calves used in experiments were Holstein x Friesian of both sexes and were bred at farms within 
the M idlothian region. Calves were 8 weeks old at the start of the experiments.
2.8.2. Culture conditions of live P. multocida
Stored cultures, thawed and plated onto 5 % (v/v) SBA (appendix 1.2.1), were incubated at 37°C 
overnight to check purity and to observe growth of bacteria. Single colonies were picked from 
plates and inoculated into 10 ml of NB. After static incubation at 37°C for 16 h, 0.5 ml aliquots of 
culture were inoculated into further 10 ml aliquots of NB and the subcultures were transferred to a 
rotary shaker (Forma Scientific Inc, Ohio, USA) for 3.5 h.
Counts of viable bacteria were estimated by inoculating 4 x 2 0  pi volumes of ten-fold dilutions of 
the original bacterial suspension onto SBA and incubated overnight. The colonies from the sample 
dilution giving discernible colonies were counted and the mean count was multiplied by 50 and the 
dilution factor to obtain the viable counts m f \
2.8.3. Production of formalin-killed P multocida
0.5 ml of static overnight culture, in NB, at 37°C of the M RI-671/90 challenge strain was 
inoculated into 50 ml NB and placed on a rotary shaker for 4-6 h at 37°C. The total dose of 10^ cfu 
cells was centrifuged at 2,000 x g for 30 min at 20°C and killed by re-suspending in 0.3 % (v/v) 
formalin overnight at 4°C. The dead bacteria were washed in PBS to remove the formalin, 
centrifuged at 2,000 x g  for 20 min at 20°C and resuspended in 300 ml PBS. The formalin-killed P. 
multocida  suspension was streaked out onto 5 % (v/v) SBA at weekly intervals throughout the 
experiment to check for bacterial contaminants.
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2.8.4. Procedure for intratracheal challenge with P multocida
For challenge, calves were restrained whilst a fibre optic bronchoscope was inserted via a nostril 
into the trachea and the challenge instilled at the bronchial bifurcation. The two types of 
formulations, live and formalin-killed were delivered into the same calf, on different occasions via 
a sterile syringe attached to the bronchoscope and into the airway during which time calves were 
observed for any adverse effects of the challenge procedure itself. The bronchoscope was sterilised 
with weak chlorhexidine solution (Novartis Pharmaceuticals UK Ltd, Camberley, Surrey, UK) and 
rinsed with saline prior to re-use.
2.8.5. Clinical monitoring
Following challenge, calves were monitored at 4 h intervals for clinical signs of disease, using a 
scoring system similar to that established for sheep (Hodgson et al., 1995) in which 0 represented a 
normal state and higher scores represented increasing disease. Signs were scored as follows: 
demeanour (normal, dull, depressed, recumbent) 0-3; respiratory rate (<60, 60-80, 80-100 and 
>100) 0-3; nature of respiration (normal, increased effort, laboured, dyspnoea) 0-3; rectal 
temperature (38-39.5, 39.51-40.5 and >40.5 or <38) 0-2; nasal discharge (absent, mild, moderate, 
profuse) 0-3; appetite (normal, depressed, anorexic) 0-2. The maximum score possible was 16 but 
intervention was set at half this limit and any calf that developed acute respiratory problems and 
dullness with a score between 8 and 10 was killed to minimise the degree and duration of any 
suffering.
2.8,6. Necropsy
Calves were killed by intravenous injection with 25 ml of Pentobarbitone Sodium B.P. (200 mg ml' 
’; Animal Care) on day 4 p.c. The trachea was exposed and clamped to avoid intratracheal 
contamination with blood, lungs were removed and the presence, extent and nature of superficial 
lesions were determined using a method developed for sheep (Gilmour et al, 1983). Briefly, the 
percentage of affected whole lung surface area was calculated from diagrams produced during the 
PM examination, whereby various regions of the lung comprised a particular percentage according 
to their area (Fig. 2.1). In addition, the severity and extent of pleurisy associated with each lung 
was assigned a score between 0 and 3, three being the most severe.
Representative samples from lung, heart, liver, kidney, bronchiolar and mediastinal lymph node 
were placed in 10 % (v/v) formol-saline and prepared for histopathological examination by
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embedding in paraffin wax and cutting into 5 micron sections, followed by staining with 
haematoxylin and eosin.
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Chapter 2
2.8.7. Bacteriological examination
Small samples of tissue (approximately 1 cm cubes, about 1 g) taken from  four pre-selected lung 
sites (apical, intermediate, diaphragmatic and cardiac lobes) (Fig. 2 .1), bronchial lymph nodes, 
heart, spleen, liver and kidney were homogenised in 9 ml peptone water and diluted in 10-fold 
steps to 10^. Aliquots (10 jil) o f each dilution from 10'^ to 10  ^ were applied to SBA plates and 
incubated at 37°C for 16-20 h. Viable counts were determined and expressed as cfu g‘‘ of tissue.
2.9 . P h agocy tic  activ ity  o f  host defen ce cells
2.9.1. Bronchoalveolar lavage
Prior to PM  examination, calves were restrained while a flexible fibrescope was inserted via a 
nostril into the trachea, past the bronchial bifurcation and into the lower airways until resistance 
was felt. Two successive 60 ml aliquots of Ca^^, Mg "^^  indicator-free hanks balanced salt solution 
(HESS) (Sigma) at RT were infused into the alveolar space via a syringe attached to the 
bronchoscope. Dislodged cells were recovered by withdrawing the fluid from  the lungs into the 
syringe. The mean recovery of BAL fluid was approximately 60 % of the 120 ml instilled. Calves 
were monitored throughout and showed only moderate discomfort during the procedure.
2.9.2. Separation of alveolar macrophages and neutrophils from lung 
wash
The recovered fluid was separated into lung phagocyte cells and supernatant fractions by 
centrifugation at 470 x g for 10 min, at 5°C. The supernatant fractions were placed in a 75 cm^ 
culture flask, (Costar, USA), weighed and stored at -40°C prior to subsequent protein analysis. The 
pelleted fractions were washed once in 10 ml of Ca^”^, Mg '^^ indicator-free HESS (Sigma), then 
resuspended in 5 ml of isotonic Percoll (Amersham Pharmacia, Biotech, Ltd), diluted to a density 
of 1.075 g ml'*with HBSS and 10 ml of Percoll (density 1.055 g m f ’) (appendix 1.8.2) layered on 
top. The gradients were centrifuged at 1,200 x g for 15 m at 4°C to produce two bands; the pellicle 
(Band 1) contained approximately 90 % alveolar macrophages and the pellet (Band 2) comprised 
95 % neutrophils with some alveolar macrophages. Both cell types were harvested and washed 
twice in Ca^^, Mg '^^ indicator-free HBSS at 4°C or until the supernatant was clear.
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2.9.3. Viability of lung phagocytes
After the final wash cell pellets were resuspended in a weighed universal with 5 ml of Ca '^ ,^ Mg^ "^  
indicator-free HBSS and concentration and viability of the cells determined using a 
haemocytometer (ORME technologies, W hitbrook Way, Stakehill Industrial Park, Middleton, 
Manchester, UK) and a light microscope (Olympus Optical Co. Ltd, 2-8 Honduras street, London, 
UK) at X 40 magnification by counting the cells over 25 large squares from 10 p.1 of a 1/10 dilution 
of the macrophages or neutrophils in 0.1 % (w/v) nigrosin (appendix 1.8.1) (Fig. 2.2). The nigrosin 
enters dead cells through perforated cell membranes. Viable cells and percentage viability were 
determined as follows:-
Number o f live or dead cells per ml = (cells x 10 x 10^)
Viability = (Number of live cells/ total cell count) x 100
The total volume was obtained and the suspensions were diluted in HBSS to give a count of 2 x 10* 
live cells ml '
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Fig. 2.2. Counting grid present on haemocytometer for the accurate determination of live and dead 
cells within a given area.
1 2
5
'
3 4
Count 5 large squares
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2.9.4. Measurement of respiratory burst
Luminol-dependent chemiluminescence (LDCL) is a sensitive method for measuring changes in 
the oxidative metabolism of phagocytes. The chemiluminescence (CL) response of bovine alveolar 
macrophages and neutrophils undergoing phagocytosis was determined at ambient RT using a 
luminometer (Model TR717, PE Biosystems). Potential stimulants of the respiratory burst included 
a.) McCoys 5A medium, b.) P. multocida opsonised with bovine antiserum (section 2.9.5), c.) P. 
multocida  A:3, non-opsonised and d.) PMA with Ca^ "^  and Mg^ "^  which generates a high LDCL 
response as a standard for comparison within and between assays.
2 .9 Â .L  R eagen ts fo r  the lum inom eter
A  stock solution of luminol (5-amino-2,3-dihydro-1,4-phthalazinedione, Sigma) was prepared at a 
concentration of 2 mg ml ' in PBS and stored in 20 |il volumes in foil-wrapped eppendorf tubes at - 
20°C. Stock luminol was thawed and diluted 1/500 in Ca^^, Mg^^, indicator-free HBSS and warmed 
to 37°C immediately before use. A stock solution of PMA (Sigma) was prepared at a concentration 
of 10 mg ml"' and stored in 5 p.1 aliquots in eppendorfs at -20°C. The working reagent was prepared 
by diluting the stock PM A solution 1/2000 in Ca^^, Mg^^, indicator-free HBSS and also warmed to 
37°C immediately before use.
2.9.4.2. L u m in o l-dependen t chem ilum inescence  assay  (L D C L )
An in vitro assay based on LDCL measures the photons of light generated by the reaction between 
luminol and reactive oxygen intermediates (ROI) produced by neutrophils or macrophages during 
and after phagocytic stimulation (Richards and Renshaw, 1986). The light emitted is a product of 
the phagocytically induced respiratory burst associated with oxygen-dependent activation of the 
hexose monophosphate shunt (Chang et al., 1985). The respiratory burst uses molecular oxygen to 
produce ROI, used by the phagocyte for microbial killing (Briheim et al., 1984).
LDCL assays were performed using 100 pi of cells at 2 x 10* cells ml ' in triplicate in Dynex 
Microlite white opaque 96-well microplates (Dynex Technologies Ltd). All wells contained 
phagocytes and luminol and the incubation temperature in the luminometer was maintained at 
37°C. Microplates were incubated for 7 m before adding the pre-warmed stimuli to appropriate 
wells. Plates were placed in the luminometer and the phagocytic respiratory burst measured. 
Measurements were obtained over a 32 min period, at 37°C with a sample time of I s repeated 
every 30 s. The mean area under the CL curve, of relative light units (RLU) against time
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represented the amount of reactive intermediates produced, and the rate of the initial CL peak was 
measured when the phagocytes were stimulated.
2.9.5. Optimisation of the opsonisation procedure
This method was performed as described by Lagergard et al., (1995) with slight modifications. P. 
multocida were grown overnight and suspended at 1 x 10* cfu ml ' in McCoys 5A medium, with 
concentration determined using a MacFarland standard number and diluting with PBS if required. 
Bacteria in a 100 pi suspension at 1 x 10^  cfu were incubated with different volumes of heat 
inactivated hyperimmune bovine antiserum raised against P. multocida A:3 (20 pi, 40 pi, and 60 
pi), at 37°C for 15, 30, 45 and 60 min and harvested by centrifugation at 12,000 x g for 10 min. 
This preparation was dispensed into duplicate wells (100 pi) of a 96-well microplate containing 
100 pi of HRP-anti-bovine IgG conjugate at 1/1000 and incubated at 37°C for 30 min. After 
washing three times with PBS, OPD substrate was added (appendix 1.5.5) and incubated for 5 min 
at RT. The reaction with OPD was stopped by the addition of 50 pi 2.5M H2SO4 and absorbance 
was read at 490 nm. The absorbance in wells containing bacteria incubated with McCoys 5A 
medium served as background and was subtracted from those of the test samples.
3.5
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Fig. 2.3. A graph to determine the optimum volume of bovine antiserum and duration of incubation 
with P. multocida to achieve efficient opsonisation; 20 pi bovine antisera (♦ ) , 40 pi bovine antisera 
(■) and 60 pi bovine antisera (A).
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The graph (Fig. 2.3) indicated that 20 pi o f bovine antiserum raised to a live challenge of P. 
multocida incubated for 30 min with P. multocida was sufficient for optimal opsonisation. The 
shape of the 20 pi curve was more consistent than the others, but the problem with this assessment 
is with the time and volume so variable, the opsonisation may vary widely also.
2.9.6. Phagocytic capacity determined by the uptake and killing of P  
multocida in vitro
Phagocytic uptake of P. multocida by bronchoalveolar macrophages harvested from calves 
challenged with either live or dead P multocida A :3, was studied using the acridine orange /crystal 
violet (AO/CV) fluorescent technique (Goldner et al., 1983) (appendix 1.8.3) and adhesion slides 
(Paul M arienfeld GM BH & Co, Lauda-Konigshofen, Germany). This method can be used to 
differentiate between ingested and extracellular adherent bacteria by the addition of CV dye to 
quench any bacterium that has not been internalised by the phagocyte (Zanetti et a l ,  1987).
Phagocytes, extracted on the day of a lung lavage, at a concentration of 2 x 10*^  cells ml"' (10 pi = 2 
X 10'' cells) were added to each reaction field and the slide placed in a 5 % (v/v) CO2 incubator at 
37°C for 15 min.
Reagents warmed to 37°C were RPMI 1640 (appendix 1.8.4) (Life Technologies Ltd, Paisley, UK) 
modified by the addition of 20 mM HEPES, 1 % (v/v), 1 % (v/v) L-glutamine, and lacking 
bicarbonate and antibiotics, while supplemented with 10 % (v/v) heat-inactivated (1 h at 56°C) 
foetal calf serum (FCS); (Life Technologies Ltd); M cCoy’s 5A medium (Life Technologies Ltd); 
Ca^^, Mg '^% indicator-free HBSS; acridine orange (AO) (10 mg ml ') (Molecular Probes Europe 
BV, Rijnsburgerweg 10, AA Leiden, The Netherlands) and crystal violet (CV) (1% aqueous 
solution (v/v) (ORME technologies) (appendix 1.8.3).
After incubation, non-adherent cells were removed from the reaction fields by washing with Ca^^, 
Mg '^*' indicator-free HBSS into a weighed container and the cells were counted using a 
haemocytometer (ORME technologies). The number of adherent cells (approximately 10^) were 
determined by difference. RPMI at 37°C was applied to the adherent cells instead of Ca^^, Mg^"’" 
indicator-free HBSS (to provide nutrient) and the reaction fields were incubated for 1 h in a 5 % 
(v/v) CO2 incubator at 37°C.
Suspensions of P. multocida type A:3 (MRI strain 671/90) in mid-log phase of growth in NB from a 
3.5 h culture were prepared, whereby the estimated viable count of bacteria were 10* cfu ml ' using 
a McFarland standard reading of 2 and a correction factor of 1.5, which takes into account variable 
colony mass and growth kinetics of different bacterial strains (Miles et ah, 1938). The culture
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suspension was adjusted by dilution in McCoys 5A medium (Life Technologies Ltd) so that 200 pi 
contained 2 x lO'’ live organisms (approximately 10 times the number of adherent cells). P. 
multocida was opsonised directly prior to use by incubating 500 pi of bacterial suspension with 100 
pi of P multocida  A:3 hyperimmune serum, heated previously at 56°C for 30 min to remove 
complement factors (20 pi per 10^ bacteria; Hodgson et aL, 1996), at RT for 30 min. Triplicate 
reaction fields were incubated with 20 pi of opsonised bacterial suspension, 20 pi of sterile 
McCoys 5A solution (control) or 20 pi of non-opsonised bacterial suspension, for 1 h (Hodgson et 
a l ,  1996). All reaction fields were then washed three times with Ca^^, Mg^^ indicator-free HBSS to 
remove non-adherent organisms, 20 pi of pre-warmed RPMI was added and the reaction fields 
incubated for a further 30 min. After a final wash with Ca "^^ , Mg "^^  indicator-free HBSS each 
preparation was stained with 20 pi of AO (14,4 mg 100 ml"' GBSS) for 45 s and using Ca^ "^ , Mg^ "^  
indicator-free HBSS, washed twice, stained with 20 pi of 1 % (v/v) CV (50 mg 100 ml ' PBS) for 
45 s and washed twice before cell-side of the adhesion slide was covered by a cover slip (Chance 
Propper Ltd, West Midlands, England) and sealed with clear nail varnish. Slides were viewed under 
oil immersion (Leitz antifluorescent oil) at a magnification of 1,250 x using an Olympus BX50 
fluorescent microscope (Olympus Optical Co. Ltd), The following measurements o f phagocytic 
activity were recorded: the mean number of ingested bacteria per macrophage, the mean percentage 
of macrophages that were phagocytic, in vitro per 100 BAM and the mean number of bacteria 
killed in vitro per BAM. CV quenches any extracellular fluorescence generated by AO, ensuring 
that only ingested bacteria are counted. Viable AO-stained organisms fluoresce green 
(oithochromasy) under ultraviolet excitation; whereas killed bacteria fluoresce dark orange 
(metachromasy) indicating a loss of viability of ingested organisms (Williams et a l ,  1991).
2.9.7. Storage of cells
The remaining cell suspension was centrifuged at 470 x g for 10 min, at 5°C and the pellet o f cells 
was re-suspended in freeze mixture (appendix 1.8.5) to 1 x 10^ cells ml '. The suspension of freeze 
mixture and cells was transferred to cryovials for overnight storage at -70°C followed by storage in 
liquid nitrogen prior to in vitro analysis.
2.9.8. Differential immune cell counting
BAL fluid samples comprising 5 x 10^ cells ml"' were centrifuged at 70 x g for 5 min using a 
cytocentrifuge (Life Sciences International, Cheshire, England) and forced through a filter 
assembly onto a slide partly covered with filter paper but with an uncovered target staining area. 
The cells were fixed immediately and stained with Diff-Quik® (Dade Behring, Switzerland). In this
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procedure, the air-dried cytospin was immersed initially in a fixative solution (fast green in 
methanol, 0.002 g f ')  for 5 s, then dipped into the first staining solution (Eosin G 1.22 g l ' in 
phosphate buffer pH 6.6), for a further 5 s and finally coloured with Thiazin-Farbsstoff dye ( l . lg  f '  
in phosphate buffer pH 6.6) for 10 s. The duration of cytospin immersion in the Diff-Quik® 
solutions was optimised to achieve the appropriate staining intensity for the detection of lung 
immune cells. Finally the cytospin was rinsed with DW and air-dried for viewing under a 
microscope. Total and differential cell counts were determined for the BAL fluid samples recovered 
at live lavage.
2.10 . S tatistica l analysis
A variety of statistical methods were used in the analysis of the data. Data were examined for 
symmetry, and where necessary were transformed using a square-root or logarithmic function to 
remove skewness. Wliere comparisons were being made between a pair of groups, t-tests were 
performed and means and standard errors of the mean (SEM) were calculated using Mini tab 
version 13. More complex statistical designs were analysed using analysis of variance (ANOVA) or 
related statistical methods. The experiment described in Chapter 4  was designed using a factorial 
formulation to increase the statistical power. Such a statistical design must be analysed in terms of 
estimating effects and interactions. However, the experiment described in Chapter 4 gave rise to 
unbalanced data, making simple ANOVA analysis difficult. In this case. Residual Maximum 
Likelihood (REML) was used to estimate differences between group data over time. REML is 
commonly regarded as the most appropriate statistical methodology for unbalanced data sets such 
as those of Chapter 4. By contrast, data from the experiment described in Chapter 6 were analysed 
using ANOVA, a simpler methodology which could be applied to this data set. It should be noted 
that the small sizes of the groups of calves and the high variability between these animals made it 
likely that only large effects would be identified as statistically significant.
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Chapter 3. Molecular  characterisation  and
LPS CHEMOTYPING OF COMMENSAL AND VIRULENT
Pa s t e u r e ll a  m u lto c id a  iso la ted  from
CONVENTIONAL CALVES.
3.1. INTRODUCTION
P. multocida isolates are grouped into five serogroups (A, B, D, E and F) based on capsular 
antigens, or into 16 somatic serotypes based on variations of LPS structure, designated according to 
the Carter-Heddleston system (Rimler and Rhoades, 1987). The organism may be isolated from the 
respiratory tract of both healthy and diseased cattle (Frank, 1989; Biberstein, 1990) indicating that 
pathogenic and commensal types may exist, but the role of possible commensal strains in the 
development of disease has not been determined. There are several potential mechanisms for 
commensal involvement; firstly, disease may result from a simple overgrowth of bacteria resident 
in the nasopharynx resulting from immunosuppression associated with certain stressful conditions 
such as weaning, dehorning, viral infection or transport (Frank, 1989). Subsequent shedding and 
inhalation of bacteria in numbers sufficient to overcome defences in the URT (Gonzalez and 
Maheswaran, 1993) may occur and cause pneumonic pasteurellosis, an acute disease associated 
with welfare problems and significant economic losses to the livestock industry (Dalgleish, 1989). 
In such cases, the bacteria involved are genetically and phenotypically identical to the organism 
causing disease within the lung, as was demonstrated in a proportion of acutely ill calves described 
by DeRosa et al (2000); however, this latter work gave no information on strains present in 
clinically healthy calves and, therefore, no distinction as to whether a commensal or new virulent 
strain was involved in the pathogenesis of disease.
This forms a second hypothesis where the disease-causing organism is entirely disparate from the 
commensal and not analogous with any strains recovered from clinically healthy animals.
A third hypothesis is that commensal bacteria may undergo genetic or phenotypic modifications as 
a result of some stimulus in healthy animals, conferring virulent attributes and enabling them to 
locate to, and subsequently infect, the lung. For example, research on serotype predominance in the 
URT in a closely related organism to P. multocida, M. haemolytica, has provided evidence for the 
rapid switch from commensal to pathogen. It has been shown that microfloral population shifts in 
favour of a more virulent M. haemolytica strain, serotype 1 (S T l) revealed by its smooth LPS, from
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serotype 2 (ST2) possessing the less virulent rough LPS (Gonzalez and Maheswaran, 1993). 
Overall however, there is still insufficient information regarding prevalence, genetic and antigenic 
variation of P. multocida thus limiting our understanding of its virulence and pathogenesis (Davies 
and Donachie, 1996).
Recent evidence suggests that antigenic variation of cell surface structures, including LPS, could be 
a key factor impeding the development of effective vaccines (Preston and M askell, 2002). Variation 
can be assessed by characterising genetic and phenotypic differences, including key surface 
structures, such as LPS. PFGE remains a useful tool for assessing the degree of genetic relatedness 
amongst a broad array of bacterial species (Tenover et al., 1995), and has been shown to be more 
discriminatory than ribotyping, random amplified polymorphic DNA and REP PCR (Hunt et al., 
2000) in the differentiation of P. multocida and M, haemolytica strains. DNA:DNA hybridisation 
techniques and extensive phenotypic testing led to the reclassification of the Pasteurella genus 
(Mutters et al., 1985) when P multocida was divided into the 3 subspecies, P multocida subsp. 
multocida, subsp. septica and subsp. gallicida. The recent development o f the multilocus sequence 
typing method has been of value for differentiating isolates to the subspecies level in addition to 
identifying outbreak isolates and the clonal relationships between strains (Maiden et al., 1998). 
This technique has been developed for Streptococcus suis, Enterococcus faecalis  and Listeria 
monocytogenes (Nallapareddy et al., 2002; King et al., 2002; Salcedo et al,, 2003) to address these 
issues and would be of value for P multocida.
Prior to this investigation allocation of biotype was based upon characteristics typical of P 
multocida on conventional bacteriological media: lack of growth on M acConkey agar; fermentative 
reaction patterns observed with acid production from certain pentoses, disaccharides and 
polyhydric alcohols; negative reaction with urease and positive reactions for oxidase, catalase and 
indole (Bisgaard et al., 1991).
Some key surface structures that interact powerfully with the host immune system, such as LPS, 
may be altered through antigenic variation, so that a single bacterium can express more than one 
form of the antigenic component, which is then recognised by the host immune system (Maskell et 
al., 1993). Although there is no evidence for this phenomenon in Pasteurella spp., whereas a 
related organism, Haemophilus influenzae, displays an array of highly immunogenic LPS antigens. 
Such variation presents problems for effective vaccination, and a better understanding of the 
natural diversity and the host immune responses to these antigens will aid strategies for pathogen 
control.
The common and unique LPS structures associated with Pasteurella spp. enable this species to be 
classified, however the variation of antigenicity shown by LPS provides scope for diversity and 
thus further classification. The intra-specific diversity of LPS has been assessed previously by
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analysing variations in the LPS profile o f M. haemolytica and P. trehalosi between and within 
capsular polysaccharide serotypes (Davies and Quirie, 1996; Davies and Donachie, 1996), but P  
multocida LPS has not been characterised.
The present work assessed the phenotypic, genotypic and LPS chemotype relatedness of 
Pasteurella spp. isolates recovered from both clinically healthy and diseased animals during a 
spontaneous outbreak of pneumonic disease at the MRI.
3.2. EXPERIMENTAL DESIGN AND METHODS
3.2.1. Bacterial isolates
A total o f 30 clinical isolates were recovered from 28 conventional calves at 8 weeks of age, by 
nasal swabbing from all animals on arrival at MRI and taking lung tissue samples from clinical 
cases at post-mortem. These samples were examined and compared with 19 reference strains 
representative of the currently recognised P multocida serotypes; an MRI pneumonic A:3 strain 
and 3 type strains of P. multocida (subsp. multocida, subsp. septica and subsp. gallicida) obtained 
from culture collections (Table 3.1). All samples were cultured on 5 % (v/v) SBA plates, and 
incubated aerobically for 16 h at 37°C; single colonies were picked and sub-cultured to ensure 
purity, and stored either in NB at -70°C  or in a lyophilised state at RT until the time of 
characterisation.
3.2.2. Molecular strain characterisation
Isolates with colony morphology similar to P multocida and which were oxidase and catalase 
positive were selected for phenotypic characterisation. Tests used were: production of urease and 
indole, (3-galactosidase activity, production of acid from arabinose, maltose, mannose, sorbitol, 
mannitol, trehalose and xylose, and decarboxylation of ornithine (Bisgaard et al., 1991).
Capsular types D or A of R multocida were determined using acriflavine or hyaluronidase tests, 
respectively (Carter et a l ,  1973 and 1975, Rimler 1994). The former test identified type D strains 
by the production of a heavy flocculent precipitate on the addition of an aqueous solution of 
acriflavine to a concentrated broth culture. The latter test identified type A strains by growth 
restriction due to the depolymerisation of capsular hyaluronic acid by hyaluronidase. Bacterial 
culture and PFGE conditions used were those described by Lainson et al., (2002) (section 2.2.1).
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LPS characterisation of P. multocida A:3  and essential reagents to assist this are described in detail 
in (section 2.3) and (section 2.5) respectively.
P. multocida in bovine nasal swabs and lung tissue was identified by PCR, using primers specific 
for the km tl gene encoding a protein involved in the synthesis of capsular polysaccharide. 
Conditions for the detection of P  multocida were those used by Townsend et al., (2001) with slight 
modifications.
Table 3.1. Pasteurella spp. isolates from a natural outbreak of bovine pneumonic pasteurellosis in 
Scotland and reference strains.
Source Host /  bacterial 
species
MRI and Rimler reference number Total no. of 
isolates /  strains
N a tu ra l ou tb reaks
Nasopharynx Bovine 14/OOR, S, B, C, G, Q, 15/OOF, 
14/OOA, D, E, H, J, L, P, N, K, T, F, I, 
M, U, I5/00A, B, C \  D \  E
26
Lung Bovine 12/00, 20/00, 21/00 \  23/00" 4
R eference s tra in s
Lung Bovine MRI-671/90' 1
Rimler reference Chicken 116/95A
strains Bison 116/95B
Turkey 
Herring gull 
Pine siskin 
Porcine 
Human 
Bovine
116/95C, D, E ,F ,I ,J ,  0 ,P ,S  
116/95G 
116/95H 
116/95K 
116/95L,M  
116/95N, Q, R
19
NCTC^ 10322 subsp. multocida 34/OlA
C1P*A125 subsp. septica 34/0 IB 3
NCTC^ 10204 subsp. gallicida 34/01C
^671/90 is an MRI pneumonic strain, somatically typed as A:3. ^NCTC; National Collection o f  
Type Cultures (NCTC), London, UK. ^CIP Collection de l'Institut Pasteur, Paris, France. 15/OOCT/ 
23 /0 (f and 15/OOD^/ 21/0& are the paired nasal and lung isolates.
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3,3. RESULTS
3.3.1. Molecular characterisation of test isolates
3.3.1.1. P h eno typ ic  characterisa tion
All 30 test isolates were catalase and oxidase positive and urease negative. PFGE profiles, capsular 
types and sugar fermentation characteristics are presented in Table 3.2. Using the P. multocida 
MRI-671/90 challenge strain (Chapter 4) as a positive control, 20 out of the 30 bovine isolates were 
found to be P. multocida subsp. multocida, while the remainder were assigned to other taxa within 
the Pasteurellaceae family, primarily Mannheimia sp. (Table 3.2). Data presented in Table 3.2 
show that phenotypic analysis of these isolates revealed the presence of 11 biovars (I to XI). O f the 
test isolates identified as P. multocida subsp. multocida the majority fell into biovai’ I and the 
remainder were distributed between biovars II-VI. 19 of the 20 P. multocida subsp. multocida 
isolates were mucoid confirming production of capsule type A, whereas the remaining isolate was 
capsular type D. Similar data for the 19 reference isolates and the type strains are presented in 
Table 3.3. Sixteen of these reference isolates were identified as P. multocida subsp. multocida, 2 as 
P multocida subsp. gallicida and 1 as R multocida subsp. septica, and all fell within 6 biovars (I, 
XI-XV). The majority (12) of the reference strains and the M RI (671/90) strain shared the same 
biovar (XI).
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Table 3.2. Phenotypic characters and PFGE profiles of field isolates"
Biovar
and
isolate
Profile Mucoid Capsule
type
Bacteria I "ODC 'ONPG A M Ma S T X Mau
I
12/00 PIO
Y A multocida + + - - - 4- 4- + + 4
14/001 P9 Y A multocida + + - - - + 4- 4- 4- 4
Î4/00M P4 Y A multocida + -t- - - - + 4- 4- 4- 4
14/OOU P lI Y A multocida + - - - -t- 4- 4- 4- 4
15/00 A P2 Y A multocida + + - - + 4- 4- 4- 4
15/OOB P2 Y A multocida + + - - - + 4- 4- 4- 4
15/OOC P2 Y A multocida + + - - - + 4- 4- 4- 4
15/OOD P2 Y A multocida + + - - - + 4- 4- 4- 4
15/OOE P2 Y A multocida + + - - - + 4- 4- 4- 4
20/00 P2 Y A multocida + + - - - + 4- 4- 4- 4
21/00 P2 Y A multocida + + - - - + 4- 4- 4- 4
23/00 P2 Y A multocida + + - - - + 4- 4- 4- 4
II
14/OOT
P4 Y A multocida + + - - - - 4- 4- 4- 4
III
14/OOF
P7 N D multocida + + - - - + + 4- - 4
IV
15/OOF
P3 Y A multocida - - + - - + 4- 4- 4- 4
V
14/OOB
P5 Y A multocida - - - - - + 4- 4- 4- 4
14/OOC P6 Y A multocida - - - - - + 4- 4- 4- 4
14/OOG P5 Y A multocida - - - - - + 4- 4- 4- 4
VI
14/OOR
P5 Y A multocida - - - - - - 4- 4- 4- 4
14/OOS P5 Y A multocida - - - - - - 4- 4- 4 4
VII
14/OOA
PI N haemolytica - - + - + + 4- - 4 -
14/OOD PI N haemolytica - - + - + 4- 4- - 4 -
14/OOE PI N haemolytica - - + - + + + - 4 -
14/OOH PI N haemolytica - - + - + 4- 4- - 4 -
14/OOJ PI N haemolytica - - + - + 4- 4- - 4 -
14/OOL PI N haemolytica - - + - + 4- 4- - 4 -
14/OOP PI N haemolytica - - + - + 4- 4- - 4 -
VIII
14/OOK
P8 N haemolytica " + + + -t- 4- - - 4 -
IX-
14/OOQ
PI N haemolytica - - - - + 4- 4- - 4 -
X
14/OON
PI N P a s te u re lla
spp-
- - + - + 4- 4- 4- 4 -
XI-
671/90
P12 Y A multocida + + - - - 4- 4- 4 4
Bovine test isolates grouped according to biovar (denoted by Roman numerals) as determined from 
biochemical fermentation patterns, showing PFGE profile, capsule characteristics and the class of sub 
species to which each belonged. "All bovine field isolates were catalase/oxidase positive, urease 
negative and resided within biovars I to X. The MRI-challenge strain 671/90 had a unique biovar pattern 
(XI). ’ODC = Ornithine decarboxylase activity; Detection of p-galactosidase activity: ‘^ ONPG = (O- 
nitro-phenyl-D-galactopyranoside); A = Arabinose; I = Indole; M  = Maltose; M a = Mannitol; S = 
Sorbitol; T = Trehalose; X  = Xylose; Man = Mannose; + positive reaction; -  negative reaction.
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Table 3.3. Phenotypic characters and PFGE profiles of Rimler reference R multocida 
isolates and type strains .^
Biovar 
and isolate
Mucoid Capsule
type
Bacteria I *’ODC 'ONPG A M Ma S T X Man
I
116/95H
N D multocida + + - - - + + 4- 4- 4-
XI N B multocida + + » - + 4- - 4- 4-
116/95B
116/95C Y A multocida + + - - “ + + - 4- 4"
116/95D Y A multocida + - - 4- 4- - + 4-
116/95E Y A multocida + + « - - + + 4- 4-
116/951 Y A multocida + + - - „ + 4- - 4- +
116/951 Y A multocida + + - - - + + - 4- 4-
116/95K N D multocida + M - + + - 4- 4-
116/95L Y A multocida + + - - _ + + - 4- 4-
116/95P Y A multocida + + - - - + + ~ 4- 4-
116/95Q N E multocida + - - - + 4- - 4- +
116/95R Y D multocida + + - - - + 4- - 4- 4-
116/95S Y F multocida + + - " - + 4- - 4- 4-
x n N D multocida + + - - - + + — - 4-
116/95F
116/95G N D multocida + 4- - - - + 4- -, - 4-
x m N D multocida + + + - - + 4- - 4- 4-
116/950
XIV N D septica + + - - - 4- - 4- 4- -
116/95M
XV Y A gallicida + + — + - 4- 4- - - ND
116/95A
116/95N N A gallicida + -f ” + - 4- 4- - - N D
Type
s tra in s
34/OA A multocida + + - f* + + -h 4-
34/OB septica + + - - + - +
34/O lC gallicida + + “ + - 4- + - "
“All reference isolates and type stiains were grouped according to biovar (denoted by Roman 
numerals) as detennined from biochemical fermentation patterns and all isolates were catalase/ 
oxidase positive and urease negative. I, Indole; '’ODC, Ornitliine decarboxylase activity; “ONPGj 
G-nitro-phenyl-D-galactopyranoside (P-galactosidase activity); A, Arabinose; M, Maltose; Ma, 
Mannitol; S, Sorbitol; T, Trehalose; X, Xylose; Man, Mannose; +, positive reaction; -, negative 
reaction. ND = not detennined.
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3.3.1.2. G enetic  characteristics
O f the test isolates examined, including the M RI-671/90 pneumonic strain, 12 pulsotypes (Table 
3.2) were identified by PFGE (Fig. 3 .land  Fig. 3.2) showing between 5 and 12 bands, ranging in 
size from  below 48.5 to 485 kb. A dendrogram was produced of best-fit analysis using the Dice 
coefficient function of the Image Master Database 3D Elite software to show the percentage 
similarity between representative isolates of the 12 pulsotypes (Fig. 3.3). Within this study, 8 of the 
9 Mannheimia  sp. isolates were uniquely associated with pulsotype P I profile and were assigned to 
3 biovars (Vll, IX and X); the remaining isolate (14/OOK) was assigned to pulsotype P8, biovar 
(V lll). Pulsotype P2 comprised 8 of the 20 P. multocida subsp. multocida isolates biovar (I) 
whereas pulsotypes P3, P6, P7, P9, PIO and P l l  contained only single isolates and were distributed 
amongst 4 biovars (1, 111, IV and V). Four of the test isolates were typed as P5, biovar (V and VI) 
and two as P4, biovar (1 and II). The dendrogram demonstrated a correlation between genetic 
relatedness and biochemical features among test isolates and the M RI-671/90 pneumonic strain, 
such that isolates 14/OOC (P6), 14/OOF (P7) and 12/00 (PIO) expressed a genetic similarity of >70% 
but belonged to different biovars, whereas isolates 14/OOM (P4), 14/OOU (P ll) ,  14/001 (P9) and 
20/00 (P2) were 70% similar and biochemically identical. Test isolate 14/OOF showed a distinct 
PFGE profile (pulsotype P7) and was the only profile that matched any of the type strains, showing 
>95% similarity to subsp. multocida.
3.3,2. LPS gel profiles
Analyses of silver stained SDS-PAGE gels o f phenol-extracted LPS from test isolates identified 6 
different banding patterns within the core oligosaccharide region, each comprising between 1 and 7 
bands (Fig. 3.4;Table 3.4). Despite using a standard methodology, silver staining of LPS from M. 
haemolytica produced clearer bands than with P. multocida, the reasons for which are unknown. 
There was no staining in the high molecular weight region of the gels, indicating the absence of O- 
antigen side-chains in all isolates. The LPS profiles of P. multocida in lung samples obtained at PM 
and in nasal samples taken a day earlier from the 3 clinical cases were identical (profile B, bands 3, 
4, 5, 6), and distinct from the lung isolate (MRI challenge strain 671/90; bands 5, 6, 7, 8) used in 
previous work. The core banding pattern of the reference strains was highly variable (results not 
shown), and bovine strain 116/95Q was the only one to exhibit an O-polysaccharide side chain.
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Fig, 3.1. Seven Apal PFGE profiles of Scottish bovine Pasteurella spp. test isolates. Lanes 1 and 
13 contain molecular mass standards 48.5-kb concatemer (lambda DNA ladder. New England 
Biolabs). Lane 2, pulsotype 1 (isolate 14/(X)D, M. haemolytica)', lane 3, pulsotype 2 (isolate 20/00, 
P. multocida); lane 4, pulsotype 3 (isolate 15/OOF, P. multocida); lane 5, pulsotype 9 (isolate 14/001, 
P. multocida); lane 6 and 8, pulsotype 4 (isolates 14/OOM and 14/OOT, P. multocida); lane 7, 
pulsotype 11 (isolate 14/(X)U, P. multocida); lane 9, pulsotype 5 (isolate 14/OOB, P. multocida); 
lanes 10, 11 and 12 are the type strains subsp. multocida, subsp. septica and subsp. gallicida.
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Fig. 3.2. Five Apal restriction PFGE profiles of Scottish bovine Pasteurella spp. test isolates. 
Lanes 1 and 10 contain molecular mass standards 48.5-kb concatemer (lambda DNA ladder, New 
England Biolabs). Lane 2, pulsotype 6 (isolate 14/OOC, R multocida); lane 3, pulsotype 7 (isolate 
14/OOF, P. multocida type D); lane 4, pulsotype 8 (isolate 14/OOK, M. haemolytica)\ lane 5, 
pulsotype 12 (isolate M Rl-671/90, P. multocida)-, lane 6, pulsotype 10 (isolate 12/00, P. multocida), 
lanes 7, 8 and 9 are the type strains P. multocida subsp. multocida, subsp. septica and subsp. 
gallicida.
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Test isolates and type strains of P. multocida 
sub.Mutt
14/OOF
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12/00
15/OOF
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Fig. 3.3. Dendrogram illustration of the genetic relatedness amongst Pasteurella spp. isolates, type 
strains and the M Rl-671/90 challenge strain.
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Fig. 3.4. Silver stained SDS-PAGE gels of phenol-extracted EPS from Scottish bovine Pasteurella 
and Mannheimia isolates showing 6 profiles (A-F) comprising between 1 and 7 core bands with no 
evidence of O-antigen. Lane 1: control profile from E. coll serotype 055:B 5: Lanes 2, 3; profile A 
(14/00A, D, M. haemolytica): Lanes 4, 5; profile B ( 15/00A, 12/00, P. multocida): Lanes 6, 7; 
profile C (15/OOF, 14/OOC, R multocida): Lanes 8, 9, 10, 11, 12, 13; profile D (14/001, M, U, T, B, 
G, P. multocida): Lane 14; profile E (14/OOF, P  multocida): Lane 15; profile F (14/(X)K, M. 
haemolytica): Lane 16; M Rl strain (671/90, P  multocida) bands 5, 6, 7, 8: Lane 17, 18; subsp 
multocida and subsp septica.
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Table 3.4, CoiTelation of LPS core profile types A - F  with pulsotypes P I -  P l l  of bovine field 
isolates.
Bacterial
species
LPS core 
profilet
LPS core banding 
pattern
Pulsotype (n*) Isolate reference 
numbers
Mannheimia A 1, 3, 4, 5, 6 PI (9) 14/OOA, D, E, H, J, L, 
N ,P ,Q
P  multocida B 3, 4, 5, 6 P2 (8), PIO (1) 15/OOA, B, C, D, E, 
20/00, 21/00, 23/00, 
12/00
P  multocida C 4 ,6 P3 (1), P6 (1) 15/OOF, 14/OOC
Mannheimia D 4, 5 ,6 P4 (2) 14/OOM, T
P  multocida D 4, 5 ,6 P 9(1 );P 11  (1); 
P5 (4)
14/001, 14/OOU, 14/OOB, 
G ,R ,S
P. multocida E 2, 4, 5 ,7 P 7 ( l ) 14/OOF
Mannheimia F 4 P 8 ( I ) 14/OOK
^Number of isolates with indicated LPS core profile 
tIsolates confirmed as M. haemolytica or P. multocida 
+ Indicates a semi band.
3.3.3. LPS Immunoblot profiles
The immune reactivity of the 6 LPS core bands were studied by immunoblotting using two sources 
o f polyclonal antiserum, raised either to a live challenge of P. multocida  A:3 in cattle or to 
formalin-killed P. multocida A:3 in rabbits (Table 3.5). All LPS core bands reacted with bovine 
antiserum and were immunogenic except for band 3 in profile F  (Fig. 3.5). Band 3 (profile F) was 
also not detected by the rabbit antiserum. The bovine antiserum raised against a rough form of P  
multocida A; 3 was able only to recognise the O-antigen of phenotypically characterised M. 
haemolytica strains (P I, LPS type A); immunoblots were still unable to reveal possible 
immunogenic O-antigen moieties for the rough P. multocida test isolates. Rabbit antiserum raised 
against formalin killed rough P. multocida A :3 was unable to detect any O-antigen moieties, and 
was able only to identify LPS core banding profiles of P  multocida (Fig. 3.6). The immunogenic 
components of the M RI challenge strain (P I2) for both target species displayed entirely disparate
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immunoblot profiles. The bovine antisera (Fig. 3.5; lane 14) detected only two reactive core bands 
(4, 5) compared to the rabbit antiserum (Fig. 3.6; lane 10) that detected an additional three reactive 
core bands (4, 5, 6, 7).
3.3.4. Correlations between pulsotype, biovar and LPS profile
Test isolates 14/OOM (P4), 14/OOU (P ll) ,  14/001 (P9) and 20/00 (P2) showed that they were 
genetically similar (70%) and biochemically identical, with the exception of 14/OOT (P4) which 
was identical in terms of genetic make-up (>95%) to 14/OOM but distinct biochemically in its 
inability to ferment mannitol. On all occasions it seemed that the 6 LPS banding types of the 
individual test isolates correlated well with pulsotype (Table 3.4).
3.3.5. PCR analysis of bovine test isolates
A single band on a DNA gel at a fragment size of 460 bp confirmed the morphological and 
biochemical characterisations of the following R  multocida test isolates; 14/OOB, C, F, Q  I, M, R, 
S, T, U, 15/OOA, B, C, D, E, F, 12/00, 20/00, 21/00, 23/00. The M RI-671/90 challenge strain was 
incorporated into the assay as the positive control (Fig. 3.7). The following test isolates 14/00A, D, 
E, H, J, K, L, N, P, Q identified phenotypically as M. haemolytica were unable to produce the 
desired PCR product, and a band was missing at the 460 bp point. Although, this PCR typing 
method was unable to reproducibly, differentiate between capsular types, the desired outcome was 
achieved using biochemical tests.
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Fig. 3.5. Immunoblots of the 6 LPS profiles (A-F) from Scottish bovine Pasteurella spp. isolates 
showing the immune reactive core bands when exposed to polyclonal antiserum raised to a live 
challenge of P. multocida A:3 in cattle. Lane I; molecular weight standard of 3-188 kDa (See Blue 
Plus 2; Invitrogen); Lanes 2, 3: profile A (14/OOA, D, M. haemolytica)-. Lanes 4, 5, 6: profile B 
(15/OOA, B, 12/00, P. multocida); Lanes 7, 8: profile C (15/OOF, 14/OOC, P. multocida); Lanes 9, 10, 
11, 12: profile D (14/001, M, U, T, P. multocida); Lane 13: profile E (14/OOF, P. multocida type D); 
Lane 14: M Rl challenge strain (671/90, P multocida); Lane 15, 16, 17: P multocida subsp 
multocida, subsp. septica, subsp. gallicida.
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Fig. 3.6. Immunoblots of the 6 LPS profiles (A-F) from Scottish bovine Pasteurella spp. isolates 
showing the immune reactive core bands when exposed to polyclonal antiserum raised to formalin- 
killed P multocida A;3 in rabbits. Lane 1: molecular weight standard of 3-188 kDa (See Blue Plus 
2; Invitrogen); Lanes 2, 3, 4 :profile B (15/OOA, B, 12/00, P. multocida); Lanes 5, 6, 7, 8: profile D 
(14/(X)T, U, G, S, /Î multocida); Lanes 9: profile E (14/OOF, P multocida type D); Lane 10: MRI 
strain (671/90, P multocida); Lane 11, 12, 13: P multocida subsp multocida, subsp. septica, subsp. 
gallicida.
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Fig. 3.7. PCR analysis of bovine Pasteurella spp. test isolates. The presence of a single 460bp DNA 
fragment confirmed the test isolate to be P. multocida. Lanes M contain molecular mass standards 
from 100-1500 bp (lOObp DNA ladder).
A: Lanes 1, 4, 5, 8, M. haemolytica isolates 14/OOA, D, E, H; lanes 2, 3, 6, 7, 9, P. multocida 
isolates 14/OOB, C, F, Q  I. B: Lanes 10, 11, 13, 14, 20 M. haemolytica isolates 14/OOL, P, K, Q, J 
and Pasteurella sp, 14/OON; lanes 12, 16, 17, 18, 19, P. multocida isolates 14/OOM, R, S, T, U. C: 
Lanes 21-26, P. multocida isolates 15/OOA, B, C, D, E, F: Lanes 27-31, P. multocida isolates 
671/90, 12/00, 20/00, 21/00, 23/00.
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3,4. DISCUSSION
Limited research has been conducted on the characteristics and diversity of a commensal bacterial 
population residing in the upper respiratory tract within a herd or between herds of cattle. It is 
believed that the flora of the nasopharynx is the potential source of infection, responsible for 
weakening the innate immune status and stimulating acquired immunity through antigenic factors 
that P. multocida possesses. The foremost Pasteurella spp. recovered from  clinically healthy and 
pneumonic cases are considered to be M. haemolytica and P. multocida (Bisgaard et ah, 1991). For 
this study we analysed the potential molecular and LPS diversity of the M RI P. multocida strain, 26 
nasal and 2 matched nasal and lung Pasteurella spp. field isolates from  28 calves. Phenotypic 
analyses of these field strains revealed that 20 were P. multocida subsp. multocida and the 
remainder were assigned to other taxa within the genus Pasteurella  spp. R multocida subsp. 
multocida could be differentiated by their fermentative patterns and their mucoid properties, 
grouping them into 7 out of the 11 biovars designated for field isolates. These results alone indicate 
the scope for prevalence of P. multocida; however, a more detailed study involving the genetic 
profile of these isolates is required to further discriminate P. multocida  samples of remarkable 
likeness and epidemiological significance.
The generation of a single DNA band of 460 bp indicated the use of this PCR assay for 
differentiating P. multocida  test isolates from other morphologically and biochemically similar 
bacteria (Townsend et al., 2001).
PFGE was used as the method for genotyping isolates, and digestion of genomic DNA with the 
restriction endonuclease, Apal, generated clear banding patterns. This allowed discrimination 
between different species of Pasteurella spp., suggesting that PFGE, in combination with Apal 
digestion, is a powerful epidemiological tool. Since there is no commonly agreed directive for 
designating pulsotypes to the fragment patterns produced by PFGE, guidelines devised by Tenover 
et al., (1995) were employed in this study. According to Tenover et al. (1995) isolates of the same 
pulsotype aie impossible to differentiate. Twelve pulsotypes were identified amongst the 26 nasal, 
2 paired nasal and lung isolates and the MRI challenge strain (671/90). These PFGE findings 
indicate that a high frequency of genetic diversity exists among a small pool o f Pasteurella spp. test 
isolates confirming the heterogeneity of P. multocida. A  similar observation has been made by 
others (Lainson et al., 2002; Buttenschon and Rosendal, 1990), and should be taken into account 
when devising control measures.
The presence or absence of 1 or 2 bands differentiated the PFGE patterns generated from Apal 
digestion. These observations, following passage through different hosts, can be caused by random
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genetic events such as insertions and deletions of DNA (Connor et al., 2000), Equivalent alterations 
in genomic DNA restriction patterns have been observed in bacterial species such as Yersinia pestis 
and Pseudomonas aeruginosa after in vitro passage or passage through different animal hosts in 
vivo (Kodjo et al., 1999). However, no variations were observed between the PFGE profile of the 
challenge material of an MRI pneumonic strain 671/90 type A:3 and the strain re-isolated after in 
vivo passage. In vitro stability of M. haemolytica strains has been reported (Kodjo et al., 1999).
Correlations were observed amongst biovar and pulsotype, however, there were instances where 
PFGE required phenotypic analysis to discriminate strains of the same pulsotype, indicating the 
fallibility of relying on one epidemiological technique to differentiate strains.
One of the molecules responsible for the virulence of pasteurellosis is LPS (Hodgson et al., 2003), 
however, the range and role of different LPS chemotypes in healthy and diseased animals has not 
been defined. The LPS profiles from  all of the field isolates contained only a core banding pattern, 
indicating that strains were rough. Such a characteristic would indicate the loss of diversity, 
variation and virulence. These attributes are associated with many Gram-negative agents including 
Salmonella typhimurium, Haemophilus, E. coli and Pasteurella spp. all possessing O-antigen.
Amongst our small pool o f field isolates and the MRI-671/90 challenge strain, 6 different LPS 
banding patterns were identified, indicating a considerable amount of diversity within the core 
region. Chemotype profiling distinguished efficiently the core banding patterns of P. multocida 
strains from M. haemolytica strains, and would appear, therefore, to be a useful tool for 
epidemiological studies. Evidence for the variation in immune reactivity amongst the 6 LPS core 
banding patterns was illustrated by immunoblotting of phenol-extracted LPS from test isolates 
probed with the appropriate antisera and this can be compared with early work by others (Brogden 
and Rebers, 1978).
Bovine antiserum raised against the M RI challenge strain containing rough LPS was able to 
recognise the O-antigen of M. haemolytica strains on immunoblot. A possible explanation is that 
the antiserum obtained was from 8 week old conventional calves that had been exposed previously 
to M. haemolytica. Neither bovine nor rabbit antisera were able to detect LPS core profile F. 
Similar observations have been made previously (Hodgson et al., unpublished data), indicating that 
low moleculai- weight core bands may be concealed from the host immune system or that the host 
is unable to differentiate the pathogen from  self. In this regard it is interesting to note the ability of 
some LPS outer core structures to mimic human gangliosides (Harvey et al., 2001; Moran & 
Prendergast, 2001; Guerry eta l., 2002).
In the case of the rabbit antiserum, a unique profile was observed, in that 5 additional LPS core 
bands were recognised in the M RI-671/90 challenge strain LPS that were not detected by bovine
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antiserum. The rabbit antiserum was unable also to detect O-antigen or core bands from LPS types 
A and C because in the case of type A, strains were Mannheimia sp. A similar phenomenon has 
been reported for M. haemolytica (Ali et al., 1992), but this observation involved only 1 core LPS 
band, and this has not been investigated with respect to P. multocida where the phenomenon seems 
more evident. The difference may indicate simply that formalin-killed preparations present 
otherwise hidden antigens to the host's immune surveillance system; however, bacteria will also be 
killed and lysed following live challenge, and the observation may indicate that some core LPS 
structures are similar in composition to bovine but not to rabbit structures and therefore not 
recognised as foreign by bovine immune cells. If so, this has important implications for our 
understanding of immune evasion and perhaps also for colonisation and existence as a commensal 
by P. multocida.
Research using bovine antiserum raised against killed bacteria is required to allow a resolution of 
this matter by direct comparison with equivalent rabbit antiserum. The antiserum should provide an 
explanation of the underlying mechanisms of virulence, which will be of value when investigating 
possible antigenic variation between commensal and virulent states in P. multocida. Commonality 
among epitopes to both host and pathogen is vital for adhesion and recognition.
LPS chemotyping has signalled the importance of this antigenic molecule for host pathogen 
interaction and for inducing a specific host immune reaction, making this antigen a prospective 
vaccine candidate. The methods employed by Davies and Donachie, (1996) to assess diversity have 
established their effectiveness as an epidemiological tool, capable of identifying surface 
components with a capacity for virulence. Comparison of isolates from  2 of the 4 calves that 
developed clinical disease from the nasopharynx pre-infection and from  the lung post-infection 
showed no phenotypic or genotypic differences, indicating that in some cases the same strain was 
able to operate both as a commensal and pathogen. These findings are in agreement with DeRosa et 
a l ,  (2000) who showed that Pasteurella spp., isolated from the URT and lungs of acutely ill 
animals were identical; however, it is questionable whether this discovery applies in the case of a 
clinically healthy animal.
Isolates obtained from diseased lung tissue were identical in phenotype and genotype to a 
previously obtained paired nasal isolate. This result supports the finding that a commensal of P. 
multocida resident in the nasopharynx can proliferate unchanged in anim al’s immunosuppressed, 
leading to shedding and inhalation of P. multocida in numbers sufficient to cause disease in the 
LRT. What remains unknown is that at the time of nasal swabbing the calf could have become 
infected with a virulent strain of P. multocida, the clinical development of disease would have been 
observed at a later period. Clearly further research is required to determine the mechanism by 
which a commensal may become a pathogen. The same LPS rough chemotype could be present
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with or without disease. No evidence of a specific link between LPS structure and disease virulence 
was found.
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PNEUMONIC PASTEURELLOSIS IN CALVES BY 
INTRATRACHEAL INFECTION WITH PASTEURELLA 
MULTOCIDA BIOTYPE A:3
4.1. INTRODUCTION
R multocida is an opportunistic pathogen of wild and domesticated animals, as well as humans 
(Adler et al., 1999) and, similarly to M. haemolytica (Donachie, 1995), is an important cause of 
respiratory disease in cattle. However, the pathogenesis of bovine pneumonic disease caused by P. 
multocida is not well characterised (Confer, 1993) and the lack of a reproducible experimental 
model in calves has limited research into the pathogenic determinants of this organism and the 
development of effective and safe vaccines. Previous attempts to induce BPP experimentally 
included challenge of calves intratracheal I y with either 10 or 60 ml of culture media containing 
between 10^ to 10'° cfu of P. multocida (Ames et al., 1985; Gourlay et al., 1989); however, lesions 
and clinical signs of disease were mild in all calves, with only transient signs of pyrexia and 
respiratory distress in the most affected calves. Thus, neither of these experimental approaches met 
criteria suggested (Houghton, 1995) for experimental induction of overt disease at an incidence and 
degree equal to or exceeding that observed for the natural disease. Conversely, in our laboratory, 
use of M. haemolytica serotype A:1 showed that a high volume (300 ml) dose containing 2 x 10* 
cfu given intratracheally resulted in a reliable and progressive development of overt pneumonic 
disease, similar to that seen in the field (Donachie, unpublished observations).
The aim of the present work was to investigate whether a similar approach could be used to 
generate a realistic, progressive and reproducible model of pneumonic pasteurellosis in cattle 
caused by P. multocida by characterising the clinical, APP changes and pathological responses of 
the host to either low or high volumes of challenge inocula. It was anticipated that future 
exploitation of such a model might assist the development of novel strategies and products for 
treatment and prevention of infection by P. multocida.
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4.2. MATERIALS AND METHODS
4.2.1. Calves and experimental design
Holstein cross Friesian male calves (n=16) of approximately two weeks of age were purchased 
from a local farm and housed in individual calf pens. Calves were assessed for prior exposure to P, 
multocida by nasal swabbing and plasma antibody analysis (Fig. 4.8) by ELISA (section 2.6.3); all 
calves seemed free from Pasteurella spp., in the nasopharynx.
Calves were weaned at 7 weeks of age from a liquid milk diet on to hay and mixed pellets and held 
in open pens for the duration of the experiment. At 8 weeks of age (designated experimental day 0)
the 16 calves were allocated randomly to groups of four and challenged according to the 2 x 2
factorial experimental design summarised below.
Group 1: 10® cfu P. multocida A3  in 300 ml of PBS
Group 2: 10® cfu P. multocida A3 in 60 ml of PBS
Group 3: 10^° cfu P. multocida A3 in 300 ml of PBS
Group 4; 10’° cfu P. multocida A3 in 60 ml of PBS.
It seemed unlikely that instillation of sterile saline alone into the lung would cause significant 
clinical or biochemical changes, as other studies of experimental P. multocida pneumonia in calves 
found no effect of intratracheal instillation of sterile brain heart infusion broth (Gourlay et al.,
1989). Therefore, an uninfected negative control group was not included, in order to restrict the
number of experimental animals required. Instead, pre-infection data from  each animal were used 
to determine negative control baselines. All experimental protocols were approved by the MRI 
Animal Experiments Committee, authorised under the Animals (Scientific Procedures) Act 1986. 
Access to veterinary care was available at all times.
4.2.2, Preparation of P. multocida for challenge
Live cultures of P. multocida A:3 M RI challenge strain 671/90 were pooled and McFarland 
readings of culture density were obtained using a Densimat (bioMerieux) and converted to 
estimated viable counts using a correction factor determined previously using standard techniques 
(Miles et al., 1938). Cultures were diluted subsequently with pre-warmed (37‘^ C) PBS to produce
challenge inocula containing an estimated 10® and 10^ ® cfu in 60 and 300 ml volumes. Actual
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bacterial doses, estimated retrospectively by plating out serial dilutions of each dose onto blood 
agar, were 1.5 x 10® cfu and 2.2 x 10*° cfu.
4.2.3. Clinical monitoring
A total clinical score (TCS) for each 24 h observational period was calculated for each calf from 
which a mean TCS over the duration of the experiment was derived (section 2.8.5).
4.2.4. Statistical analyses
Mean TCS, pleurisy scores and viable lung counts were distributed in a skewed manner, and were 
transformed using a square root or logarithmic transformation, as appropriate, to produce a more 
symmetrical distribution of data (Crowder and Hand, 1990). Differences between factor levels for 
these measurements were analysed for statistical significance using the residual maximum 
likelihood (REML) application of the Genstat software (Release 4.2) (Payne, 2000). The use of 
REML was indicated by the non-orthogonality of the data after humane removal of two animals 
that developed endotoxic shock. Respiratory rates, rectal temperatures and APP concentrations 
against time were summarised using the area under the curve (AUC) adjusted to individual time- 
zero baseline values and analysed using REML. The choice of AUC was chosen to provide a robust 
method of analysing repeated measures, from  a relatively small number of animals in which the 
responses were not linear with time.
4.2.5. Plasma assays
Jugular vein blood samples were collected into vacutainers (Becton Dickinson) containing 1 ml of 
EDTA (Sigma) as anticoagulant from  all calves on day of arrival, the day of challenge (day 0), 4 h 
p.c., and daily thereafter until the day of necropsy (day 4). Plasma was separated and stored at - 
40°C until analysis for viral antibodies; BVDV, PI-3, RSV and IBRV, APP; AGP, SAA , Hp and 
IgG levels.
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4.3. RESULTS
4.3.1. Clinical observations
All calves were healthy and alert prior to and immediately after infection. The challenge procedure 
took approximately 10 min and was well tolerated by all animals, causing only mild coughing. 
Within 4-6 h p.c. 12 of the 16 calves became depressed and recumbent, with signs of laboured 
breathing, mild nasal discharge and reduced appetite, and were unresponsive to mild noise or visual 
stimuli. Rectal temperature increased rapidly in all groups after infection, peaking at 5 h p.c. 
(Group 2) and at 23 h p.c. for all other groups (Fig. 4.1a). Mean temperatures fell thereafter in all 
groups but did not return to normal during the course of the experiment. The AUC for rectal 
temperature was significantly higher in calves given the high volume challenge (P < 0.05). The 
volume by dose relationship was not statistically significant; however, calves in the high dose high 
volume group did show the highest temperature rises. Rapid and marked rises in respiratory rates 
(Fig. 4.1b) were observed in all four treatment groups after infection. In calves given the high dose, 
low volume challenge mean respiratory rates varied between 35 and 59 min * (clinical score of 0) 
prior to infection, increasing to an average of 81 min * (clinical score of 1) 5 h p.c,. Differences in 
mean AUC of respiration rate against time were not statistically significantly affected by dose, 
volume or dose by volume interactions; however, high dose, high volume challenge tended to be 
associated with high respiration rates.
Within 5 h p.c. one animal in each of the high dose groups (Groups 3 and 4) showed signs of 
endotoxic shock, including depression, dyspnoea, a rise followed by a drop in rectal temperature, 
salivation and recumbency (Nagaraja et a l ,  1979; Lohuis et a l ,  1988). To minimise suffering, both 
were killed humanely.
Overall clinical signs peaked at 5-23 h p.c, thereafter signs began to resolve such that there was an 
obvious improvement in the health status of the calves towards the latter stages of the experiment. 
Calves given the high dose challenge exhibited a secondary clinical response during which 
respiratory rates increased at 48 h p.c. and remained elevated until the scheduled PM date. Both 
high dose challenges caused greater disease, as measured by mean TCS, but group differences were 
not statistically significant (P>0.05). The mean TCS in Group 2 (low dose, low volume) was 
consistently low and associated with mild disease only (Table 4.1).
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4.3.2. Gross pathology and bacteriology
Lung lesions varying from pale grey to purple, often associated with acute congestion, abscessation 
and thickened gelatinous pleura, were present in all calves (Fig. 4.2D), and with the apical lobes 
being most affected (Fig. 4.2A). On sectioning, the lesions were solid and the colour varied 
between red to brown. W hite small nodules were frequently observed (Fig. 4.2C). Pleurisy and 
pleural adhesions were observed in all groups (Fig. 4.2B), but there was no correlation between 
degree of pleurisy and dose or volume by dose of challenge. Surface lesion scores (Table 4.1) 
tended to be low in Group 2 calves, high in calves given the higher challenge dose (Groups 3 and 
4), but overall there was no statistically significant effect of dose, volume, or dose by volume 
interaction on the area of lung affected. P. multocida  was recovered from  the lungs of 9 pneumonic 
calves and from the 2 animals that developed signs of endotoxic shock, primarily in lobules 
exhibiting extensive consolidated lesions. The viable counts of individual calves varied from 3 x 
10'^  cfu g'* to 1.4 X 10^ cfu g '\  and analysis o f the recovered bacteria by PFGE confirmed that 
isolates were identical to the inoculum strain. Recovery of bacteria from  lung tissue was lowest in 
Group 1 animals (Table 4.1). Bacteria were not recovered from  heart, heart blood, spleen, kidney, 
liver and lymph node tissues.
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Table 4.1. Mean TCS, surface lesion scores, pleurisy scores and bacterial recoveries from lung 
tissue (cfu g'*) of all calves challenged intratracheally with P. multocida.
Group Calf Dose
(cfu)
Volume
(ml)
Mean
TCS
Surface lesion 
score
Pleurisy Viable lung count 
(cfu g ’)
1105 4 10 0 1.4 X 10’
1 1115 10’ 300 2 0 0 No bacteria
1380 3 20 1 No bacteria
1388 4 10 3 No bacteria
1111 2 10 2 No bacteria
2 1384 10’ 60 2 10 2 No bacteria
1386 2 5 0 3 x 1 0 ^
1401 1 5 1 1 x 10*
1109 5 20 2 3x10*
1112 10^ 300 2 10 0 1 .2 x 1 0 ’
3 1377* 11 5 0 2.4 X  10’
1379 7 20 3 1.3 X  10^
1106 4 10 1 1x10*
1113 10’“ 60 2 20 1 4 x  10®
4 1389* 12 5 0 6.5 X  lO’
1390 3 10 1 4 x 1 0 *
Calves 1377"' and 1389* developed endotoxic shock and were euthanased prior to the scheduled 
PM  date.
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Fig. 4.2. Gross pathological changes observed in calf 1109 given a high volume, low dose 
challenge of P. multocida A:3, 4 d p.c. A: Whole excised lungs to illustrate the bilateral 
cranioventral area (1) as being most affected. The lesions appear typical of a bacterial induced 
purulent pneumonia similar to those seen in field cases of M haemolytica infections. B: Ventral 
surface of the lung lying within the thoracic cavity, note the excess pleural fluid (2 ) between the 
rib cage and the lung. C: Cross section through a right apical lobe of a pneumonic lung to 
demonstrate consolidation and the presence of fibrin and oedema obstructing the bronchial 
airways (3). D; Multiple abscesses on the cranioventral lung surface (4).
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4.3,3. Histopathology
Lesions observed in lung samples varied from  mild to severe multifocal fibrinopurulent 
bronchopneumonia with a tendency to abscessation (Fig. 4.3A), but there was no apparent 
association between the degree of effect and the administered treatment. The predominant findings 
(9 of the 16 cases) were foci of central coagulative necrosis, surrounded by a zone of densely 
packed neutrophils, mononuclear cells and spindle-shaped, degenerative inflammatory cells (Fig. 
4.3A), commonly known as oat cells (Dungworth, 1993). On occasion, large numbers of P. 
multocida could be observed in these foei. In addition, in areas less affected lesions were 
characterised by the accumulation of loosely packed neutrophils and macrophages (Fig. 4.3B). In 
10 of the 16 calves, there was severe oedema as well as fibrin clots within the interlobular septa 
(Fig. 4.3C). In 3 animals, encapsulated abscesses were observed in the lung parenchyma (Fig. 
4.3D).
Activation of the mediastinal lymph nodes was evident from the presence of a large number of 
secondary follicles. No significant histopathological changes were observed in any of the samples 
taken from spleen, heart, liver or kidney tissues.
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Fig. 4.3. Histopathological changes observed in calves infected with P. multocida. A: calf 1380 
given high volume, low dose challenge, 4 d p.c. (H&E, original magnification x 40); necrotic 
tissue ( 1), surrounded by a zone of densely packed inflammatory cells, sometimes referred to as 
‘oat cells’ (2), thickening of the pleura (3); B: calf 1112 given high volume, high dose challenge 4 
d p.c. (H&E, original magnification x 400) accumulation of neutrophils (4) and macrophages (5) 
in alveoli; C: calf 1384 given low volume, low dose challenge, 4 d p.c. (H&E, original 
magnification x 100); oedema and dilation of lymphatics in the interlobular septa (6 ); D: calf 1111 
given low volume, low dose challenge, 4 d p.c. (Masson’s trichrome, original magnification x 40) 
abscess with necrosis (1) and prominent capsule (7).
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4.3.4, Plasma assays
4 3 .4 J .  Viral an tibody analysis
Standard ELISA for detection of antibodies against viral antigens showed that all pre-infection 
plasma samples were negative for IBRV with the exception of calf 1112 that gave a reading of 
0.286 units, but most samples contained antibodies to BVDV (Fig. 4.4) PI-3 (Fig. 4.5), RSV (Fig. 
4.6). For most calves, comparison of titres in samples taken before infection and immediately prior 
to post-mortem showed a decrease in titre; however, in six calves, BVDV antibody titres increased 
by 30 % during the experiment, although no viraemia was detected. Evidence for seroconversion 
was observed for Pl-3 (1388, 1389) and RSV (1388, 1389, 1401).
4 3 .4 .2 . A n a lysis  o f  acu te p h a se  pro te in s
In all calves, mean plasma Hp concentrations increased linearly to values significantly greater 
(P<0.05) than those of the mean pre-infection samples, falling gradually thereafter (Fig. 4.7 a). A 
statistically significant effect (P<0.05) of high volume on the Hp AUC was identified. Increases in 
the concentration aiA G P were more gradual than those observed for SAA or Hp and maintained 
for longer (Fig, 4.7b). All calves exhibited a steady increase in the a ,  AGP response over the course 
of the experiment, but for Group 2 calves this rise was less sustained and reached a peak mean 
concentration of 435 mg l ’ at 48 h p.c., declining thereafter with a slight recovery between 72-96 h 
p.c. The mean AUC for a jA G P  was higher after high volume challenge but the effect was not 
statistically significant, and there was no evidence of a dose effect.
Plasma concentrations of SAA increased rapidly between 5 and 23 h p.c. (Groups 1, 3 and 4) or 
between 5 and 48 h p.c. (Group 2) (Fig. 4.7c). Thereafter concentrations in Groups 1 and 4 
remained elevated (approximately 550 - 600 mg l ’) until falling dramatically to approximately 5 
mg r ’ between 72 and 96 h p.c. Concentrations in Groups 2 and 3 fell progressively from peak 
values (approximately 415 - 465 rag ] ’) to between 70 and 120 mg l ’ at 96 h p.c; however, there 
was no statistically significant evidence of any effect that could be attributed to either dose or 
volume.
4.3 .4 .3 . A n a lysis  o f  an tibody to P. m ultocida
Plasma concentrations of IgG prior to challenge with P. multocida appeared to exhibit a positive 
response which varied from an OD of 0.3 to 1.55, in addition a similar range was observed post­
infection, 0.33 to 1.65 (Fig. 4.8). Calves that tended to have a high IgG concentration prior to
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challenge remained close to that OD value post-infection, this was particularly observed with 
Group 1 calves.
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Fig. 4.4. BVDV antibody titres in pre-infection O )  and post-mortem (B ) bleeds from calves 
inoculated with P. multocida A:3 at either lO’ or 10’“ in 60 or 300 ml PBS. Data presented 
corresponds to challenge groups; (a) Group 1 lO’ ciu multocida in 300ml PBS; calf 1115 
no response; (b) Group 2 lO’ cfu P multocida in 60ml PBS; (c) Group 3 10’“ cfu P. 
multocida in 300ml PBS: calf 1379 no response; (d) Group 4 10’“ cfu P. multocida in 60ml 
PBS.
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Fig. 4.5. RSV antibody titres in pre-infection (D ) and post-mortem (■) bleeds from calves 
inoculated with P. multocida A:3 at either 10^  or 10'° in 60 or 300 ml PBS. Data presented 
corresponds to challenge groups; (a) Group 1 lO’ cfu R multocida in 300ml PBS: calf 1380 
no response; (b) Group 2 10* cfu P. multocida in 60ml PBS: calf 1111 no response; (c) Group 
3 10^ ® cfu P. multocida in 300ml PBS: calf 1109 no response; (d) Group 4 10*® cfu P. 
multocida in 60ml PBS.
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Fig. 4.6. PI-3 virus antibody titres in pre-infection (P) and post-mortem (■) bleeds from calves 
inoculated with P. multocida A:3 at either lO’ or 10‘® in 60 or 300 ml PBS. Data presented 
corresponds to challenge groups; (a) Group 1 10^  cfli multocida in 300ml PBS: calf 1380 no 
response; (b) Group 2 lO’ cfu P. multocida in 60ml PBS: calf 1111 no response; (c) Group 3 
10’° cfu P. multocida in 300ml PBS: calf 1109 no response; (d) Group 4 lO’® cfu P. multocida in 
60ml PBS: calf 1390 no response.
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Fig. 4.8. IgG plasma antibody titres in pre-infection (Q  ) and post-mortem (■) bleeds from calves 
inoculated with P. multocida A:3 at either 10^  or 10‘® in 60 or 300 ml PBS. Data presented corresponds 
to challenge groups; (a) Group 1 10^  cfu R multocida in 300ml; (b) Group 2 10* cfu P. multocida in 
60ml PBS; (c) Group 3 lO’® cfu P multocida in 300ml PBS; (d) Group 4 10*® cfu P. multocida in 60ml 
PBS.
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4.4. DISCUSSION
The investigation established for the first time an experimental model for BPP caused by R  
multocida and provided an opportunity to evaluate the effect o f infectious lung challenge with the 
bacterium on pathological and biochemical changes in calves. It should be noted that the small 
number of animals available for analysis reduced the effective power of the REM L procedure, 
making it likely that only large effects would be identified as statistically significant by this study. 
This applies particularly to the investigation of interaction effects. Nevertheless, various aspects of 
biological interest to this study were highlighted. Such as, the effect o f treatment on respiration 
rates, area of lungs affected and pleurisy scores.
All treatments elicited a moderate to severe response, and induced clinical signs of bovine 
pneumonic pasteurellosis consistent with those characteristically observed in natural cases of 
disease, including moderate depression, pyrexia, laboured breathing, mild nasal discharge and 
anorexia. In addition, the gross pathological and microscopic changes observed were similar to 
those reported both for experimental induction (Furrow et al., 1986) and field cases (Blood et at., 
1979) of bovine pneumonic pasteurellosis associated with P. multocida. The APP results indicated 
that, of the two treatment variables used (dose and volume), volume was the more influential factor 
inducing pneumonic disease, and this, combined with the observation of two cases of endotoxic 
shock in calves given high dose challenge, mitigated against using the higher dose in any model 
formulation. These considerations, supported by the observation that the low dose, high volume 
treatment produced significant effects on rectal temperature and plasma Hp concentrations, 
identified this approach as the one to adopt in future experimental studies of the pathogenesis and 
prevention of R multocida  respiratory disease.
Plasma concentrations of APP change by at least 25 % during inflammation (Godson et al., 1995) 
and are useful markers with which to determine the progression of disease with time and to 
characterise initial host responses. Hp is particularly useful as a sensitive marker of bacterial 
infection (Conner et al., 1988; Heegaard et al., 2000), increasing between 10 to 100-fold after 
challenge (Godson et al., 1996; Skinner et a i ,  1991). It is interesting that animals given the high 
volume challenge exhibited higher (P<0.05) peak responses in Hp. The high volume challenge 
probably affected greater lung areas, especially if an initially slow response in Hp production 
allowed more time for the bacteria to proliferate. Examination of a iA G P  concentrations for all 
treatments indicated that the high volume challenge gave rise to a greater increase from resting 
level than the low volume challenge. Similar correlation of a iA G P  with severity of disease has 
been reported for other disorders aside from pneumonic pasteurellosis (Horadagoda et al., 2001),
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and in previous work examining natural acute versus chronic inflammation in cattle (Horadagoda et 
a l ,  1999).
P. multocida challenge dose used was deliberately 1 or 2 logs higher (10* or lO’® cfu) than that 
routinely used in our laboratory for M. haemolytica, because of the expected lower virulence of the 
former strain (Ames et a l ,  1985). Indeed, even at the dose administered, bacteria were not 
recovered from lung tissue in 3 out of 4 (Group 1) and 2 out of 4 (Group 2) animals. This may have 
been due to the sampling technique involving small samples taken from a restricted selection of set 
sites that did not include infected tissue. Alternatively, it may reflect a faster lung clearance of 
bacteria over the 4 d between challenge and PM  by animals receiving the lower challenge dose, 
possibly linked with an effect of APP responses helping restrict bacterial numbers, as suggested by 
others (Horadagoda et a l ,  2001). However, in the present work there was no correlation between 
APP concentrations and lung bacterial clearance.
All calves were reared conventionally with access to maternal colostrum and it was not surprising 
that we detected antibody to a range of viruses. In most samples the antibody titre decreased with 
time indicating that viral antibodies resulted from passive colostrum transfer and were not an active 
response to infection; however, the rise in antibody to BVDV in some calves indicated an active 
infection. Recent work has shown an enhanced risk of bovine respiratory disease in association 
with BVDV (Martin et a l ,  1999) but the present results suggested that severity of disease was 
associated with dose and volume of challenge and not with BVDV antibody status.
It was hardly surprising that calves prior to challenge exhibited rather high IgG levels, which was 
attributable to the passive transfer of IgG through maternal colostrum. Following challenge with P. 
multocida some calves showed a decrease in IgG concentration because at 8 weeks of age the level 
of maternal antibody is decreasing and the naïve calf is developing its innate immunity, also when 
the animal grows the plasma blood volume expands and becomes diluted, thus lowering the 
concentration of IgG  The reasons for an increase in IgG could also be due to analytical variation 
within the assay, as it is highly improbable that an immune response could develop by 5 days 
following a bacterial infection.
To conclude, the model produced a range of detectable clinical and pathological responses 
consistent with the natural disease, and showed the validity of APP as indicators of bovine 
pneumonic pasteurellosis. Future work will use the model to improve our understanding of host- 
pathogen interactions after infection with P. multocida, and in the longer term use this knowledge 
in an attempt to develop a multi valent vaccine, effective against agents responsible for bovine 
respiratory disease.
105
Chapters.A preliminary study to identify
DISEASE MARKERS IN LAVAGE FLUID FROM CALVES 
INFECTED EXPERIMENTALLY WITH PASTEURELLA 
MULTOCIDA USING 2D-ELECTROPHORESIS AND 
MALDI-TOF MASS SPECTROMETRY.
5.1. INTRODUCTION
Disease mechanisms attributable to P. multocida in BPP have not been fully defined. Recent 
evidence in calves suggests that the presence of P. multocida either alone, or in association with a 
virus, attenuates the animal's natural resistance, promoting bacterial colonisation of the mucociliary 
apparatus, invasion of the innate mucosal defence system and subsequent infection of the lung 
(Ackermann and Brogden 2000).
There are numerous proteins present in bronchial secretions, released from secretory cells such as 
goblet cells and mucus glands that can both assist mucociliary clearance and act as antibacterial 
factors during host-bacterial immune interaction. These proteins comprise the film of mucus on the 
alveolar surface and which aids gaseous exchange, and others that encompass surfactant which 
prevent the lung from collapsing (Wu et al., 2003). Evidence has been presented of the importance 
of epithelial lining fluid in the diagnosis of human lung diseases such as idiopathic pulmonary 
fibrosis, sarcoidosis and adult respiratory distress syndrome (Lenz et a i ,  1993). It is believed, from 
the analysis of human BALE that the overall protein composition of the epithelial lining fluid of the 
alveolar and distal airways of the lung may change during the initiation and developmental stages 
of pneumonic pasteurellosis (Chang He et al., 2003).
Innate defences of the lung against P. multocida are mediated by an array of resident inflammatory 
and immune effector cells. In the healthy animal these are mainly macrophages lying within the 
alveolar epithelial lining fluid (Babiuk et al., 1995). Upon stimulation by bacteria, alveolar 
macrophages generate a chemotactic gradient through the production of proinflammatory cytokines 
and chemokines (IL-8, IL -I, TNF-a) to recruit neutrophils into the alveolar lumen (Sibille and 
Reynolds, 1990). These cells act in conjunction with a variety of soluble factors, in particular 
chemokines and cytokines that either up or down-regulate the activity of specific leukocytes 
(Babiuk et al., 1995). Secretory products released by both macrophages and PMN can alter the 
protein composition of pulmonary fluid in such a manner as to deter bacteria from proliferating and
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colonising the lung, by inhibiting adherence to epithelial lining and enhancing subsequent 
phagocytosis and killing. These secretions include proteases, oxidants, lactoferrin and cytokines. 
Other proteins that are located on mucosal surfaces and secreted from epithelial cells located in the 
URT and LRT include defensins (TAP and LAP), cathelicidins, lysozyme, lactoperoxidase, Ig-A 
and G and surfactant proteins (SP-A and SP-D) (Ganz and Weiss, 1997). It may be postulated that 
expression of the genes encoding these proteins will vary according to their requirement during the 
disease process. Collectively they alter the composition of pulmonary fluid
Recent studies have shown the protective effects o f these proteins and their possible role in 
controlling respiratory infection. For example, an ovine cathelicidin SMAP29 decreased the 
concentration of bacteria in both BALF and necrotic lung tissues of pneumonic lambs (Brogden et 
al., 2001). The roles for other proteins in the lung have been discovered more recently; for 
example, Hp is expressed at a high level in lung cells, and may help reduce oxidative damage 
associated with haemolysis (Yang et a l ,  2003).
Stressors, such as viral or bacterial overload, may compromise the functional integrity of the 
epithelial cell surface, and allow infection to spread out of control, with the result that pulmonary 
fluid becomes altered in such a manner as to promote bacterial survival. Low levels of 
antimicrobial proteins, and high levels of proteins that make the alveolar mucus more viscous, may 
contribute towai'ds reducing bacterial clearance from the lung by cilia and promoting bacterial 
proliferation (Babiuk et a l ,  1995).
Recently, a technique of sequential live bronchoalveolar lavage has been developed to provide 
samples of lung fluid prior to infection and at different stages of disease (Caldow, 2001). This 
technique, combined with recently available cytokine probes, will provide valuable information on 
the cellular and secretory components of the lung, particularly those that may influence the 
initiation of pneumonic pasteurellosis. Such evidence may provide useful markers of clinical 
disease. Changes in inflammatory cytokine profiles in BALF following inoculation with M. 
haemolytica have been reported (Morsey et a l ,  1999; Malazdrewich et a l ,  2001), but changes in 
the overall protein composition of bovine lung fluid following bacterial infection have not been 
assessed. This is now possible through advances in the field of proteomics, using state of the art 
technology that allows the identification of proteins responsible for virulence, pathogenesis, and 
protective immune responses that may be increased or decreased specifically in the diseased lung. 
Characterising protein changes during pneumonic pasteurellosis may provide insight into the 
underlying mechanisms of pathogenesis and lead to new and improved methods of disease 
prevention and control. In addition, the characterisation of this disease process may shed light on a 
related human disease, pulmonary sarcoidosis that is also associated with the accumulation and 
stimulation of inflammatory cells within the lung (Sabounchi-Schutt et a l ,  2003).
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Aims of the study
The proposed work will extend the established experimental model that successfully indicated the 
susceptibility of calves to an intratracheal challenge of P. multocida at 10* cfu in 300 ml of PBS 
and the extent of disease. The model will be used to provide a detailed description of the clinical 
development of pneumonic pasteurellosis and preliminary information on changes in pulmonary 
fluid content during lung infection with P. multocida A:3. Pre-infection lung fluid samples will be 
included in the study to assess the protein composition of a normal healthy lung. Results from the 
former will be compared with post-infection samples and, using 2-DE, MS and databases, changes 
in protein composition following infection will be tracked and any novel bovine and or bacterial 
proteins identified.
5.2. EXPERIMENTAL DESIGN AND METHODS
5.2.1. Animals and challenge procedure
Male Holstein cross Friesian calves (n=16) of approximately two weeks of age were purchased 
from  farms within Midlothian and housed in individual calf pens. Calves were assessed for prior 
exposure to R multocida by nasal swabbing and plasma antibody analysis, performed by an ELISA 
specific to R  multocida cell envelope; all tests were negative.
Calves were weaned at 7 weeks of age from a liquid milk diet to hay and mixed pellets, and held in 
open pens for the duration of the experiment.
At 8 weeks of age (designated experimental day 0) the 16 calves were allocated randomly to two 
groups. A control group (Group 1; n=6) were given 300 ml PBS to allow comparison of clinical 
responses to those of experimentally infected animals, and to see how protein production in the 
lung was affected by the live lavage procedure. The remaining 10 animals (Group 2) were 
challenged with 10* cfu of exponentially growing (log phase) R multocida A:3 in 300ml of PBS. 
Calves in Groups 1 or 2 were challenged intratracheally via a bronchoscope at 8 weeks of age (day 
0) with either PBS or R multocida, respectively (Chapter 4).
5.2.2. Live lung lavage procedure
Lung lavage samples were taken from all calves 2 d before challenge (day -2) to determine 
negative control baselines and on day 1 and day 4 after challenge and at PM  (Table 5.1). All 
experimental protocols were approved by the MRI Animal Experiments Committee, authorised
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under the Animals (Scientific Procedures) Act 1986, and the intervals used complied with the 
Home Office (HO) project licence. Access to veterinary care was available at all times.
5.2.3. Lung fluid protein identification
Unless stated otherwise all reagents and protocols used for the analysis o f proteins in lung fluid 
were purchased from Amersham Pharmacia Biotech UK Ltd, Amersham Place, Little Chalfont, 
Buckinghamshire, England. Lung fluid isolated from only 3 of the 6 Group 1 calves (20, 35 and 41) 
and 3 o f the 10 Group 2 calves (11, 42 and 43) were randomly selected for protein analysis.
2-DE is a technique in which proteins are separated according to their p i (first dimension) and then 
subsequently on the basis of size (second dimension). As a result, proteins present in a sample are 
displayed as spots on a gel. Protein positions can be mapped and differences in composition or 
level of expressed protein compared in samples obtained at different stages of disease and from 
other sources (O ’Farrell, 1975).
Full details of lung fluid protein analysis, separation by electrophoresis and detection by mass 
spectrometry are given in section 2.7.
A PlusOne 2-D Quant Protein assay kit was used according to the manufacturer’s instructions 
(Amersham Pharmacia Biotech UK Ltd, Buckinghamshire, England) to determine accurately the 
concentration of protein present in samples prior to 2-D gel analysis. It was found that 100 pg of 
protein resuspended in 200 pi of rehydration buffer was optimum for the procedure. Samples were 
loaded on 11 cm IPG strips, pH range 3-10 and run on an IPGphor at 100 V for 2 h, 500 V for 1 h, 
1000 V for 1 h, 2500 V for 1 h and 8000 V up to 38.8 kVh. (section 2.7.3).
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Table 5.1. Live lung lavage and bacterial challenge schedule for both groups of animals, control 
and infected.
Treatment
Day - 2 0 1 4 7
CalfLD
Control LV Challenge LV LV PM
Group 1
1 2 3
9,14,20,
Infected LV Challenge LV LV PM
Group 2
1 2 3
10, 11, 
12,24, 
25,
Control 
Group 1
35,41,38
Infected 
Group 2
39,42, 
43,45,48
-5
LV
1
LV
1
0 1 4  7
Challenge LV LV PM
2 3
Challenge LV LV PM
2 3
Challenge = 300ml PBS, 10* CFU P. multocida A3  MRI-671/90 challenge strain. 
LV = Lavage
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Following first dimension electrophoresis, second dimension was carried out by placing each 11 
cm IPG strip on a 12.5 % (w/v) homogeneous 2D-ExcelGel on a M ultiphor II (Amersham 
Biosciences) that separated proteins according to their molecular weight (section 2.7.4). This size 
of gel showed that 100 pg of protein in 200 pi o f rehydration buffer was an optimum concentration 
for clear separation of proteins of interest within lung fluid samples and for compaiative studies to 
be conducted between gels.
Following electrophoresis, protein in the gel was detected by Colloidal Coomasie blue stain 
(Genomics Solutions, Ann Arbor, Michigan) (section 2.7.5), scanned using Imagemaster 
(Amersham Bioscience) and processed using Imagemaster 2D software.
Following the analysis o f 2-D gels, spots were excised for further analysis by MALDI-TOF 
(section 2.7.6). Prior to M ALDI-TOF it was necessary to fragment the 155 spots of interest by 
digestion with trypsin (a proteolytic enzyme that cleaves proteins after the amino acid lysine to 
produce peptides), so that the mass of each fragment could be determined by mass spectrometry. 
Proteins were identified from Swiss-Prot, Mass Spectrometry Database (MSDB) and P. multocida 
databases.
5.2.4, Statistical analyses
The mean rectal temperature and respiratory rate were analysed by subtracting the baseline value, 
to adjust for intrinsic animal variability and a two sample t-test was performed on the data set to 
determine statistical significance between the two animal groups.
5.3 . R esu lts
5.3.1. Clinical observations
Clinical signs such as demeanour, laboured breathing, and reduced appetite were observed 2-6 h 
p.c. in all Group 2 animals. Mean rectal temperatures for Group 2 calves increased significantly (P 
= 0.001) from 38.9 (± 0.09) °C before inoculation to a peak of 40.2 (± 0.1) °C 30 h p.c. (This peak 
occurred at 23 h p.c. in work reported in Chapter 4). Mean rectal temperatures in Group 1 calves 
did not differ significantly for the first 8 h p.c., increasing from 38.9 (± 0.1) ° C 2 h  before challenge I
to 39.4 (± 0.2) ° C 8 h  p.c. (Fig. 5.1a) Following this sampling point and until 68 h p.c. mean rectal 
temperatures were erratic, fluctuating between 38.8 (± 0.1) °C and 39.4 (± 0.05) °C. Mean 
respiratory rates for Group 2 calves increased significantly (P = 0.001) from  33 (± 2.3) min'* prior
m
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to infection to 103 (± 2.9) min ' 8 h p.c. and remained higher than Group 1 calves for the duration 
of the experiment (Fig. 5.1b). Group 1 calves demonstrated a slight increase in respiratory rate 
from a baseline value of 29.5 (± 2.6) min ' to 47.8 (± 3.5) min ' by 8 h p.c., values that were within 
the normal respiratory range and remained so for the duration of the sampling period.
(a)
40 -
-30 30 60 90 120
Time Post-Infection (h)
150 180
(b)
120 1
100
I s  80 -E
40 -
-30 0 30 90 120 150 18060
Time Post-Infection (h)
Fig. 5.1. Mean (± S.E) clinical measurements from calves inoculated with P. multocida A:3 
at 10^ cfu in 300 ml PBS (a) Mean rectal temperature (°C); (b) Mean respiratory rate (rate 
min '). Data presented corresponds to challenge groups 1 (control 300ml PB S*) and 2 
(Infected 10^ cfu R multocida A: 3 in 300 ml PBS ■).
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5.3.2. Gross pathology and bacteriology
Lung surface lesions from Group 2 calves were characterised by severe congestion and
haemorrhage, giving the affected area an intense red to purple discolouration (Fig 5.2A) due to the 
.active hyperaemic response during early stages of inflammation; the apical lobes were most '
affected, as described in Chapter 4. Plaques of fibrinous exudate were located on the lung surface 
and were often responsible for the cranioventral lobes adhering to the thoracic cavity and to each 
other (Fig 5.2B). On sectioning, the lesions seemed nodular and often associated with abscessation.
A high level of fibrinous exudate was present in the bronchial airways. All calves in Group 1 had 
healthy lungs; in some cases (calves 14, 38 and 41) there was evidence of old lesions that were not 
consolidated and some flecks of necrotic tissue that were not acute.
Pleurisy and pleural adhesions were observed in 40 % of calves in Group 2, with no such evidence 
for Group 1 calves. R multocida was recovered from the lungs of 8 pneumonic calves (Group 2), 
largely in areas exhibiting congestion and abscessation. The viable counts from lungs of individual 
calves varied from 2.5 x 10^  cfu g'^  to 1.9 x 10^  cfu g"\ A high bacterial count and high percentage |j 
of surface lesions were observed in this study, similar to that seen in Chapter 4 for this specific 
formulation (10* cfu in 300 ml PBS).
There was no bacterial recovery from heart, heart blood, pericardial or pleural fluid, spleen, kidney, 
liver and lymph node tissues taken from Group 1 animals (Table 5.2).
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Table 5.2. Percentage of surface lesions, pleurisy scores and bacterial recoveries from lung tissue 
(cfu g'^) o f all calves challenged intratracheally with R  multocida A:3 at 10* cfu m f  ^ in 300 ml 
PBS.
Group Calf % lung surface 
affected
Pleurisy Viable mean lung 
count (cfu g'^)
9 0 0 0
14 5 0 0
Control 20 0 0 0
35 0 0 0
38 6.5 0 0
41 2 0 0
10 36 0 4 x 1 0 ^
11 52 2 1.2 X 10*
12 26 0 1.9 X 10*
24 4 0 0
Infected 25 47 0 1x10*
39 20 1 4.2 X 10’
42 47 2 2.8 X 10’
43 25.5 0 0
45 19 1 2 .1x10^
48 10.5 0 2.5 X 10^
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B
Fig. 5.2. Gross pathological changes observed in calf 11 given 10*cfii of P. multocida A:3 in 300 ml 
PBS, 4 d p.c; A: whole excised lungs to illustrate the cranioventral area as being most affected, 
characterised by consolidation and red to purple discolouration (1) of the lung surface; B: ventral 
surface of the same lungs lying within the thoracic cavity, note fibrinous plaques on the 
cranioventral lobe adhering to the thoracic cavity (2).
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5.3.3. Histopathology
Microscopic examination of the selected lesions in Group 2 calves showed that they were typical of 
a moderate to severe fibrinopurulent bronchopneumonia. In all Group 2 calves the interlobular 
septa appeared oedematous as indicated by their marbled appearance and they were filled with 
fibrinocellular exudate, neutrophils and macrophages. As a result, the air supply and muco-ciliary 
apparatus for that part o f the lung became disabled, resulting in tissue necrosis. Focal areas of 
coagulative necrosis contained densely packed inflammatory cells and were present in pulmonary 
parenchyma of all calves in Group 2 except for calf 24. In contrast, the lung tissue of all Group 1 
calves appeared healthy, containing large alveolar air spaces and only the occasional activation of 
bronchial associated lymphoid tissue (BALT) in confined areas around the bronchi. No significant 
histopathological changes were observed in any of the samples taken from  spleen, heart, liver or 
kidney tissues.
5.3.4. 2-Dimensional Electrophoresis; Protein spot patterns
The protein content of lavaged lung fluid detected by the 2D-Quant kit ranged from 154 ~ 5200 |ig 
ml ’ and each sample was adjusted so that 100 pg of protein (section 2.7,2) was loaded on each gel.
2D-gels of lung fluid from both groups of calves resolved up to 155 protein spots of interest, with 
numbers and staining intensity on most occasions being greatest 1 d p.c. The spots were located 
within the region corresponding to molecular masses of 6-75 KDa and within a p i range of 3-10. 
All 2D-gels seemed to present a similar spot pattern whether the animal was in a healthy or 
diseased state. A  large dense area between 80 and 66 KDa, identified as albumin, was observed on 
all 2D-gels and comprised up to 50 % of the total protein. Colloidal Coomasie staining detected a 
dense area of protein (90 to 75 KDa), above albumin that was present throughout the experiment 
but at varying levels o f intensity, illustrated by spots 89, 90 and 91 (Fig 5.3.b and Fig 5.3.C, calf 11) 
and spots 51, 52 and 53 (Fig. 5.6, calf 20), on all gels except for those shown in Fig 5.3.a and Fig.
5.4.C.
Below the albumin area, between 66 and 31 KDa the degree of protein expression varied and there 
was evidence of spots appearing and disappearing at different stages of sampling. A  line of 4 spots 
(93, 94, 95 and 96) are absent in Fig 5.3.a. but appear faintly in Fig 5.3.b and with increased 
expression in Fig 5.3.c. These spots were selected for identification by MS as it seemed that they 
might represent suitable markers o f disease, although these spots were observed also at all 
sampling stages in a control calf (Fig. 5.6, calf 20).
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Varying levels of protein expression were observed in an area directly below albumin (Fig, 5.6, calf 
20). This area showed a high level of protein expression in all animals at the sampling phase prior 
to challenge and appeared to decrease markedly 1 d p.c., only to increase 4 d p.c (spots 44 to 47). 
This spot pattern was also observed in gels shown in Fig. 5.8, calf 41, Fig. 5.7, calf 35 and Fig. 5.5, 
calf 43. MALDI-TOF analysis and a database search showed that spots excised from this area of 
the gel were albumin fragments in multiple forms.
The central region of the gel, between 36 and 28 KDa exhibited a consistent overall pattern of 
spots, although levels of intensity and expression of spots were altered throughout the experiment. 
For example, 6 spots (26, 27, 28, 29, 30 and 31) were present only prior to challenge. Fig. 5,5.a 
indicating their association with normal, healthy bovine BALF. Spot 40 was selected for MS due to 
its appearance 1 d p.c. (Fig. 5.5.b, calf 43). Spots 119 and 120 were taken from  the gel shown in 
Fig. 5.4.a because they were absent from  samples collected on day 1 and 4 p.c., and thus 
corresponded to healthy BALF. Additional spots (113, 114, 115, 116, 117 and 118) were detected 1 
d p.c., and may play a role in infection by R multocida, although BALF taken on day 4 p.c., from 
calf 42, did not show this protein spot pattern, despite re-analysis.
Differences in levels of protein expression were observed in the lower molecular weight region of 
the gel (14.4 to 6 KDa), illustrated in Fig. 5.6.a., Fig. 5.6.b., Fig. 5,6.c. Spot 56 showed decreasing 
intensity throughout the sampling period, whereas spots 57 and 58 exhibited maximum intensity 1 
d p.c; spots were only excised from  this region if they were stained intensely, indicating a high 
concentration of protein.
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5.3.5. Mass spectrometry results
In order to identify the proteins that were either absent or present at designated sampling periods or 
those with varying levels of expression, in 6 experimental calves, all 155 protein spots were 
subjected to M ALD-TOF MS. All spots circled on the gel Fig 5.3 to Fig. 5.8 yielded results by MS 
and keratin contamination was avoided. The fingerprints from  each sample exhibited three sets of 
peaks, one set corresponding to the CHCA matrix, a second corresponding to autodigestion 
products of trypsin and a third for the protein excised from the 2-DE gel. The fingerprints generated 
by the MS for the standards and the proteins with significant hits are located in Appendix 2. 
MALDI-TOF results are in the form of molecular masses of each fragment from the tiypsin digest. 
These masses were placed into three databases; Swissprot, MSDB (~http://ca.expasv.org/0, 
('http://linuxl/mascot/cgi/index.pl?page=../home.htmn and P. fnw/rocida
('http://lenti.med.umn.edu/pub/PM70/) to identify proteins of interest.
5.3.6. Protein identification in bronchoalveolar lavage fluid
Protein identification from excised spots of interest was successful only using the Swissprot 
database. The P. multocida database was unable to identify any bacterial proteins from the 155 
spots excised. The results from the Swissprot database search identified 12 proteins that were 
different among Group 1 calves (Table 5.3) and Group 2 calves (Table 5.4) from the 155 spots 
excised. Many of these proteins were present in multiple forms (isoforms and fragments). Among 
proteins present in multiple forms were apolipoprotein A-1 precursor, serotransferrin precursor, 
bactenecin (antimicrobial peptide precursor), hypothetical protein precursor (a novel protein that 
has yet to be annotated), and bovine serum albumin precursor. Additional proteins that were not 
fragments included aldehyde dehydrogenase-1, annexin-I, tropomyosin-2, antioxidant protein-2, 
actin, annexin V and tropomysoin a -4  chain. It was found that fragments of bovine serum albumin 
were the most predominant protein isolated from all calves. Annexin V was considered the only 
protein with association to the disease state as this was detected 1 d following challenge with P 
multocida  in calf 42 (Table 5.4) and was not identified in BALF of control animals. Annexin I from 
the same family as Annexin V was primarily associated with control animals 1 d p.c. All other 
proteins mentioned above were found to some degree in samples from both control and infected 
animals.
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Chapter 5
5.4 . D iscu ssion
The investigation demonstrated clinical and pathological responses consistent with pneumonic 
pasteurellosis and these responses were reproduced with the challenge formulation 300ml 10^ cfu 
ml"' used in the work and described in Chapter 4. Furthermore, these marked clinical effects were 
not induced by PBS in this experiment, as confirmed by normal clinical signs following 
administration of PBS in Group 1 animals.
The 2-DE patterns of bovine BALE identified 12 different proteins amongst animal groups 1 and 2, 
from over 155 colloidal Coomasie-stained protein spots (intact proteins and fragments). Colloidal 
Coomasie blue was the stain of choice because uptake by different proteins is relatively linear, 
allowing assessment of differential levels o f protein expression, which the stain itself is MS 
compatible. Silver stain is more sensitive but faint spots probably would not contain sufficient 
protein for analysis using our MS setup and also uptake of stain is non-linear.
Proteins which could not be identified by MS were generally those with low intensity, small 
diameter and often within the low Mr region. These proteins could be analysed further by digestion 
with another protease and the peptide sequence elucidated using automated Edman degradation. All 
the proteins identified were host proteins, secreted by pulmonary epithelial cells in response to P. 
multocida infection and to PBS. There was no evidence of bacterial protein, with no hits on the P. 
multocida database search.
Pneumonic pasteurellosis is known to be associated with the accumulation and activation of 
inflammatory mediators and immune cells within the lung (Babiuk et ah, 1995). However, 
secretory products such as IL-8 and IL -ip  (chemoattractants for neutrophils secreted by 
macrophages), surfactant (reduces bacterial growth), Hp (antimicrobial agent), granule contents of 
neutrophils such as lysosomal enzymes, MPO and collagenases were not identified. Other 
constituents of neutrophil granules, antimicrobial peptides, were detected in BALE but they were 
located primarily in the low M r region, making detection by MS difficult. Products from neutrophil 
granules, for example, may compromise the integrity of the alveolar-capillary barrier, leading to an 
increased passage of solutes and plasma proteins and a loss of the gas-exchange capacity during 
pneumonic pasteurellosis (Maheswaran et al., 1992).
In this study the majority of protein spots identified in BALE 2D-E related to either serum albumin 
or albumin precursors, which were indicated by a large spot with an undefined perimeter at 
approximately 70 to 66 KDa, and present in all lavage samples irrespective of treatment. A similar 
albumin pattern and content has been observed for BALE isolated at various stages of disease from 
sheep infected with M. haemolytica (unpublished observations).
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This result is in agreement with the composition of BALF which is reported to contain 
approximately 50 % albumin and 30 % IgA/IgG (Noel-Georis et ah, 2002). Surprisingly 
immunoglobulins did not produce significant results with the Mascot search in this study. The 
abundance of albumin may mask the detection of high molecular weight proteins, such as those 
implicated in the pathogenesis of pneumonic pasteurellosis. To date there is no efficient method 
available for the removal of these major proteins without affecting the composition of the minor 
BAL fluid proteins (Lenz et al., 1993). Preliminary studies however have been conducted at MRI 
to address this problem and to improve the identification of possible disease markers in BALF that 
would otherwise be masked by albumin and immunoglobulins. It is essential that an additional step 
is included to remove the albumin, and this could be achieved by running the samples through an 
affinity column with antibodies to bovine albumin (Lopez et al., 2002) or a column (affinity-blue) 
with immobilin dye, known to bind albumin, and allowing other proteins of a similar mass and pi 
to appear on the 2D-gel.
Another reason for the inability of 2-DE to detect proteins in low abundance and at high molecular 
weight may be due to the dilution of lung fluid during bronchoalveolar lavage. Mammalian lungs 
contain only a thin layer of epithelial lining fluid that surrounds the airways and the alveoli 
(Wattiez et ah, 2000); any more fluid would affect the surface area for gaseous exchange and 
reduce lung efficiency. Host proteins are confined to this layer of epithelial lining fluid, though 
some may originate from the blood due to pulmonary tissue damage.
The value of using bronchoalveolar lavage as a means to analyse the cellular components of lung 
fluid has been established as a research tool (Caldow, 2001). It maybe that technical limitations in 
this study may affect the recovery of low abundance proteins. For instance the infusion of 2 x 60 ml 
Ca^ % Mg^  ^ free HBSS solution at the alveolar epithelial lining would dilute any low abundance 
proteins present at the time of lavage and they may even not appear as only about 60 % of the fluid 
can be aspirated from the lung. Therefore protein such as albumin that constitutes a large amount of 
total protein within BALF has a greater probability of being recovered.
Annexins are proteins that bind phospholipids in a Ca^^-dependent manner. Pulmonary tissues, 
macrophages and neutrophils are rich in these proteins and Annexins I, II, IV and VI have been 
purified from bovine pulmonary tissue. These proteins may be involved in the suppression of 
inflammation, suggesting a role for them in the process of pulmonary inflammatory disease (Katoh 
et aU, 1999). Annexins I and IV have been detected in BALF from calves inoculated 
experimentally with M. haemolytica. Annexin IV was detected more specifically in response to 
bacterial challenge (Katoh et ah, 1999). In the present study Annexin I was primarily associated 
with control calves and its detection has been associated with glucocorticoids, which are increased 
through stress or underlying bacterial infection (Breazile, 1988; Peers et ah, 1993). The insertion of
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a bronchoscope fo r bronchoalveolar lavage or bacteria l challenge could  be  a cause o f  stress. In  th e
'jstudy o f  form alin-killed  P. multocida-'mducQd  pneum onic pasteurellosis (C hapter 6), concentrations 
o f  SAA, H p and A G P (indicators o f  increased  stress) w ere elevated  in  all calves fo llow ing 
bronchoalveolar lavage p rio r to  challenge w ith  either P. m ultocida  or PBS.
I t w ou ld  be o f  interest to m easure the  serum  glucocorticoid  levels o f  all calves in th is study to  
strengthen the explanation tha t stress w as the causative agent o f  the ind irect re lease o f  A nnex in  I in 
G roup 1 calves, as no bacteria  w ere  recovered  from  these anim als a t post-m ortem  and the ir serum  
v ira l antibody titers w ere decreasing.
B y com parison w ith  A nnexin  I, the  detection o f  A nnexin  V  w as associated  essentially  w ith  infected  
calves. T his is the first iso lation  o f  A nnexin  V  from  bovine BALF, th is calcium  and phospho lip id  
b inding  pro tein  possesses po ten t anticoagulant activity (A ndree e t ah, 1990) and has been  show n to  
inhibit phospholipase A 2 activity. T his la tter p roperty  appears to  determ ine the functional ro le  o f  
A nnexin  V  as an  an ti-inflam m atory  m ed ia to r by preventing  the release o f  arachidonic acid  by 
phospholipase A 2 (Aim e t aL, 1988). O ne m ay expect the secretion o f  A nnexin  V  in response to  P  
m ultocida  infection considering its anti-inflm nm atory function. H ow ever, A nnexin  V  w as isolated 
only from  one inoculated  anim al and fo r th is protein to  becom e a po ten tial m arker for 
inflam m atory d isease caused by  P  m ultocida  it is essential tha t i t  is iso lated  from  a m ajority  o f  
infected calves to  allow  defin itive conclusions to  be m ade. F urther research  w ould  be requ ired  to 
elucidate the  ro le  o f  A nnexin  V  in  the pathogenesis o f  pneum onia in naturally  and experim entally  
infected anim als.
O ther host proteins o f  in terest include antioxidant protein  2, apolipoprotein  A-1 precursor, 
aldehyde dehydrogenase A -1, serotransferrin  precursor, antim icrobial peptide, actin  and 
tropom yosin. N one o f  these pro teins w ere  specifically  presen t in  lung flu id  because o f  a  FÎ 
m ultocida  challenge because som e o f  these  pro teins w ere also presen t in the lung flu id  o f  anim als 
g iven  only PBS.
Future  studies should focus on the  rem oval o f  album in from  the sam ple by pre-ffactionation  
leading to  the  reduced  overlapping o f  spots w ith  a sim ilar p i and m ass to  album in, so th a t pro teins 
in  low  abundance could be detected. In  addition, the  production  o f  a  c learer gel w ith  the spots w ell 
separated  and easy to  see can be ach ieved  by use o f  the longer 18 cm  IPG  strips; bu t th is w as 
outw ith  the  scope o f  th is prelim inary  investigation. A tten tion  should  be focused on m ethods to  
im prove the efficiency o f  the  aspiration  technique to  ensure the recovery  o f  pro teins in  low  
abundance w hich  m ay have possib le  roles in the pathogenesis o f  disease. Very recently, the use o f  a 
series o f  narrow  range IP G  strips covering the pH  interval 4.5 - 6 .7  enabled  the  detection  o f  low  
abundance proteins (Sabounchi-Schutt e t aL, 2003). Pre-fractionation  can be  com pared to  the  use 
o f  narrow  range gradient gels, as m ore p ro tein  ex tract can  be loaded onto a  narrow  range gradient
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and thus the probability of detecting the scarcer proteins will be greater (Sabounchi-Schutt et aL, 
2003).
It would be of interest to isolate bacterial proteins from lung fluid which may provide clues to the 
pathogenesis of disease; this could be addressed by probing bovine lung fluid sample with specific 
immune serum. 2-DE proved to be a useful research tool in the analysis of relative changes in lung 
fluid protein composition as the appearance, disappearance and alterations in level of protein 
expression could be observed. However, these relative changes were not associated specifically 
with pneumonic disease and were observed in control animals as well. It is possible that the 
removal of major proteins such as albumin will reveal proteins concerned primarily with disease.
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Chapter 6. Pathophysiological and 
PHAGOCYTIC RESPONSES PRIOR TO AND FOLLOWING 
LUNG CHALLENGE WITH FORMALIN-KILLED 
P A S T E U R E L L A  m u l t o c i d a  BIOTYPE A:3 IN CALVES.
6.1. INTRODUCTION
Chapter 4 summarised novel information on the interaction of an active infection of P. multocida 
with the host in an experimental model of pneumonic pasteurellosis, in which significant clinical 
and systemic responses were recorded.
There is little if any information on how R multocida bacterin may interact with, or stimulate, the 
immune mechanisms within the lung. Components of bacterin include LPS and, following the 
interaction of bacterial LPS with macrophages resident in the lung alveoli, it is understood that 
recruitment of neutrophils occurs by local production of pro-inflammatory mediators (IL-8, IL-6, 
lL-1 and TNF-a) (Soethout et aL, 2002). The migration of neutrophils to the site of inflammation 
occurs soon after infection and assists resident macrophages in the phagocytic killing of pathogens 
and prevents bacterial dissemination to the systemic system. Sustained neutrophil activity often 
contributes to tissue necrosis and levels of these phagocytes tend to be highest in areas of lung 
affected by lesions and high numbers of P. multocida (Davies and Pen warden, 1981).
It is believed that bacterin introduced in vivo would be unable to produce virulence factors and 
antigens such as IRP due to their inability to multiply compared with live bacteria that have 
demonstrated the production of IRP-OMP. Antibodies against these iron sequestering proteins will 
starve the bacteria of iron, rendering them non-viable (Ruffolo et aL, 1998). However IRP are only 
likely to exist if the bacteria were grown initially in iron-restricted conditions.
The systemic response to infectious challenge of the lung is variable and will depend on the 
bacterial agent. For example, intratracheal inoculation of M. haemolytica in calves caused an 
increase in serum TNF-a (Horadagoda et aL, 1994) but research in buffalo challenged intranasally 
with a haemorrhagic form of P. multocida reported a lack of response in serum TNF-a (Horadagoda 
et aL, 2001). Additionally, APP such as Hp was measured in both experiments and exhibited a more 
rapid response following challenge with P. multocida than with M. haemolytica. SAA was also 
measured in the study of Horadogoda et aL, (1994) and showed a marked early rise following 
challenge with M. haemolytica. These APP tend to have longer half lives than T N F-a and may
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prove better indicators of systemic disease than pro-inflammatory mediators. There is growing 
evidence that APP are expressed, and presumably secreted, by tissues other than the liver. The lung 
in particular produces mRNA for Hp (Yang et aL, 1995), even in response to a systemic 
stimulation. Presumably, non-hepatic production would be even more responsive if  the stimulus 
was local, as in the form  of a Gram-negative bacterial infection. In earlier work (Chapter 4) Hp and 
AGP were produced in response to an intratracheal challenge of live P, multocida and AGP may 
have a direct effect on increasing resistance to bacterial infection (Crestani et a l ,  1998).
Many researchers have looked at the stimulatory or inhibitory effects of bacterial components, such 
as exotoxin on resident macrophages. Results from these studies have highlighted the detrimental 
effects of M. haemolytica leukotoxin, on phagocytes and their ability to phagocytose pathogens 
(Markham and Wilkie, 1980). No such exotoxin exists for P. multocida, but this bacterium plays a 
significant role in the pathogenesis of pneumonic pasteurellosis (Ashfaq and Campbell, 1986). The 
LDCL assay has been used to measure production of oxygen radicals during the interaction 
between phagocyte and pathogen, and by applying this technique it is possible to determine the up 
or down regulatory effects o f bacterial components on lung macrophages.
Aims of the study
The study was designed to evaluate the clinical, pathological, lung phagocytic cell and systemic 
responses to an inactivated challenge in which the in vivo expression of virulence factors and 
virulence associated with the ability of bacteria to grow and disseminate in host tissue were 
disabled. The host responses during the early onset and development of disease will be compared 
with equivalent responses following challenge with live organism (Chapter 4). In order to obtain 
information on the effect of exposure to bacterial antigens in vivo on the efficiency of uptake and 
killing of live P. multocida by alveolar macrophages in vitro, lung cells were harvested at intervals 
by a technique of sequential bronchoalveolar lavage.
6.2. EXPERIMENTAL DESIGN AND METHODS
6.2.1. Animals
Prior exposure to P. multocida was determined by screening serum samples for the presence of ;
antibody using a specific ELISA and by culturing nasal swab samples on vancomycin SBA, a 
selective medium that excludes Gram-positive bacteria such as Streptococcus spp, which often
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mask underlying P. multocida colonies. Only calves that showed no growth of P. multocida were 
selected for the experiment.
Twenty clinically healthy calves aged 1 week old and of either sex were selected from farms within 
the M idlothian region and housed as ten pairs, in individual calf pens. Nasal swabs and blood 
samples were collected weekly and all nasal swabs were negative for R multocida prior to 
challenge, though the ELISA detected high antibody titre to R multocida  in a majority of calves 
prior to challenge. Calves were weaned at 7 weeks of age on to hay and mixed pellets, and 
remained housed in individual pens until day 21 (Chapter 7).
6.2.2. Experimental procedure
At 8 weeks of age (designated experimental day 0) the 20 calves were paired according to age and 
allocated randomly to 2 treatment groups of 10 animals each: Group 1 (300ml PBS) and Group 2 
(formalin-killed R multocida in 300 ml PBS). Intratracheal challenge with either PBS or formalin- 
killed R  multocida was given using a fibre optic bronchoscope, in accordance with the 
experimental design summarised in Table 6.1.
Calves were monitored throughout the experiment for clinical signs of disease, using a scoring 
system established previously that provides a quantitative measure o f disease for control and 
infected animals (section 2.8.5) and allows collective action to be taken if necessary. Access to 
veterinary advice and treatment was available at all times.
BALF was recovered from  all calves, using a fibre optic bronchoscope, 2 d before challenge, and 
on day 1 and day 4 after challenge, for the measurement of phagocytic function in vitro and for 2- 
DE in future studies (Chapter 5 and section 2.9). Due to the amount of work scheduled for each 
batch of freshly lavaged cells, the maximum number of lavages that could be processed on any one 
day and still allow time to monitor and, where necessary, treat challenged animals was four. Thus, 
as far as possible, calves were procured over a period of 10 days so that no more than 4 calves were 
scheduled for either lavage and or challenge procedures on any one day.
Alveolar macrophages were separated from PM N by a Percoll gradient centrifugation method 
(section 2.9.2). The efficiency of separation was evaluated by differential count of Diff-Quik 
stained cytospin preparations and cell viability was measured by nigrosin exclusion (sections 2.9.8 
and 2.9,3). The capacity of macrophages and neutrophils to generate a respiratory burst was 
measured by an LDCL assay (section 2.9.4). The effect o f bacterial exposure in vivo on the 
phagocytic efficiency of macrophages was determined in vitro by fluorescence microscopy (section 
2.9.6). The first 100 cells in view were counted and examined for intracellular bacteria. The
133
Chapter 6__________________________________________________________________
number of organisms in each cell and the fluorescence (red or green) of each were recorded and the 
total number of bacteria ingested per reaction field, and the percentage killed, were calculated.
On day 5, at the end of the sampling phase. Group 1 was divided into groups la , lb  and Group 2 
into groups 2a and 2b. The subscript a refers to the animals given either PBS (Group la) or 
formalin-killed P. multocida A:3 (Group 2a). Four animals were assigned to each of these groups to 
determine the effect of dead challenge and PBS on lung pathology (Table 6.1). The remaining 
calves of Group 1 (n=6) and Group 2 (n=6) were now placed into Group lb  and Group 2b (Table 
6.1). The 6 calves in Group 2b (with Group lb  as controls) were used to evaluate the protective 
effect of lung exposure to formalin-killed P. multocida on subsequent immunity (at day 21) to lung 
challenge with live R multocida (Chapter 7).
6.2.3, Serology
Blood samples were collected from a jugular vein into heparinised vacutainers from  all calves prior 
to purchase, on day of arrival, day 0, 4 h p.c, and daily thereafter until day 5 p.c. Plasma was 
separated and stored at - 40°C until analysis for APP. Plasma concentrations of Hp were measured 
(Eckersall et aL, 1999) with purified bovine Hp as a standard. A radial immunodiffusion kit and an 
ELISA kit were used to measure plasma levels o f AGP and SAA respectively, (section 2.6.2).
6.2.4. Statistical analysis
Differences between treatments for AUC (-48 h to 120 h) for Hp, SAA, AGP, respiratory rate and 
mean rectal temperature were tested for statistical significance by ANOVA with treatment groups 
fitted as a factor and the value of the variable on day 0 fitted as a covariate. This was preferred to 
simply looking at the AUC above the day 0 level because on some occasions, and for some 
variables, this method over-adjusted. The choice of AUC was made to provide a robust method for 
the analysis o f repeated measurements from a relatively small number of animals and where the 
responses were not linear with time.
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Table 6.1. Experimental design illustrating the bronchoalveolar lavage schedule at days -2, 1 and 4 
and the intratracheal challenge schedule of calves at day 0 with either PBS or formalin-killed P. 
multocida A \3  (dead challenge).
Day -2 0 1 4
G roup C alf ID
la 457, 459, 530, 534
lb 435,441, 443, 704, 
706, 709,
Lavage
1
Intratracheal challenge 
with 300ml PBS
Lavage
2
Lavage
3
2a 458, 529, 531,532,
2b 172,437, 440, 705, 
707, 708
Lavage
1
Intratracheal challenge 
with 300ml 10^ cfu 
formalin-killed R  
multocida
Lavage
2
Lavage
3
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6.3. RESULTS
Pathophysiological and cellular responses to formalin-killed P. multocida and PBS were 
determined as changes in clinical, acute phase and phagocytic responses.
6.3.1. Clinical observations
All calves appeared healthy and alert prior to and immediately after challenge with either PBS or 
formalin-killed P multocida. The challenge procedure took about 10 min and was well tolerated by 
all animals, causing only mild coughing and a slight increase in respiratory rate. Within 3-5 h p.c. 
clinical signs were observed in Group 2, including dullness, signs of increased respiratory effort, 
mild nasal discharge and reduced appetite.
Mean rectal temperatures for Group 2 calves increased rapidly from a baseline value of 38.9 (± 0.2) 
°C to a peak of 40 (± 0.2) °C, at 5 h p.c., returning to within the normal range (38 to 39.5°C; 
clinical score 0) by 24 h p.c. Mean temperatures for Group 1 calves remained within the normal 
range throughout (Fig. 6.1.a). A secondary temperature response was observed in Group 2 calves at 
48 h p.c. when the mean increased by 0.3°C. Rectal temperatures higher than the mean at the 
beginning of the experiment tended to stay higher throughout the 5 day measurement period. There 
was strong evidence (p = 0,012) of initial differences (0 to 5 h p.c.) in the rate of temperature rise 
between Group 1 and Group 2 calves. However, apart from  initial differences, there was no 
statistically significant difference between the two treatment groups for the remainder of the 
experiment.
Respiratory rates were similar for both groups during monitoring prior to challenge (-48 to 0 h p.c.) 
(Fig. 6.1. b) and the data were pooled. Rapid and marked rises in respiration rates were observed in 
both treatment groups after challenge (0 to 5 h p.c.), doubling from 44.5 min'^ (± 0.7; clinical score 
0) prior to challenge (-48 h to 0 h) to 87.6 min ' (± 6.7; clinical score 2) 5 h p.c. Thereafter, 
respiratory rates in control animals fell rapidly to within normal levels (<60) by 24 h p.c. However, 
the decline in Group 2 animals was not as dramatic and from 12 h p.c. a secondary response was 
observed in which respiratory rates increased from 63.7 min"' (± 2.45; clinical score 1) to a peak of 
77 min"' (± 4.89; clinical score 1) at 48 h p.c., remaining higher than Group 1 animals throughout. 
The mean AUC of respiratory rate against time over the 5 d clinical monitoring period was 
consistently higher for Group 2 than for Group 1 animals (p = 0.043).
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Clinical signs for Group 1 animals showed a similar trend to that of Group 2 animals but mean total 
clinical scores were consistently higher for Group 2 animals, increasing rapidly to 4 within 5 h p.c. 
and showing two further peaks, although lower than the initial peak, at 48 h p.c and 96 h p.c. 
Overall, it was evident that adverse responses to challenge were consistently higher for Group 2 
than for Group 1 animals, although none of these differences was statistically significant, apart 
from the accumulated score over the 5 d initial monitoring period for respiratory rate.
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6.3.2. Serology
Viral antibody and IgG titres for all 20 calves in this experiment aie reported in Chapter 7, where 
the final blood sample was taken at PM  on day 28. Plasma levels o f APP were determined for the 
first 5 days following challenge.
6.3.2. L  A cu te  p h a se  response
Mean plasma Hp concentrations prior to infection were 189 (± 81.7) and 253 (± 114.7) |j,g mb' for 
Group 1 and Group 2 animals, respectively, and increased to 362 (± 111,6) (Xg ml ' by 24 h p.c. in 
Group 2 (Fig. 6.2.a.). Changes in mean plasma SAA concentrations were rapid for Group 2 calves 
between 5 and 24 h p.c., increasing from  29 (± 2.5) to 81 (± 10.3) |xg ml '. The rate of increase 
during this period was slower for Group 1 calves, increasing from 21 (± 4.0) to 67 (± 22.5) p.g ml"'. 
Thereafter concentrations in Group 2 fell dramatically to 36 (± 4.9) |Xg ml ' between 24 and 48 h 
p.c. SAA concentrations in Group 1 fell gradually to 20 (± 3.5) fxg ml ' at 120 h p.c. (Fig. 6.2.c) 
Mean plasma AGP concentrations prior to infection were 369 (± 34.2) and 345 (± 30.2) |Xg ml"' for 
Group 1 and Group 2 animals, respectively. After challenge, increases in AGP were more gradual 
than those observed for Hp and SAA, reaching 438 (± 64.3) |xg ml"' at 24 h p.c. and 450 (± 51.9) 
p-g ml"' at 48 h p.c. for Group 1 and Group 2 animals, respectively (Fig. 6.2.b). The AGP 
concentrations in both treatment groups was sustained above values measured on day 0 for the 
duration of the experiment. However, none of the differences between the two groups of calves in 
Hp, SAA or AGP concentrations were statistically significant.
6.3.3. Reactivity and function of BALF cellular components
The recruitment, function and reactivity of phagocytes residing in the lungs of cattle challenged 
with formalin-killed P. multocida and PBS was determined.
6.3.3.1. M ea su rem en t o f  residen t a n d  recru ited  cell p o p u la tio n s w ith in  the lung
The proportions of lung phagocytes in BALF were assessed on day 2 prior to challenge and on day 
1 and day 4 following challenge with either formalin-killed R multocida  A;3 or PBS by differential 
counts of cytospin preparations (Fig. 6.3). On day -  2, macrophages were the dominant cell type, 
comprising 74 (± 5.5) % and 75 (± 4.7) % of the resident cell population for Group 1 and Group 2 
calves, respectively; the remaining cells were PMN (Fig. 6.4.). By day 1 p.c. neutrophils recruited 
to the lung BALF were the principal cell type comprising 68 (± 4,8) % and 57 ± (6.3) % of the cell
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population in samples from Group 2 and Group 1 animals, respectively. There was little change in 
the proportion of immune cell counts for either treatment groups on day 4 p.c., when 67 (± 4.8) % 
and 64 (± 5.0) % of the lung fluid cells were neutrophils in Group 1 and Group 2 animals, 
respectively (Fig. 6.4.).
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Fig. 6.3. Cytological preparations from bronchoalveolar samples to illustrate the cell types recorded 
as a percentage of the total cells counted at various stages of disease. A: Predominately 
macrophages (1) with some syncytial cells (2) prior to challenge with formalin-killed P. multocida 
and B: the presence of neutrophils (3) and vacuolated macrophages (4), 1 day p.c. with formalin- 
killed P. multocida. Diff Quik stain x 40.
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6.3.3.2. V iability o f  p h a g o cy te  p o p u la tio n s  in lung lavage sam ples
The effect of treatment on the viability of macrophages and neutrophils were compared on day 1 
and day 4 following challenge (Fig. 6.5). Formalin-killed P. multocida  did not appear to affect the 
viability of either cell type as similar phagocyte viability was recorded between the two treatment 
groups. The viability of neutrophils was 89 % in lung wash samples and was consistently higher 
than that for macrophages by an overall mean of 7 %, in*espective of treatment (Fig. 6.5). There 
were minor changes in viability between day 1 and day 4 for each cell type and treatment group.
6.3.3.3. In  vitro  m easurem en t o f  the up take  a n d  killing  o f  o p so n ised  a n d  non~opsonised  
bacteria  by a lveo lar m acrophages
A summary of results for bronchoalveolai- macrophages (BAM) from  calves on days -2, 1 and 4 
p.c. with PBS and formalin-killed P. multocida is presented in Table 6.2. The mean number of 
ingested bacteria killed during incubation with BAM was not affected by the intratracheal 
instillation of either PBS or formalin-killed P. multocida (Fig. 6.6, Fig. 6.7; Table 6.2.). The number 
of ingested bacteria per BAM  ranged from 2.2 (± 0.2) to 4.8 (± 2.5) for phagocytes incubated with 
non-opsonised P. multocida and from 2.1 (± 0.2) to 2.6 (± 0.1) for phagocytes incubated with 
opsonised P multocida  (Table 6.2; Fig. 6.8 and Fig. 6.9).
The mean phagocytic efficiency of BAM was determined by calculating the number of 
macrophages that had ingested bacteria. There was a 10 % increase in phagocytic efficiency from 
day -2 to day 4 for cells from  Group 2 animals incubated with opsonised bacteria and a 4 % 
decrease in phagocytic efficiency for cells from Group 1 animals incubated with non-opsonised 
bacteria (Fig. 6.10; Table 6.2.). However, this parameter failed to show any statistical significance 
throughout the sequential lavage or between challenge groups.
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B
Fig. 6.7. Bronchoalveolar cells isolated from calf 534 1 d p.c. with PBS (Group la). A: 
Macrophages ( 1 ) devoid of bacteria as they have been placed on a control reaction field of the 
BioRad slide. B: Macrophages incubated with P. multocida on another reaction field. The central 
macrophage contains 6 bacteria (2) within the cytoplasm along the same focal plane as the nucleus 
(AO and CV fluorescent stain x 1250).
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D
Fig. 6.9. Bronchoalveolar cells isolated from calf 529 1 d p.c. with formalin-killed P. multocida 
(Group 2a). A: Macrophages devoid of bacteria as they are from a control reaction field of the 
BioRad slide, note the activated macrophages (1) possibly due to formalin-killed P. multocida 
exposure in vivo. B: Two macrophages containing a total of 10 live phagocytosed bacteria (2) 
within the cytoplasm. C: Two macrophages containing a total of 15 live phagocytosed bacteria (2) 
within the cytoplasm. D: Macrophages were incubated with opsonised P multocida., note the 
presence of 3 dead bacteria (3) within the cytoplasm of the two macrophages.
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6.3.3.4. In  vitro  resp ira tory burst o f  B A M  a n d  P M N  a fte r  exposure to e ith er  fo rm a lin -
k illed  P. m u ltocida  o r  P B S
Purified BAM  and PM N adjusted to equivalent concentrations (2 x 10*" cells ml"') were incubated 
with a PK 'C  agonist PMA, and live opsonised or non-opsonised P. multocida., and their respiratory 
burst activity was compared with control treatment (McCoys 5A medium) or antiserum. PMN were 
incubated with antiserum, opsonised P. multocida., PMA and McCoys as a comparison.
Marked increases in LDCL, upon exposure to PMA were observed from both neutrophils and 
macrophages recovered from all animals. The respiratory burst o f macrophages occurred at a rate 
of 5 541 RLU s'* (Group 2 day 1 p.c.) over 473 s (Fig. 6.11). In contrast, the respiratory burst of 
neutrophils occurred 213 s earlier than that of macrophages and a maximal respiratory response 
was 3.5 fold greater for neutrophils at 19 519 RLU s'* (Group 2 day 4 p.c.) (Fig, 6.12). For 
macrophages the LDCL value decreased gradually thereafter, on average by 42 % regardless of 
treatment in vivo (Fig. 6.11; Table 6.3). The decline in response observed for neutrophils prior to 
challenge was only 18 % and increased to 33 % p.c. There was no statistical significant difference 
in the respiratory burst for BAL cells obtained prior to or following challenge in vivo or between 
treatment groups 1 and 2.
Macrophages from day -2 incubated in vitro with opsonised P. multocida  produced a gradual 
increase in LDCL that reached a plateau at 816 s for both Group 1 and Group 2 (Fig. 6.13).
A different response was observed in cells incubated with opsonised P. multocida, obtained at days 
1 and 4 p.c., in which the LDCL response increased by 50 % to a peak at 900 s (Group 1, day 1 
p.c.) and by 100 % to a peak at 1030 s (Group 2 day 1 p.c.), after which values were lower on day 4 
p.c., by 30 % and 14 %, for groups 1 and 2, respectively. A similar pattern for the response curve 
was observed on stimulation of neutrophils with opsonised P. multocida  (Fig. 6.14), except that the 
overall RLU value was 5 fold higher than that generated by macrophages.
The stimulation of macrophages with antiserum produced a LDCL kinetic pattern comparable to 
that of the opsonised bacteria for Groups 1 and 2 animals prior to and post challenge, except that on 
days 1 and 4 p.c. the antiserum response was slightly depressed (by 9 % and 21 % respectively, Fig.
6.13). A different relationship between opsonised bacteria and antiserum was observed for 
neutrophils (Fig. 6.14). A high LDCL response was observed for neutrophils isolated from both 
treatment groups prior to challenge, reaching accumulated values of 3 700 RLU s'* over 343 s (Fig.
6.14). For both treatment groups this value increased substantially by day 1 p.c., particularly for 
Group 1 calves. In contrast, on day 4 p.c., the LDCL response for opsonised bacteria and antiserum 
decreased markedly to the levels o f the control, McCoys, with both treatment groups showing a 
remarkably identical response.
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The stimulation of macrophages with non-opsonised P. multocida produced only low levels o f light 
emission and exhibited a response curve comparable to that o f the response to McCoys. On 
addition of McCoys to neutrophils only a gradual stimulation was observed and a peak LDCL value 
was not reached during the assay for either treatment groups (Fig. 6.14)
Total integrated LDCL values expressed as mean RLU sec'* x 10*^  were calculated for the area 
under the profile curve and shows the overall reactive oxygen intermediate production for the 32 
min sampling period. The respiratory burst was 5 fold higher on exposure of PM N (Table 6.4) to 
PM A than the response from macrophages (Table 6.3). The addition of opsonised P. multocida to 
both cell types produced a measurable respiratory burst, higher than that observed with McCoys 
and live P. multocida. There was no significant difference in the mean integrated LDCL responses 
for BAL cells obtained prior to or following challenge in vivo or between treatment groups 1 and 2 
or to any of the stimulants.
6.3.3.5. In itia l linear rate o f  resp ira tory burst
The rate of increase of the respiratory burst was rapid and more pronounced for neutrophils (Table 
6.4) than for macrophages (Table 6.3).
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Chapter 6
6.3.4. Gross pathology and bacteriology
Results for gross pathology, bacteriology and histopathology refer only to 8 calves that were 
challenged either with formalin-killed P. multocida (Group 2a, n= 4) or with PBS (Group la, n= 4).
Surface lung lesions of all calves in Group 2a were identical to those of calves given live challenge 
(Chapter 4) except that on sectioning there was little evidence of exudate within the bronchi. The 
lung lesions were confined to the right and left apical lobes, affecting on average 10 % of the lung 
surface area (Table 6.5) (Fig. 6.15). Two animals (Calf 457 and 530) in Group la  had 9 % and 16 % 
of their lung surface area affected respectively. Calf 457 showed scattered lesions in all four lung 
lobes. For Calf 530 both apical lobes were consolidated and contained microabscesses and 
collapsed alveolar tissue, but little evidence of exudate within the bronchi. The remaining control 
animals, 534 and 459 (Group la), had no discernable gross lung pathology and appeared normal.
P. multocida was recovered from  the lungs of 6 calves 2 of these animals were given only PBS, and 
the bacteria were located in lung tissue exhibiting extensive consolidation. The viable counts of 
individual calves varied from 0 cfu g'^ (Group la) to 1.2 x 10  ^ cfu g’‘ (Group 2a). On average, 
recovery of bacteria from lung tissue was lowest in Group la  animals and highest in Group 2a 
animals (Table 6.5). There was no significant association of bacterial count with treatment group. 
There was no evidence of bacterial count being associated with respiratory rates, or any of the 
acute phase proteins (Table 6.5). Bacteria were not recovered from pericardial, or pleural fluid or 
heart blood.
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Fig. 6.15. Gross pathological changes observed for calves given 300ml PBS (Group la) and lO’ cfu 
formalin-killed P. multocida A:3 (Group 2a); A: healthy lungs in situ from calf 534 challenged with 
PBS (Group la) and; B: view of the ventral surface of the same lungs when removed from the 
thoracic cavity, no evidence of lesions; C: lungs in situ from calf 529 challenged with formalin- 
killed P. multocida (Group 2a) and; D: view of the ventral surface of the same lungs when removed 
from the thoracic cavity. Consolidation of the right apical lobe is evident in both photographs.
1 6 1
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Table 6.5. Percentage of surface lesions, pleurisy scores and bacterial recoveries from lung tissue 
(cfu g"‘) of calves challenged intratracheally with PBS or formalin-killed P, multocida A:3.
Group Calf % lung surface 
affected
Pleurisy Viable lung count 
(cfu g'^ )
4 5 7 9 .2 0 8.0 X 10^
la 5 3 4 1.3 0 No bacteria
4 5 9 6 1 No bacteria
5 3 0 * 16 1 1.3 X 10^
4 5 8 1 0 .5 0 1.3  X 10^
2a 5 2 9 12 0 1.2 X 10^
5 3 1 7 .2 0 6 .5  X 10“^
5 3 2 9 .2 1 1.0 X 10^
* C ^ f 530. Unfortunately this calf was housed with P. multocida challenged animals.
6.3.5. Histopathology
All four calves given only formalin-killed R multocida (Group 2a) showed evidence of moderate- 
severe broncho-interstitial pneumonia in the right apical lobe, and 3 of the 4 calves contained 
alveolar oedema (Fig. 6,16.). All calves showed evidence of mild-moderate depletion of BALT and 
in calves 458, 531 and 529 the BALT appeared active. Neutrophils were migrating through the sub­
mucosa of the respiratory epithelium and were present in airways.
Two animals assigned to Group la  (457 and 530) exhibited histopathological findings typical of 
bacterial purulent pneumonia (Fig. 6.17.). Calf 457 showed evidence of mild, acute broncho­
pneumonia in all four lobes and calf 530 showed signs of acute, severe broncho-interstitial 
pneumonia solely in the right apical lung lobe. The lungs of calves 534 and 459 showed no 
evidence of bacterial infection. Occasional foci of PM N were located in the respiratory epithelium 
and airways of all four calves, with greater concentrations found in calves 457 and 530. No 
significant histopathological changes were observed in any of the samples taken from the spleen, 
heart, liver or kidney.
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Fig. 6.16. Histopathological changes observed in Group 2a calves challenged with lO’ cfu 
formalin-killed P. multocida A:3 ; A: calf 458 28 d p.c. (H&E, original magnification x 20); mostly 
normal lung tissue from the left apical lobe with occasional areas of thickening of alveolar septa 
(1): note the presence of BALT which appears contained (2); B: calf 458 28 d p.c., left apical lobe 
(H&E, original magnification x 100); thickening of the alveolar septa due to the presence of cells, 
possibly interstitial macrophages, within the septa (3); C: calf 529 28 d p.c., (H&E, original 
magniftcation x 40): fibrinous broncho-pneumonia of the right apical lobe as shown by the 
presence of alveolar oedema and fibrin in the alveolar spaces (4), which are in various stages of 
collapse and consolidation: all bronchioles contain a mixed, predominately PMN, inflammatory 
cell infiltrate; D; calf 529 28 d p.c., (H&E, original magnification x 100): fibrinous broncho­
pneumonia of the right apical lobe as denoted by extensive alveolar oedema along with fibrin 
formation in alveolar air spaces (4): bronchiolar airways are obliterated due to the presence of 
mixed inflammatory cell infiltrate (5).
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Fig. 6.17. Histopathological changes observed in Group la calves challenged with 300 ml PBS; A: 
calf 534 28 d p.c. (H&E, original magnification x 20); left apical lobe illustrating normal bronchi 
(1), inter-lobular septa (2) and alveoli (3). The corrugations present in bronchial epithelium are a 
post-mortem/fixation artifact as is slight collapse of alveoli (4); B; calf 534 28 d p.c., left apical 
lobe (H&E, original magnification x 400); bronchial respiratory epithelium (5), with occasional 
PMN migrating through the epithelium (6) in normal lung tissue; C: calf 534 28 d p.c., left apical 
lobe (H&E, original magnification x 40); normal lung, note BALT (7) and lack of cells within 
terminal (8) and respiratory (9) bronchioles and alveolar spaces (10); D; calf 534 28 d p.c., left 
apical lobe (H&E, original magnification x 200); normal expanded alveoli devoid of any 
inflammatory cell infiltration (11).
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6.3.6. Nasal swab analysis
It was found that 2 of the 4 animals by 3 weeks p.c., from each group (457, 534, 459, 530; Group 
la  and 458, 532, 531, 529; Group 2a) not given live challenge, tested positive for P. multocida 
(Table 6.6). At PM, bacteria were also recovered from tracheal swabs and lung tissue of all calves 
except 534 and 459 (Group la). These 2 animals remained negative throughout the experiment.
Table 6.6. P. multocida detection from nasal swabs taken periodically in all calves prior to and 
following inoculation with PBS and formalin-killed P. multocida A:3 at 10^ cfu in 300 ml PBS. 
Data in the table until week 4 (PM) corresponds to the respiratory tract status of P. multocida for 
those calves that were not exposed to live P. multocida.
Group CalfLD Prior to 
challenge
Week 1 Week 2 Week 3: Prior 
to live P. 
m ultocida
Week 4 
PM
457 - + - + +
la 534 - - - - -
459 - - - - -
530 - - - + +
458 - - - + +
2a 532 - + - - +
531 - - - - 4-
529 - - - + +
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6.4 . D iscu ssion
The investigation was designed to compare and contrast the effects of formalin-killed P, multocida 
or PBS on lung and systemic pathophysiology on animals given a live challenge (Chapter 4). In 
addition, the effects o f formalin-killed P multocida on lung cell-mediated changes were assessed.
6.4.1, Clinical responses to challenge
Adverse responses such as pyrexia, increased respiratory rate and laboured respiration were 
observed for calves given formalin-killed P. multocida, but, surprisingly, similar responses were 
observed also for animals challenged with PBS. It is unlikely that these clinical responses found in 
control animals were due to the volume of fluid and or the physical insult of the challenge 
procedure, because a clinically normal response to PBS alone was observed in work described in 
Chapter 5, suggesting that these unexpected responses may be attributable to environmental 
conditions. The question to address, which leads us to Chapter 7 is whether an adaptive response 
against a homologous challenge had been generated.
6.4.2. Acute phase protein responses to challenge
To my knowledge the increase in SAA shown here is the first description of an APR to a killed 
pathogen, but along with Hp and AGP was not significantly greater in the treated than in control 
animals. Hp and especially SAA are sensitive indicators of inflammatory disease in cattle and their 
levels in blood during acute events are usually 10 to 100 fold (Conner et aL, 1988) and 100 to 1000 
fold greater, respectively, than the normal physiological levels, which are often near the limit of 
detection (Eckersall and Conner, 1988). Although the calves appeared healthy at the beginning of 
the study, elevated plasma concentrations of these acute phase proteins were observed in 
approximately 30 % of the calves prior to challenge and indicated the presence of a subclinical 
infection.
Any changes in mean Hp and AGP concentration were small and statistically non significant for 
either group throughout the study. The slight rise in Hp and AGP was more than likely due to the 
challenge procedure and not the effect of formalin-killed P multocida. The responses for Hp and 
AGP were similar in Group I calves, although in Group 2 animals the progressive rise in AGP 
concentration was delayed until 12 h p.c. The Hp and AGP responses to formalin-killed challenge 
were markedly different from those seen following a live challenge (Chapter 4 and Chapter 7). The 
Hp response following live P. multocida challenge (Chapter 4) increased linearly and peaked at 1 g
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r ‘ as opposed to peaking at 400 jug ml ‘ by 5 h p.c., observed in Group 2 calves. Whereas the AGP 
response following live P. multocida challenge (Chapter 4) was more gradual and sustained 
reaching concentrations of 620 mg 1'*, a delayed AGP response was observed for Group 2 calves in 
this study.
The rise in plasma SAA level was rapid for Group 2 calves, occurring after challenge more quickly 
than Hp. A similar observation has been reported for SAA response to M. haemolytica in cattle 
where it was suggested that SAA could have been released from local cells such as alveolar 
macrophages instead of hepatocytes (Horadogoda et aL, 1994). The differences in SAA 
concentration between infected and control animals in the current study were not significant, 
although the degree of increase in SAA for Group 2 calves was higher. This finding may be 
explained by the presence of P. multocida antigens in the blood triggering the synthesis of SAA for 
the purpose of scavenging foreign material. A similar but greater SAA response was observed 
following live R multocida challenge (Chapter 4) peaking at 600 mg T* between 5 and 12 h p.c., 
although SAA levels fell at the end of the sampling period which was not the case in this study.
6.4.3. Cellular responses to challenge
Resident alveolar macrophages constitute a primary line of innate defence against foreign invaders 
and keep microbes at bay before neutrophils arrive in substantial numbers from the blood (Celli 
and Finlay, 2002). The presence of neutrophils in BALF may be used as an indicator of 
inflammatory disease (Walker et aL, 1985; Caldow, 2001) and in this study formed part of the 
cellular response of calves to formalin-killed P. multocida. In normal, healthy calves alveolar 
macrophages constitute 90 % of the cells present in BAL fluid, the remaining cells being 
neutrophils, epithelial cells and lymphocytes (Allen et aL, 1992a). However, with the onset of 
bovine respiratory disease, the proportion of macrophages decreases as neutrophils are recruited 
into the lung tissue and become the dominant cell type (Allen et aL, 1992b).
In this study the unusually high proportion (25 %) of neutrophils present in the pre-challenge
lavage was surprising as neutrophils are usually recruited to the site of infection as a result of a 
foreign invader. This may indicate an underlying infection of a bacterial or viral nature, prior to
challenge, as indicated also by the high initial concentrations of APR
Additional neutrophil recruitment was observed in both groups following challenge but formalin- 
killed P. multocida produced a greater effect on the recruitment of neutrophils on day 1 p.c. 
compared with the PBS challenge by 11.6 %, though the difference between the two groups was 
not statistically significant. These findings are supported by a study on differential cell counts in 
feedlot calves treated for respiratory diseases (Allen et aL, 1992b) while similar findings have been
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reported in cases where the resident alveolar macrophages have been overloaded with bacteria 
(Davies and Penwarden, 1981). To my knowledge there is no evidence within the public domain 
showing recruitment of cells in the presence of dead bacteria. However, it is unlikely, with a 
challenge of formalin-killed bacteria for overloading to occur, as no viable bacteria were present. It 
seems more credible that the physical presence of the bronchoscope and the volume of fluid that 
entered the lung is responsible for the similar percentage of neutrophil recruitment in both 
challenge groups on day 4 p.c., which would be supported by the demonstration in dogs and 
monkeys that a pulmonary lavage alone can stimulate neutrophil movement from the blood into the 
lung (Cohen and Batra, 1980).
Moreover, subclinical disease unrelated to experimental treatment may have been affecting the lung 
on any of the sampling days (Allen et aL, 1992b) as indicated by the recovery of P. tnultocida by 
nasal swabbing of the animals. Gram positive bacteria could also have been present in the URT 
though this cannot be confirmed as the swabs were plated onto SB A, suppressing any growth of 
Gram-positive organisms so that the presence of Gram-negative organisms would be easily visible 
if present.
The in vitro viability of recovered neutrophils was consistently higher than that of macrophages by 
a mean of 10 % for all calves throughout the study. The LDCL response was also higher for 
neutrophils than macrophages, even though the same number of viable cells was used in either test. 
It is possible that the resident alveolar macrophages were disabled by the unlooked for presence of 
a pathogen, whereas the neutrophils had been recruited fresh to the site o f infection from the blood, 
ready for phagocytic killing as reflected by their large LDCL response in this study.
6.4.4. Phagocytic responses to stimulants following in vivo challenge 
with bacterin
The interactions between bovine mononuclear cells and P. multocida  are poorly understood and 
have not been characterised to the extent that other respiratory pathogens, such as M. haemolytica 
and Haemophilus somnus (Czuprynski and Hamilton, 1985 and Czuprynski et aL, 1987) have been. 
In this study of in vitro interactions between alveolar macrophages and P. multocida a few points of 
biological interest have been raised such as the failure of the phagocyte to bind opsonin, the 
phagocytic uptake of P multocida independent of opsonisation and the survival of P. multocida for 
at least 1 h in the hostile environment of the macrophage.
The similar rate of phagocytic uptake of both opsonised and non-opsonised bacteria indicated that 
opsonisation of P. multocida using heat-inactivated immune polyclonal antiserum was unsuccessful 
despite using serum raised to this specific strain. Formalin-induced alterations of the bacterial
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surface components such as the trapping of carbohydrate and lipid molecules within a matrix of 
insoluble cross-linked proteins could conceivably interfere with antibody/phagocyte interaction, 
however, low concentrations of formalin used in the present work were unlikely to have affected 
the physiochemical and immunogenic properties of the bacteria (Nencioni et aL, 1991). It was not 
possible to control the incubation period for the opsonisation process as tightly as anticipated, and 
due to the nature of response curves whereby the margin of error was small, there was always a risk 
of low rates of opsonisation (section 2.9.5).
It is feasible that a change in the target antigen in a nutrient deficient environment in vitro may 
have arisen (Faustian et aL, 2001) or that the bacteria exhibited antigenic variation at the late log- 
to-stationary phase of growth, as has been demonstrated in Neisseria sp, (Serkin and Seifert, 1998). 
However, it seems unlikely that this could have occurred at the stage of growth that P, multocida 
were used at, which was mid-log phase.
Despite the apparent lack of opsonisation of P. multocida, there was evidence of bacterial 
internalisation. Macrophages are able to ingest bacteria and other pathogens by a variety of 
mechanisms. Opsonin-independent phagocytosis is elicited by the interaction of macrophage 
surface receptors with microbial surface components that include mannose receptors, type A 
scavenger receptors and integrins (Celli and Finlay, 2002). Another mechanism that can promote 
contact between bacteria and phagocytes is surface phagocytosis of immobilised bacteria a process 
that has been confirmed for S. epidennidis and E. coli by PM N and alveolar macrophages (Gordon 
e taL,  1989).
Fluorescent microscopy demonstrated that P multocida had the capacity to survive within 
macrophages for a short period in vitro, illustrated by the negligible bactericidal activity of 
macrophages to P multocida during a 1 h incubation period. Several mechanisms for intracellular 
survival of pathogens exist; escape into the cytoplasm, inhibition of phagolysosomal fusion and 
disabling of the respiratory burst.
Studies of phagocytosis with Haemophilus somnus, an organism that exhibits similar pathogenesis 
to that of P multocida, revealed a survival tactic that involves the prevention of phagosome and 
lysosome fusion, thus inhibiting the respiratory burst (Gomis et aL, 1998). In this work a low to 
negligible LDCL response by lavaged macrophages in the presence of live bacteria indicated 
inhibition of the respiratory burst. A similar LDCL response from BAM  has been reported for a live 
logarithmically growing or stationary phase of H. somnus (Gomis et aL, 1997).
The evidence presented in this work suggests that P. multocida may interfere with the oxidative 
dependent bactericidal ability of mononuclear cells. The low LDCL response to live non-opsonised 
P multocida corresponds with results from adhesion slides, which show bacterial uptake but low
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bactericidal activity. M easurement of the LDCL response following the addition of PMA to 
macrophages and live P. multocida would need to be performed to confirm the theory of pathogenic 
interference in reactive intermediate production; if there was no response curve the mechanism of 
respiratory burst has been disabled.
The environment, in which the macrophages and bacteria were suspended for both the cell- 
adhesion slide work (Goldner et al., 1983) and the LDCL assay, must be taken into account when 
comparing the results between both these in vitro experimental setups. The cell-adhesion slide 
method requires RPMI medium during the incubation stages to provide macrophages with nutrient 
and help maintain viability throughout the procedure. The LDCL assay does not require medium, 
so it is plausible that the low LDCL response of macrophages to live P. multocida measured by the 
LDCL assay may have been due to the absence of medium, making the macrophages more 
susceptible to bacterial killing.
The rate of increase of the respiratory burst produced by phagocytes was greater for neutrophils 
than macrophages, suggesting that neutrophils produce precursors for reactive intermediates at a 
greater speed and quantity than do macrophages. In contrast, the rate of respiratory burst increase 
was gradual for macrophages regardless of the stimulus, indicating that hexose monophosphate 
shunt activity was depressed, delaying the production of oxygen intermediates.
Gross pathology results for calves (Group 2a) exposed to formalin-killed P. multocida A:3 showed 
that a greater area of lung was affected compared to that of control calves given PBS (Group la). It 
is unlikely that a neutrophilic response alone could be responsible for the tissue necrosis, as 
differential immune cell counts on lavaged cells indicated little difference in neutrophil population 
for Group 1 and 2 calves at day 1 and day 4 p.c. This observation may be attributed to the 
unexpected recovery of P. multocida from lung tissue, which was greater for Group 2a than Group 
la  animals, reflecting a persistent underlying infection caused by a different strain of P. multocida. 
It would be of interest to perform PFGE on the bacteria recovered from  the lungs of calves in 
Group la  and Group 2a and characterise the adventitious pathogen and compare it with the 
homologous challenge used for Group lb  and Group 2b animals. Formalin-killed bacteria contain 
LPS which is responsible for the release of injurious agents such as reactive oxygen/nitrogen 
species and elastase from phagocytes. This toxic integral component of the P. multocida membrane 
may have been the likely cause for the greater area of lung consolidation recorded for Group 2a 
calves, than for Group la  calves, in addition to the isolation of resident P. multocida.
Nasal swabbing was deemed an inaccurate and unreliable test for the detection of adventitious 
pathogens and only at PM  was the bacterial status of the respiratory tract clarified, wherein 75 % of 
the calves that were given either PBS or formalin-killed bacteria tested positive for live P. 
multocida. It is conceivable that those animals that tested positive at PM had P. multocida residing
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in the respiratory tract from the start of the experiment and undetected by swabbing of the nasal 
passages. Furthermore, the bronchoscope used for challenge and lavage may have introduced live 
bacteria from the URT to the LRT.
6.4.5. Conclusions
The investigation was unable to demonstrate a significant difference in blood levels of APP to 
between calves treated with formalin-killed P. multocida, compared to control animals and this 
finding showed with the low clinical response.
The opsonisation procedure appeared unsuccessful indicated by similar LDCL responses for 
antiserum alone and opsonised bacteria, however the phagocytic uptake of R multocida in vitro still 
took place, as shown using cell-adhesion slides by the presence of P. multocida internalised within 
macrophages.
Comparable LDCL responses observed for both challenge groups showed formalin-killed P. 
multocida had no debilitating effect on the respiratory burst of the phagocytes.
Despite active phagocytosis P  multocida were able to survive intracellularly, as demonstrated by 
the AO/CV fluorescence technique. However, this process was observed only for a 60 m incubation 
period and it would be of interest to extend this period and monitor the ability for the bacteria to 
survive within the alveolar macrophage. Additionally, an accurate assessment of bactericidal 
activity was not achieved due to the Strugger effect, whereby dead bacteria appeared red in the first 
instance and rapidly turned green, despite the use of Cityfluor as antifade, making the accurate 
recording of dead (red) bacteria difficult.
The LDCL response of cells to P. multocida with opsonising antiserum or to opsonising antiserum 
alone was similar. Serum protein alone can cause the release of CL (Easmon et ah, 1980) and this 
phenomenon was observed and quantified in the present work.
The clinical, biochemical and cell-mediated responses noted from this study indicated that the host 
immune response to infection occurred mainly within the lung as there was no evidence of a 
systemic antibody response, although there was evidence of an APR. Future work should use the 
results of this study to improve the methodology and focus more on cytofluorometric techniques as 
these are likely to be simpler, rapid, more reproducible and objective (Chaka et ah, 1995; 
Raybourne et ah, 2001) in helping to elucidate the host-microbial interactions occurring at the site 
of infection or in vitro. M oreover it would be of interest to examine different dose formulations of 
formalin-killed P. multocida. In this experiment the same number of bacterial cells was used as for 
the live challenge (Chapter 4). The live dose, however, has the ability to multiply bacteria to levels
m
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greater than that administered. In contrast formalin-killed bacteria are unable to multiply and for a 
fair comparison a larger dose of dead bacteria may have been needed. It would seem that Group 2 
calves coped well with the exposure to bacterial antigens, since the clinical response was sizable 
but little difference was observed from control animals, raising the possibility that this approach 
may be useful in generating protection against a subsequent live infection.
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Chapter 7. Effect of lung exposure to 
FORMALIN-KILLED P A S T E U R E L L A  M U L T O C I D A  
BIOTYPE A:3 ON SUBSEQUENT RESPONSE TO 
HOMOLOGOUS LUNG CHALLENGE IN CALVES.
7 .1 . In trod u ction
The pathogenic mechanisms of fibrinous pneumonia in cattle due to P. multocida A:3 are poorly 
understood and the prevention and treatment of disease remains inadequate. To date no vaccine 
exists against P. multocida A:3, though many vaccines have been designed to reduce the incidence 
of pneumonic pasteurellosis caused by M. haemolytica, including whole cell, capsular, leukotoxin 
extract and iron-regulated vaccines (Panciera et al., 1984b; Donachie et al., 1983; Shewen and 
Wilkie, 1988; Gilmour et al., 1991). These vaccines containing bacterial antigen offer variable 
levels o f protection, due possibly to the mode of administration or type of adjuvant used, though it 
seems more plausible that the ability of the host to develop antibodies against IRP-OMP that are 
present in some vaccine formulations and not others would contribute to this variability (Confer et 
a l.,2 0 0 \) .
The use of formalin-killed Pasteurella spp., as a candidate vaccine antigen to control pneumonic 
pasteurellosis has been of limited value for M. haemolytica (Confer et al., 1985) and to my 
knowledge no such studies have been associated with P. multocida. Several field trials were 
conducted to assess the effect o f vaccination with killed M. haemolytica on resistance to subsequent 
experimental exposure with the live organism (Confer et aL, 1985, 1987). It was acknowledged 
that, despite the production of a serum antibody response, no protection was observed and lesion 
scores were comparable to control calves given PBS (Confer et al., 1987; Mosier et al., 1998). 
These results suggest that a systemic antibody response does not necessarily confer protection and 
may denote only exposure to somatic antigens, providing further support for the need to clarify 
pathogenic mechanisms of disease occurring within the lung. Furthermore, the inability of 
formalin-killed P. multocida to produce IRP would be a likely cause of a reduced antibody response 
in the work conducted by Confer et al., (1985). In contrast, the administration of immune serum 
that is likely to contain antibodies to IRP, directly into the systemic system, has provided 94-100 % 
protection of recipients compared to control lambs against experimental pneumonic pasteurellosis 
(Jones e ra /., 1989).
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The potential for mucosal immunity to confer protection was considered in a study showing that 
initial priming of the nasal cavity by a natural infection enhanced the systemic immune response, 
leading to improved protection against experimental exposure of Pasteurella spp., (Conlon et al., 
1995). Mucosal and localised immunity within the upper respiratory tract and the lung, 
respectively, in the protection of ruminants against pneumonic pasteurellosis, may not be primed 
effectively by intramuscular or subcutaneous immunisation.
Repeated intranasal exposures to formalin-killed M. haemolytica A:2 have led to significant levels 
of secretory IgA, IgM and IgG in the lung fluid indicating the potential of killed cells as vaccine 
antigen (Zamri-Saad et al., 1999). Tlie efficacy of an intranasal instillation of formalin-killed M. 
haemolytica A:2 in goats to provide protection through mucosal immunity was demonstrated by the 
reduced severity and occurrence of lung lesions compared with unvaccinated animals (Effendy et 
aL, 1998). With this in mind, the treatment described in Chapter 6 may provide initial priming of 
the host lung immunity by lung exposure to formalin-killed P. multocida, enhancing the innate 
immune response and leading to better protection against a homologous challenge of P. multocida.
Aims of the study
Continuation of the work described in Chapter 6 involved an examination of whether prior 
exposure to formalin-killed P. multocida  conferred protection against a live homologous challenge, 
as a possible vaccine strategy. The approach used to administer the inoculum would be different 
from that used by Effendy and colleagues (1998), with the expectation that administration of 
formalin-killed P. multocida  directly into the lung would stimulate a localised immune response 
and provide a similar degree of protection to that observed with stimulation of the URT mucosa by 
intranasal instillation of formalin-killed M. haemolytica.
7.2. EXPERIMENTAL DESIGN AND METHODS
The animals used in this study were those assigned to Group lb  and Group 2b as explained in 
Chapter 6.
7.2.1. Preparation of live P. multocida inoculum
P. multocida A:3 was cultured to the log-phase stage of growth and diluted in PBS to give a total 
dose of 10^ cfu in 300 ml (section 2.8.2.) The range of actual live bacterial doses, estimated 
retrospectively by plating out serial dilutions of each dose onto blood agar, was 1.5 to 2 x 10^ cfu.
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7.2.2. Experimental procedure
Calves belonging to Group lb  (435, 441, 443, 704, 706, 709) and Group 2b (172, 437, 440, 705, 
707, 708) challenged previously on day 0 with either formalin-killed P. multocida (Group 2b) or 
PBS (Group lb) were challenged intratracheally on day 21 with live P. multocida at 10^ cfu in 300 
ml PBS, followed by PM on day 28. Calves were monitored throughout the experiment for clinical 
signs of disease, using a scoring system established previously (section 2.8.5.) while access to 
veterinary care was available at all times.
7.2.3. Necropsy
Post-mortems were performed on day 28 p.c. after calves were killed by i.v., injection with 25 ml 
of Pentobarbitone Sodium B.P. (200 mg ml ’; Animal Care). Details of necropsy and scoring of 
gross pathology are given in section 2.8.6.
Representative samples from the lymphoid system, respiratory system and other organs of 
significance were placed in two preservatives; 10 % formol-saline or zinc salts and prepared for 
histopathological examination using standard techniques.
7.2.4. Bacteriological examination
Small samples of tissue (approximately 1 cm cubes, about 1 g) were taken from four pre-selected 
lung sites (apical, cardiac, intermediate and diaphragmatic lobes), bronchial lymph nodes, caudal 
and raid mediastinal lymph nodes, tonsils, spleen, liver, kidney and heart. The samples were 
homogenised in 9 ml peptone water and diluted in 10-fold steps to 10 *". Aliquots (10 pi) of each 
dilution from 10'^ to 10'^ were applied to SBA plates and incubated at 37°C for 16-20 h. Viable 
counts were determined and expressed as cfu g’’ of tissue (section 2.8.7).
7.2.5. Serology
Blood sampling from a Jugular vein from 12 of the 20 calves resumed on day 21 prior to 
intratracheal challenge with live P. multocida A:3 4 h p.c. and daily thereafter until and including 
the day of necropsy (day 28). Plasma was separated and stored at -40°C until analysed for viral 
antibodies, IgG levels and AFP (Hp, AGP and SAA) (section 2.6.2). Levels of viral antibody to 
BYDY, IBRY, RSY and PI-3 in sera prior to challenge and at PM were detected by an ELISA 
(section 2.6.4). Levels of antibody to P. multocida in the sera were measured by an ELISA (section 
2.6.3) using microtitre plates coated with P. multocida envelope.
Ï75
Chapter 7__________________________________________________________________
7.2.6. Statistical analysis
The AUC for the same time period as in Chapter 6 (-48 h to 120 h p.c; with 0 h being time of live 
challenge) was measured for the following parameters: Hp, SAA, AGP, respiratory rate and rectal 
temperature. Differences between groups in AUC were assessed for statistical significance by 
ANOVA. Treatment groups were fitted as a factor and the value of the variable on day 0 fitted as a 
covariate. An ANOVA, adjusted for covariate was also carried out for percentage of lung affected 
and mean bacterial burden per gram of lung tissue. Lung bacterial count was analysed on a log 
scale because of the skewed nature of the data.
7.3. RESULTS
Protection against a subsequent homologous live challenge of P. multocida  A:3 was assessed by 
measuring pathophysiological responses between day 21 and day 28 p.c. Clinical measurements 
and blood sampling were recorded up to day 26 in order to make a direct comparison with the 
effects of formalin-killed challenge (Chapter 6).
7.3.1. Clinical observations
At day 21 p.c. all calves showed normal clinical signs and appeared healthy prior to and 
immediately after challenge with live R  multocida at 10^ cfu in 300 ml PBS (Groups lb  and 2b). 
The challenge procedure was well tolerated by all animals, causing only mild coughing as observed 
on day 0. Within 5 h p.c. all animals became dull with signs of increased respiratory effort, 
mucopurulent nasal exudate and reduced appetite. Similar clinical observations after 5 h p.c. with 
live P. multocida A:3 were also reported (Chapter 4).
Mean rectal temperatures increased for all calves from a baseline value of 38.6°C (± 0.1) (Group 
lb) or 39.0°C (± 0.2) (Group 2b) to a peak of 40°C at 10 h p.c. (± 0.4 Group lb: ± 0 .1  Group 2b) 
(Fig. 7.1a), returning to within the normal range (Chapter 4) by 24 h p.c. A secondary temperature 
response was shown by calves in both treatment groups, when an increase in mean rectal 
temperature of 0.7°C (Group 2b) and or 0.4°C (Group lb) was observed at 24 h p.c. Group 2b 
calves had the higher mean rectal temperature between days 21 and 26 compared to Group lb  
calves, although there was no statistically significant difference between the two groups. Rectal 
temperatures for Group lb  calves reached a peak value comparable to that observed for calves 
given 300 ml 10^ cfu (Chapter 4), although the peak occurred at 10 h p.c in this study instead of 23 
h p.c recorded (Chapter 4).
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Prior to infection mean respiratory rates for Group lb  and 2b calves were pooled, 51 (± 3.0) and 
48.5 (± 4.9) min ’ (Fig. 7.1b), representing a clinical score of 0. Rapid and marked rises in 
respiratory rates were observed in both treatment groups after infection, increasing to an average of 
101 (± 5.7) mill’’ at 5 h p.c., representing a clinical score of 3, in all infected animals. Calves in 
Group lb  and 2b exhibited a secondary response during which respiratory rates increased at 72 h 
and 24 h p.c., respectively and remained above the normal range until the scheduled PM  date. 
There was no evidence of a difference in mean AUC of respiratory rate against time between 
Groups lb  and 2b. However, respiratory rates for both treatment groups were significantly higher 
(p = 0.026) than for animals challenged with PBS at day 0 (Group la . Chapter 6). Higher 
respiratory rates were observed at day 21 compared to day 0 for calves given live R multocida 
challenge (Chapter 4).
Overall clinical signs for Group lb  showed a similar trend to that of Group 2b animals, with 
marked, rapid responses within 5 h p.c. Thereafter, clinical symptoms for Group lb  began to 
resolve such that there was an obvious improvement in the health status of the calves until 72 h 
p.c., when there was a secondary clinical response to infection. The degree of clinical disease 
appeared greater for Group 2b animals between 48 h and 96 h p.c. as a result of a secondary 
clinical response. However, there was no statistically significant difference in the overall clinical 
response from the onset of exposure to R multocida until 10 h p.c. between both treatment groups. 
From 24 h p.c. and until the end of the clinical monitoring phase, the clinical response appeared to 
be consistently higher for Group 2b animals compared to that of Group lb , although none of these 
differences was statistically significant.
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Chapter 7
7.3.2. Serology
7.3.2.1. Viral an tibody analysis
M easurement of antibodies to viral antigens showed that 70 %, 95 %, 90 % and 70 % of pre­
infection plasma samples contained antibodies to IBRV (Fig. 7.2), RSV (Fig. 7.3), PI-3 (Fig, 7.4), 
and BVDV (Fig. 7.5), respectively. For most calves the comparison of antibody level in samples 
taken before infection and immediately prior to PM showed a variable decrease in antibody, 
indicating that the calves were seronegative for these respiratory viruses. The decrease in antibody 
ranged from  39 to 100 % for BVDV, 21 to 62 % for P I -3 ,12 to 100 % for RSV and 19 to 100 % for 
IBRV. However, though the RSV antibody titre for calf 530 (Group la ) increased by 5 % during the 
experiment, the calf appeared clinically healthy.
7.3.2.2. Ig G  im m une response
Mean plasma IgG titres at 1:100 dilution for all samples ranged from  OD 1.41 (± 0.03) to 1.43 (± 
0.03) on day 0 prior to challenge with either PBS or formalin-killed P. multocida A:3 (Fig. 7.6). 
Following challenge the IgG response was very similar for all treatment groups showing a mean 
increase in O.D of approximately 0.03, on day 21 which was sustained until the end of the 
sampling period on day 28.
7.3.2.3. A cu te  p h a se  p ro te in  response
Mean plasma (± SE) Hp concentrations, prior to challenge with live P. multocida on day 21 were 
136.7 (± 35.3) and 45 (± 10.6) |.ig ml‘‘ for Group lb  and 2b animals respectively and increased to 
806 (± 253.3) pg ml ' and 856 (± 300) pg  m b' by 48 h p.c., in Group lb  and 2b animals 
respectively (Fig.7.7.a). Thereafter mean concentrations decreased gradually to 498 (± 228.5) pg 
mb' for Group 2b animals, whilst those in Group lb  animals showed a slight increase to 835 (± 
314.5) pg m b' by the end of the sampling period (Fig.7.7.a). A  t-test indicated no statistical 
significance in differences in mean Hp concentrations between groups lb  and 2b.
The rate of increase for mean plasma SAA concentrations was very rapid in both treatment groups 
and occurred between 5 and 24 h p.c. for Group lb  animals, increasing from 11.2 (± 1.9) to 101.3 
(± 20) pg mb' (Fig.7.7.c) and between 0 and 10 h p.c. for Group 2b animals, increasing from 26.8 
(± 4.3) to 67.4 (± 17.4) pg m b' (Fig.7.7.c).
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Fig. 7.2. IBRV antibody titres in pre-infection ( □ )  and post-mortem (■) (28 days) bleeds from 
calves inoculated with PBS, formalin-killed, P. multocida and P. multocida A:3 at 10^  cfu in 300 ml 
PBS. Data presented corresponds to challenge groups; (a) Group la (300ml PBS) calves, no 
response for calf 459; (b) Group lb (300ml PBS and lO’ cfu live P. multocida in 300ml PBS) 
calves, no response for calf 709; (c) Group 2a (10* cfu formalin-killed P. multocida in 300ml PBS) 
calves; no response for calf 531; (d) Group 2b (10* cfu formalin-killed P multocida and 10* cfu live 
P multocida in 300ml PBS) calves, no response for calves 705 and 437.
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Fig. 7.3. RSV antibody titres in pre-infection ( □ )  and post-mortem ( ■  ) (28 days) bleeds from 
calves inoculated with PBS, formalin-killed P. multocida and P. multocida A:3 at 10*cfu in 300 ml 
PBS. Data presented corresponds to challenge groups; (a) Group la (300ml PBS) calves; (b) Group 
lb (300ml PBS and 10* cfu live P multocida in 300ml PBS) calves, no response for calf 709; (c) 
Group 2a (10* cfu formalin-killed P multocida in 300ml PBS) calves; (d) Group 2b (10* cfu 
formalin-killed P multocida and 10* cfu live P multocida in 300ml PBS) calves.
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Fig. 7.4. PI-3 antibody titres in pre-infection ( □  ) and post-mortem (■) (28 days) bleeds from 
calves inoculated with PBS, formalin-killed P. multocida and live P. multocida A:3 at 10* cfu in 
300 ml PBS. Data presented corresponds to challenge groups; (a) Group la (300ml PBS) calves; 
(b) Group lb (300ml PBS and 10* cfu live P multocida in 300ml PBS) calves, negative response 
for calf 709; (c) Group 2a (10* cfu formalin-killed P. multocida in 300ml PBS) calves; (d) Group 
2b (10* cfu formalin-killed P multocida and 10* cfu live P multocida in 300ml PBS) calves, 
negative response for calf 172.
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Fig. 7.5. BVDV antibody titres in pre-infection (Q ) and post-mortem (■) (28 days) bleeds from 
calves inoculated with PBS, formalin-killed P. multocida and P multocida A:3 at 10* cfu in 300 ml 
PBS. Data presented corresponds to challenge groups; (a) Group la (300ml PBS) calves, negative 
response for calf 530; (b) Group lb (300ml PBS and 10* cfu live P multocida in 300ml PBS) 
calves, negative response for calf 709; Group 2a (10* cfu formalin-killed P multocida in 300ml 
PBS) calves, negative response for calves 529 and 531; (d) Group 2b (10* cfu formalin-killed P 
multocida and 10* cfu live P. multocida in 300ml PBS) calves, negative response for calves 437 
and 172.
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Fig. 7.6. Mean (± SE) plasma IgG titres in pre-infection (day 0), post-infection (day 7 and 21) and 
post-mortem (day 28) bleeds from calves inoculated with PBS, formalin-killed P. multocida and P. 
multocida A:3 at 10  ^ cfu in 300 ml PBS . Data presented correspond to challenge groups. Group 
la: 300ml PBS ( ♦ ) ,  Group lb: 300ml PBS and 10  ^cfu live P. multocida in 300ml PBS (■), Group 
2a: lO’ cfu formalin-killed P. multocida in 300ml PBS ( ), Group 2b: 10^ cfu formalin-killed P. 
multocida and 10^ cfu live P. multocida in 300ml PBS ( • ) .
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Thereafter the SAA increase in Group 2b was more gradual and sustained for longer to 48 h p.c, 
peaking at 92.8 (± 15.4) pg ml"'. Thereafter SAA concentrations in both treatment groups decreased 
to about 55.7 (± 10.3) pg ml ' at 96 h p.c., and remained at this level for the remainder o f the 
experiment. There were differences in the SAA response between Groups lb  and 2b, although these 
differences were not statistically significant. However, the group of calves given only PBS 
(Chapter 6) had approximately half the mean SAA levels of Group lb  calves throughout the 5 day 
sampling periods between day 0 and day 5 and between day 21 and day 26.
Calves that had high levels of a jA G P  prior to exposure with live P. multocida  tended to have high 
levels following infection. Increases in the mean plasma a iA G P  concentration for Group lb  
animals were more gradual and sustained than those observed for Hp or SAA (Fig,7.7.b). All calves 
in Group lb  exhibited a steady increase in the aiA G P  response over the course of the experiment, 
similar to the aiA G P response reported in Chapter 4, but for Group 2b calves (Fig.7.7.b) this rise 
was less sustained and reached an initial peak mean concentration of 492 (± 77.3) pg ml ' at 48 h 
p.c., decreasing to 438 (± 70.1) pg ml ' at 72 h p.c. Thereafter the mean a ,A G P  concentration 
increased gradually to 510 (± 43.4) pg ml ' by the end of the sampling period. There was no 
evidence that any of the differences in the oc,AGP response between Groups lb  and 2b were 
statistically significant.
There was no evidence of statistically significant differences in the responses of Hp, a jA G P  or 
SAA to treatment between Groups lb  and 2b animals. There was no evidence of a difference 
between the treatment groups in the change of these acute phase proteins from the period following 
challenge with formalin-killed P. multocida (Chapter 6) to challenge with live P. multocida.
7.3.3. Gross Pathology of the lung
Affected areas of lung tissue were collapsed, consolidated, varied from  pink to purple in colour and 
often contained abscesses and thickened gelatinous pleura (Fig. 7.8). These observations were 
characteristic of all calves given the live challenge (Groups lb  and 2b) with the apical lobes being 
affected consistently (Fig. 7.8). On many occasions the apical lobes had fibrinous adhesions to the 
thoracic wall and the pericardium. Caudal lung lobes were variably affected with the lesions more 
scattered. The gross pathological features described here for Group lb  calves are similar to those 
described for calves given the same treatment (Chapter 4).
On sectioning of the affected areas the bronchial mucosa was oedematous, inflamed and often 
contained exudate within the airways. The mean percentage of surface lung affected was 23 %  for 
calves in Group 2b and 16 % for calves in Group lb  and this difference was statistically significant
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(p = 0.013) (Table 7.1.). There was a statistically significant correlation between Hp and percentage 
of lung affected. Calves with high values of Hp tended to have greater lung damage (p = 0.031). 
Pleurisy was observed in all four groups, but there was no correlation between degree of pleurisy 
and treatment, though the extent of pleurisy was more pronounced in animals from Groups lb  and 
2b (Table 7.1.) than those animals in Groups la  and Group 2a (Chapter 6).
Bronchial and mediastinal lymph nodes from infected animals were often inflamed and in some 
cases (Calf 437 Group 2b) the cortex of the bronchial lymph nodes was barely discernible. In calf 
706 (Group lb) the pericardium appeared inflamed and contained excess yellow/green pericardial 
fluid. The tracheal mucosa of calves given the live challenge of P. multocida  was yellow, inflamed 
and mucus was often present. The trachea appeared normal in control animals.
7.3.4. Bacteriology of the lung
p. multocida was recovered from the lungs of the 12 calves challenged intratracheally with live P. 
multocida, primarily in lobules exhibiting extensive consolidated lesions. The viable counts of 
tissue from individual calves ranged between 5.3 x 10'' cfu g ' (Group 2b) and 4.0 x lO’ cfu g‘* 
(Group lb) (Table 7.1.). On average, recovery of bacteria from lung tissue was lower in Group 2b 
than in Group lb  animals by approximately 1 log. The mean P. multocida  lung count was similar 
for infected animals (Groups lb , 2b) and there was no significant effect o f treatment on bacterial 
load. However, calves with high temperatures also tended to have a higher bacterial count and this 
correlation was statistically significant (p = 0.029). There was no evidence of bacterial count being 
associated with respiratory rate, or any of the APP (Table 7.1.). P. multocida was also recovered 
from tracheal swabs of all calves, which was to be expected due to the inoculation of live bacteria. 
Bacteria were recovered from only one calf (Chapter 4) given 300 ml 10^ cfu P. multocida, whereas 
in this study bacteria were recovered from all calves in Group lb  and Group 2b.
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Fig. 7.8. Gross pathological changes observed for calves in Group lb and Group 2b given 
homologous challenge on day 21 following challenge with either PBS or formalin-killed P. 
multocida. A: Dorsal surface of lungs in situ from Calf 441 (Group lb) and B; Dorsal view of the 
same lungs removed from the thoracic cavity; consolidation of the right apical lobe is appreciable 
in both photographs (1). C: Dorsal surface of lungs in situ from Calf 708 (Group 2b) and D: 
Ventral view of the same lungs removed from the thoracic cavity. Consolidation of the right apical 
lobe is evident in both photographs (2) and some flecks of necrotic tissue in the upper area of the 
caudal lobe (3).
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Table 7.1. Percentage of lung surface affected by lesions, pleurisy scores and bacterial recoveries 
from lung tissue (cfu g'*) of Group lb  and Group 2b calves.
Group Calf % lung surface 
affected
Pleurisy Viable lung count (cfu g‘^ )
435 18 1 1 .2 x 1 0 '
441 12 0 1.3x10*
lb 704 3 2 1.2 X 10'
706 28 1 4.0 X  10’
443 10 0 4.2 X 10'
709 28 0 4.0 X 10*
707 15 0 1.1x10*
172 21 1 1.1 X  10*
2b 708 21 0 4.8 X  10'
440 24 1 1.6 X 10*
705 31 1 5.3 X  lO''
437 27 1 1.1 X 10'
7.3.5, Histopathology
Lesions observed in the lung samples varied from  mild-moderate to severe multifocal 
fibrinopurulent bronchopneumonia. Lesions were well compartmentalised by the prominent inter­
lobular septa present in bovine lung. The predominant inflammatory cell was the neutrophil 
indicating the lesions were acute in nature.
All six calves assigned to Group 2b showed evidence of acute, severe broncho-interstitial 
pneumonia in the right apical lobe (Fig, 7.9). Only half of the calves had lesions in the left apical 
lung lobe and these ranged in severity from mild to severe with half having mildly affected caudal 
lung lobes (Fig. 7.9). BALT appeared to be very active in some sections from  calves 172 and 437. 
M ild to severe alveolar oedema was present in 50 % of calves and a high level of neutrophils 
present in airways, alveolar air spaces, migrating through the respiratory epithelium of all 6 calves. 
All six calves assigned to Group lb  showed evidence of acute, severe to very severe broncho-
189
Chapter 7__________________________________________________________________
interstitial pneumonia with the right and left apical lung lobes affected consistently (Fig.7.10). 
BALT appeared stimulated in 5 of the 6 calves in various lung lobes with no evidence of severe 
depletion of lymphoid cells. Alveolar oedema was present occasionally, mostly mild but severe in 
the left apical lobe of calf 435. Occasional foci of neutrophils in airways, alveolar air spaces and 
respiratory epithelium were present (Fig.7.10). Bacteria were not recovered from pericardial or 
pleural fluid, or from heart blood. Bronchial (right and left) and mediastinal (mid and caudal) 
lymph nodes appeared active in all calves as denoted by the presence of a large number of 
secondary follicles. PMN leukocytes were present along the cortical trabeculae and in the 
medullary cords of the lymph nodes. No significant histopathological changes were observed in 
any o f the samples taken from  the spleen, heart, liver or kidney.
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Fig. 7.9. Histopathological changes observed in Group 2b calves challenged with lO’ cfu formalin- 
killed P. multocida in 300ml PBS and also with 10^  cfu live P. multocida in 300ml PBS, 3 weeks 
later. A: Calf 172 28 d p.c., right apical lobe (H&E, original magnification x 40); severe 
bronchopneumonia as denoted by collapse and consolidation of lung parenchyma and airway 
lumen completely full of inflammatory exudate (1). Note the presence of BALT (2), some 
containing germinal centres (3). B: Calf 172 28 d p.c., right apical lobe (H&E, original 
magnification x 100) illustrating complete obliteration of the luminal airspace by exudates (4). C: 
Calf 437 28 d p.c., left caudal lung lobe (H&E, original magnification x 100); note mild 
inflammatory cell infiltration into the bronchial airway (5). Note the presence of BALT (6). D; Calf 
437 28 d p.c., right apical lobe (H&E, original magnification x 200); airway inflammatory exudate 
consists of mixed, predominately PMN, inflammatory cells with a significant population of what 
appears to be activated macrophages (7). Note the presence of PMN streaming through the intact 
respiratory epithelium (8) and the sub-epithelial mass of lymphoid cells that comprise the BALT 
(9).
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Fig.7.10. Histopathological changes observed in Group Ib calves infected with lO’ cfu live P. 
multocida in 300ml PBS. A: Calf 443 28 d p.c., left apical lobe illustrating severe broncho­
pneumonia (H&E, original magnification x 40); large areas of collapsed and consolidated alveoli 
(1) are present along with a severe inflammatory cell infiltration while bronchi and bronchiolar 
airspaces are obliterated due to the presence of inflammatory cells (2) and interlobular septa are 
swollen and oedematous (3). B: Calf 441 28 d p.c., right apical lobe (H&E, original magnification 
X 100); inflammatory cells are PMN (4), while alveolar air spaces contain many PMN (5) and 
interlobular septa appear swollen and oedematous (6). C: Calf 441 28 d p.c. right apical lobe 
illustrating severe broncho-pneumonia (H&E, original magnification x 40); alveoli are collapsed, 
consolidated and contain inflammatory cells (7) and all airways contain inflammatory exudates. D: 
Calf 443 28 d p.c., left apical lobe (H&E, original magnification x 400); inflammatory cells can be 
identified as predominately PMN (8), while monocytes (9) and activated macrophages (10) are also 
present.
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7.3.6. Nasal swab analysis
Nasal swab cultures from 10 of the 12 calves prior to live challenge were positive on day 21 of the 
experiment, before exposure to a homologous challenge of P. multocida  (Table 7.2).
Table 7.2. P. multocida detection from nasal swabs taken periodically prior to challenge with live P. 
multocida A: 3 and at PM (day 28) for calves in Group lb  and Group 2b.
Group C alfL D Prior to 
challenge
W eek l Week 2 Week 3; Prior to 
challenge with live P. 
multocida
Week 
4: PM
435 - + - + +
441 - + - - +
lb 704 - - + +
706 - + - + +
443 - + - + +
709 - + + + +
707 - + - - +
172 - + + + +
2b 708 - - - + +
440 - + - + +
705 - - + + +
437 - - - + +
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7.4, Discussion
The study was designed to evaluate the protective effects of formalin-killed P. multocida against a 
homologous (live) challenge as assessed by measuring pathophysiological changes. In addition, 
comparisons were made between the pathophysiological responses following homologous 
challenge in Group lb  calves and the pathophysiological responses following live challenge (300ml 
at 10^ cfu) in Chapter 4.
Clinical responses to live P multocida such as pyrexia and increases in respiratory rate were 
comparable to those responses observed previously (Chapter 4), except for rectal temperature 
which was slightly lower (40.2°C) in this study. There was no difference in the clinical response for 
the initial phase of the experiment (0-24 h p.c.) in calves belonging to groups lb  and 2b indicating 
that exposure to formalin-killed P multocida failed to stimulate the appropriate immune response 
necessary to provide protection for calves on exposure to live P  multocida. Furthermore, clinical 
signs for Group 2b calves seemed to be more severe than for Group lb  from 24 h p.c. until the end 
of the experiment. The sizable clinical response and percentage of surface lung affected for Group 
2b calves compared to Group lb  calves indicated that the formalin-killed P. multocida challenge 
exacerbated the clinical response to exposure to homologous challenge. At this point one would 
consider that formalin-killed P multocida  was detrimental to the host, yet a log lower bacterial 
burden was recorded for the calves in Group 2b compared with calves in Group lb . One may 
postulate that calves in Group 2b had a lower proportion of apoptotic neutrophils than calves in 
Group lb  and that the presence of a higher proportion of neutrophils is likely to result in the 
removal of more bacteria while causing extensive lung damage. The fraction of apoptotic 
neutrophils in the recovered BALF was not assessed in this study though this would be of value for 
future work.
The APR exhibited by animals (Chapter 4) given the same treatment as calves in Group lb  in this 
study, demonstrated a far more gradual increase in SAA concentration that peaked at 23 h p.c., 
though the time to peak was the same in both cases. However, the SAA concentration was lower by 
400 mg r '  for calves in chapter 4 than that recorded in this study. Calves (Chapter 4) given 300 ml 
10® cfu P. multocida showed a very slow rise in a ,  AGP which was quite different to that described 
in this study for Group lb  calves. Calves (Chapter 4) given 300 ml 10® cfu P  multocida 
demonstrated a more gradual increase in Hp concentration than that observed in Group lb  in this 
study, and the peak Hp concentration was higher and occuned at the same point (48 h p.c.) as that 
observed in this study. Overall, the levels o f Hp and SAA detected in the plasma reported in 
Chapter 4 were greater; in contrast mean AGP levels in Chapter 4 were lower, perhaps due to 
between-animal variation in the innate APR. The lack of a significant difference in APR between
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the vaccine group 2b and the control Group lb  was evidence that prior exposure to formalin-killed 
R inultocida alone had little effect on the systemic system.
The fact that these clinical and APR occurred in Group 2b animals following exposure to a 
homologous challenge indicated that formalin-killed P. multocida did not prime the immune system 
as anticipated initially, leading to uncertainty with regard to the method of bacterin production, the 
quality of the bacterin formulation and the mode of administration. It is possible that formalin 
treatment may have destroyed the conformational structure of the epitopes responsible for 
induction of immunity. This has been the possible cause for failure of formalin-inactivated BHV-1 
vaccines, wherein certain BHV-1 glycoprotein epitopes are highly susceptible to destruction by 
formalin treatment (Duque et al., 1989). However, it has been shown that low concentrations of 
formaldehyde, as used in this study, maintain the antigenic integrity of many important epitopes 
involved in inducing protection although the concentration of induced pathogen-neutralising 
antibodies is low (Nencioni et al., 1991). It is feasible, therefore, that the formalin-killed challenge 
contained an insufficient concentration of protective antigens and that one or more repeat 
instillations of bacterin may be required to achieve and maintain the optimum level of protective 
antigens and stimulate the immune response.
Evidence, in this study, for the bacterin's inability to produce a protective immune response stems 
from the serum IgG response. Prior to challenge in 8 week old conventionally reared calves, 
antibody to respiratory viruses and P multocida  was detected and the age of the animals indicated 
that this was due to immunity passively acquired from the mother via colostrum and or their own 
immune response, which is often well developed at 8 weeks of age. In all samples the antibody 
levels to the viruses (BVDV, PI-3, RSV and IBRV) decreased with time, indicating that the viral 
antibody at the start o f the experiment was attributable to passive transfer and not to an active 
response to infection.
Following challenge with formalin-killed P. multocida there was a low and biologically 
insignificant change (0.03 OD) over the four weeks of the experiment in the high level of IgG 
detected prior to challenge with live P multocida. Work by Black et al., (1985) showed an optimum 
level of systemic antibody when vaccination is expected to work, above which the presence of 
maternally derived antibodies (MDA) may suppress the response to vaccination. The lack of an IgG 
response in this study may have been due to high levels of MDA prior to challenge with formalin- 
killed P. multocida that could have suppressed the development of the young calf’s active immune 
responses to these antigens (Black et al., 1985). For future studies it would be of benefit to define 
the level at which antibody provides protection and to challenge the calves below this point, 
reducing the risk of MDA interfering with the active response to vaccination.
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The route of challenge adopted in this study may be a contributory factor to the lack of an IgG 
response. Effendy et a l ,  (1998) demonstrated that repeated intranasal exposures to formalin-killed 
M. haemolytica A:2, followed by an intratracheal challenge, led to the local production of IgG and 
IgA and stimulated also a systemic antibody response. Intratracheal instillation of formalin-killed 
bacteria as used in this study may have bypassed the priming of the mucosal epithelial layer of the 
URT which, when analysing the work conducted by Effendy and others (1998), seems to be a 
requirement for stimulation of systemic immunity. When evaluating the nature of formalin-killed 
bacteria, which are fixed and have no independent movement or opportunity to disseminate via, for 
example, penetrating the mucosal epithelial barrier, one would expect the immune response to be 
highly localised and the release of antibodies, primarily IgA into the lung and not into the systemic 
system (Wilkie, 1982). In this experiment the route of infection was the same as that used in 
Chapter 4 so that a direct comparison could be made between the pathophysiological responses 
attributed to live and killed P. multocida.
Lung pathology of animals given formalin-killed P. multocida was attributable to the host response 
to foreign material. However, P multocida  in the range of 1.3 x 10^ and 1.2 x 10  ^ cfu ml * was 
recovered from these animals, suggesting that the role of natural infection must be addressed since 
these calves were conventionally derived, with access to colostrum and the risk of natural exposure 
to Pasteurella spp. It has been reported that prior natural exposure to Pasteurella spp. enhanced 
resistance to an experimental infection of pneumonic pasteurella (Confer et a l ,  1984). In the 
current work, the challenge dose of live P. multocida increased considerably the surface area of 
lung affected in animals primed with formalin-killed P multocida (Group 2b), probably due to the 
ability of P. multocida  to proliferate and disseminate leading to extensive lung pathology.
Group lb  calves showed a log higher lung bacterial burden, than did Group 2b calves. This result 
seems to indicate that the lung clearance mechanism for Group 2b calves is more efficient at 
removing bacteria than for Group lb  animals. A possible advantage of administering formalin- 
killed P  multocida but this result was not statistically significant. However, the restrictive sampling 
technique on lung tissue for recovery of bacteria may have omitted areas containing a high 
bacterial load. This was discussed in some detail earlier (Chapter 4) and may provide an 
explanation for this 1 log difference in bacterial recovery between Groups lb  and 2b, thereby ruling 
out a possible protective factor of formalin-killed P  multocida challenge.
P  multocida  was recovered from the lungs of all calves in Group lb  but this was not the case for 
calves given similar treatment previously (Chapter 4), where bacteria were recovered from only 
one calf. It may be possible that the presence of a persistent underlying infection in Group lb  
calves exacerbated the pathology resulting from the live challenge with P  multocida  by
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overloading the alveolar macrophages with bacteria and contributing to the reduced lung clearance 
in this study.
A significant, positive correlation (P<0.05) was found between lung damage and concentration of 
plasma Hp for calves in Group 2b, One may postulate from this result that lung damage could be 
responsible for the local production of Hp. The synthesis of Hp in the alveolar fluid within the lung 
has been reported and moreover provides a source of anti oxidant and antimicrobial activity (Yang 
et al., 1995). The mechanism of Hp induced antimicrobial activity has been demonstrated in 
transgenic mice where Hp was over-expressed in alveolar macrophages (Yang et a i ,  2003). These 
mice demonstrated an increase in haemoglobin clearance leading to attenuated blood-induced lung 
injury and inflammation attributable to a lung bacterial infection.
If killed products of P. multocida are to become effective vaccine antigens, it would be of benefit to 
focus research on identifying and characterising the protective antigens (Confer et al., 1985). 
Furthermore, the choice of adjuvant is vital to ensure a good immune response (Confer et al., 
1985). Studies using different adjuvants have demonstrated a significant difference in the serologic 
responses in calves. For example, a greater serum antibody response was observed in calves 
vaccinated with bacterin, initially with Freund's complete adjuvant followed 7 d later with Freund’s 
incomplete adjuvant resulting in enhanced resistance against exposure to live M. haemolytica, 
when compared to aluminium hydroxide in gel adjuvant (Confer et al., 1987), A  similar result has 
been demonstrated in lambs vaccinated with capsular M. haemolytica  combined with different 
adjuvants (Wells et al., 1979). An adjuvant was omitted from the bacterin formulation in this study 
as the main aim was to make a direct comparison between responses to challenge with live 
(Chapter 4) or killed (Chapter 6) P  multocida.
In summary, the observed pathophysiological responses indicated that the formalin-killed P 
multocida treatment was ineffective in protecting the animal from a live formulation of P  
multocida. Instead it appeared to make the animal more susceptible to live challenge as shown by 
the percentage of surface lung area affected. However, the discovery that calves in Group 2b had a 
log lower bacterial load than did calves in Group lb  indicated that formalin-killed P multocida 
may have induced the production of local antibody, neutralising the presence of immunogens and, 
furthermore, the proportion of apoptotic and killer neutrophils may favour greater bacterial 
clearance for Group 2b animals. However, it would seem reasonable given the lack of conferred 
protection in this study that the lung would not be the preferred route of immunization. From the 
results documented by Effendy et al., (1998) and Zamri-Saad et al., (1999), repeated intranasal 
instillations of formalin-killed bacteria would seen to be the preferred route of challenge in order to 
enhance the systemic immune response and to lead to better protection against exposure to a 
homologous challenge.
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The mechanisms by which P. multocida A:3 causes disease are not fully characterised. The aims of 
this thesis were to develop a progressive and reproducible model of pneumonic pasteurellosis in 
conventional calves, comparable with the clinical and pathological responses observed in field 
cases that would allow also a more detailed characterisation of disease pathogenesis. Using the 
model, analyses of the pathophysiological responses to live and formalin-killed formulations of P. 
multocida were conducted insight into key mechanisms of host-pathogen interactions were gained 
by the investigation of cellular and secretory responses to infection within the lung.
This general discussion will summarise the key findings of the work in the context of current 
knowledge, emphasising their specific and general relevance to the topic of pneumonic disease. For 
the questions which remain unanswered, suggestions are made which may provide the basis for 
future work.
The increasing incidence of P. multocida isolation in cases of bovine pneumonic pasteurellosis and 
from calves that appear healthy indicates the need for detailed research into what is an emerging 
disease. Characterisation of the bacterium and, specifically, how it interacts with the host will help 
us understand the pathogenesis of the disease and provide the information necessary to design 
novel methods of detection and control.
LPS is considered an important virulence factor (Adler et a i ,  1999). Therefore, a preliminary 
epidemiological study was conducted to characterise the LPS from P. multocida A:3 and from the 
MRI challenge strain (671/90). This LPS, and that of all field isolates, was found to be of the rough 
form, indicating that none of the collected strains were able to synthesise the variable region, the O- 
antigen. This discovery that may facilitate the development of cross-reactive vaccines targeted 
against the more conserved core region of LPS. However, LPS chemotype profiling of the core 
region of these isolates exhibited 6 LPS core banding patterns, while immunoblot studies revealed 
the potential for low molecular weight core bands to remain concealed from the host surveillance 
system. This finding demonstrates the potential for diversity and a strategy for the pathogen to 
evade host immune defence components. There was no evidence that a particular LPS structure was 
associated with either commensal or pathogenic P. multocida strains.
M odification of LPS in Gram-negative bacteria plays a vital role during infection in the evasion of 
immune system recognition, resistance to host antimicrobial proteins and maintenance of virulent 
genes (Gunn and Miller, 1996). Neisseria gonorrhoeae are known to avoid immune recognition by 
the transfer o f sialyl groups to the surface of its LPS and this inhibits any possible reaction with
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bactericidal antibody (Parsons et aL, 1989). Structural modifications of Salmonella typhimurium  
LPS, such as fatty acid additions to the core and lipid A regions and acétylation of the O-antigen 
are induced by a two component regulator PhoPQ, which regulates genes for the intracellular 
survival o f S. typhimurium  in macrophages and resistance to cationic peptides (Guo et a l ,  1997). A 
PhoPQ system has also been identified in Yersinia pestis which expresses lipo-ohgosaccharide 
(LOS) and alterations to the core region of LOS may be required for the survival of Yersinia pestis 
(Hitchen et aL, 2002). No such PhoPQ regulatory system has been identified for P. multocida LPS, 
which may provide key clues for the control of R multocida pathogenesis and lead to novel 
approaches for the prevention of pasteurellosis.
Pulsed-field gel electrophoresis characterised the genetic aspect of the bacterium and revealed the 
potential for much genetic diversity. Thus it is unlikely that any one simple control strategy would 
prove effective. It is anticipated that the findings presented in Chapter 3 will initiate a larger 
epidemiological study that will stimulate further investigation in this area.
An experimental model of BPP was a first and essential step to simulate cases of BPP occurring in 
the field in order for studies of pathogenesis to proceed. Despite several attempts reported in the 
literature (Ames et al., 1985; Gourlay et al., 1989; Chengappa et al., 1989) to produce a suitable 
animal model of P. multocida infection there was no reliable, reproducible model that closely 
mimicked the field situation. The approach adopted was to use groups of animals each subjected to 
challenge with 4 different combinations of the MRI rough P. multocida type A:3 strain and volume 
of bacterial suspension. The results presented in Chapter 4 show that 300 ml at 10® cfu of P. 
multocida suspension produced progressive disease, eliciting a moderate to severe clinical, 
biochemical and pathological response lasting 24 to 48 hours and representative of the situation 
observed in field cases. Clinical signs of disease showed a rapid onset, appearing by 5 h p.c., and a 
short course, with fever, cough, respiratory distress and dyspnoea being common symptoms 
amongst infected animals. Calves that recovered from the bacterial infection often had persisting ill 
health that, in a commercial context, would be expected to reduce the milk output and meat quality 
of the animal. Levels of APP were determined as they have been shown to be highly sensitive 
indicators of bacterial infection (Horadogoda et al., 1994; Godson et al., 1996). This work showed 
for the first time that significant increases in the concentrations of APP, in particular Hp, were 
associated with P multocida A;3 challenge. A similar Hp response has been observed following the 
intravenous inoculation of P. multocida  serotype B:2 endotoxin in buffalo (Horadogoda et aL, 
2002). The tip of the bronchoscope was placed at the bifurcation of the trachea when dosing the 
calves, making it likely that the greater volume of bacterial suspension disseminated affecting a 
greater area of lung than did the lesser volume (60 ml) used (Donachie, unpublished observations). 
The experimental model (Dowling et aL, 2002) has made a significant contribution to the work 
described in the thesis and the consistency of the pathophysiological responses between the animal
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experiments reflect the reliability and reproducibility of the model which is o f importance for 
future experimental studies.
Subsequent work (Chapter 5) confirmed the reliability and reproducibility of the animal model in 
terms of clinical and pathological responses to infection. Control animals were incorporated into 
the study to determine whether a large volume of PBS alone and the invasive challenge procedure 
using the bronchoscope would have any adverse effects on the clinical response of the animals or 
whether the responses observed (Chapter 4 and Chapter 5) could be attributed primarily to R 
multocida. The latter was shown to be the case as calves that were challenged with PBS alone 
exhibited only a slight rise in mean rectal temperature and respiratory rate and these remained 
within the normal range. In addition, lung and nasopharyngeal samples were free of P. multocida.
Reproducing the model (Chapter 5) and the establishment of a proteomics unit at MRI provided an 
ideal opportunity to analyse the constituents of the pulmonary lung fluid prior to infection and at 
day 1 and day 4 following experimental infection with R multocida. The choice of these sampling 
days was made for the following reasons. Firstly, due to the timing of the clinical response 
described in Chapter 4, it was appropriate for the lavage to take place on the day following 
challenge. Secondly, the HO project licence required a minimum of 3 days between lavages, this 
limited the opportunities for examining the pulmonary defence system during progression of the 
disease but was considered necessary with respect to animal welfare. Nevertheless, this use of live 
lavage was entirely novel and provided information for the first time on events within the lung 
during the development of pneumonic pasteurellosis.
It would be of great value for vaccine development to be able to identify host and bacterial proteins 
within lung fluid. Bacterial proteins may have the potential to play a significant role as protective 
antigens in the pathogenesis of pneumonic disease. Immune sera raised against R, multocida A:3 
could be used to probe for the presence of bacterial proteins by western blotting of 2-DE gels. Host 
proteins identified during the inflammatory response included Annexin I and V, apolipoprotein A-1 
precursor, antioxidant protein 2, serotransferrin precursor and antimicrobial peptides. However, 
these proteins were not associated specifically with R. multocida because they were also found in 
the pulmonary fluid of calves administered PBS. No bacterial proteins were identified using the R. 
multocida database (http://lenti.med.umn.edu/pub/PM 70/i.
Albumin comprised almost half of the host protein found in the lung and often masked the recovery
of high molecular weight lung fluid proteins, thus obscuring an area of gel that contains proteins
with potentially vital roles in the pathogenesis o f disease. Future studies on BALF analysis will
concentrate on the removal of albumin from the lavage sample by running the samples through
either an affinity column with bound antibodies to bovine albumin (Lopez, et al., 2002) or a
column (affinity-blue) with immobilin dye which is known to bind albumin, thus allowing other
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proteins of a similar mass and pi to appear on the 2D-gel. The use of 11 cm gels restricted the 
amount o f protein extract to be loaded onto gels and decreased the probability o f detecting low 
abundance proteins and the resolution of the protein spots. In retrospect, these problems could have 
been overcome by using larger 18 cm gels with a narrow pH gradient. Moreover, larger gels would 
have allowed more efficient protein separation (Sabounchi-Schutt et aL, 2003).
The animal model was used to study and compare host responses to both live and killed E  
multocida A:3 challenge. It was important to see if 300 ml at 10^ cfu of formalin-killed P. 
multocida  was able to cause lung and systemic pathophysiological responses comparable to that of 
live R multocida suspended in the same volume of PBS and at the same dose of bacteria. So as to 
differentiate between diseases caused by bacterial components expressed in vivo. This has already 
shown to be important with IRP of M. haemolytica and supplements other approaches such as 
signature tagged mutagenesis (Fuller et al., 2000) and in vivo expression technology (Hunt et al., 
2001).
This work (Chapter 6) was designed to provide new information on the innate immune response of 
the host on which future control strategies could be based. A marked clinical response occurred 
after the formalin-killed challenge, though a similar response also was observed in control calves. 
This response was not reeorded in control calves administered 300 ml of PBS alone (Chapter 5) 
suggesting that these discernible responses for both challenge groups were due either to 
environmental conditions or to the presence of R. multocida throughout the respiratory tract that 
was not detected by nasal swabbing prior to day 0 of challenge. Fluctuations in environmental 
temperature occurred prior to and during the course of the experiment (Chapter 6), and may have 
compromised the animals respiratory defence system prior to challenge. Previous studies have 
demonstrated that clinically healthy calves up to 6 weeks of age were unable to tolerate acute 
changes in ambient temperature, from 5 to 35°C (Elmer and Reinhold, 2002). The main clinical 
findings of that study were significant increases in body temperature and respiratory rate. 
Microbiological examination of lung tissue from calves exposed to 5°C confirmed that mainly 
Mycoplasma sp, were found while R. multocida and M. haemolytica were the only bacteria found in 
the lung tissue of calves exposed to 35°C (Reinhold and Elmer, 2002). It has been suggested by 
Jones, (1987) that rapid proliferation of Rasteurella spp. in the nasopharynx is often accompanied 
by a change in climate (Jones, 1987). It would be of benefit for future animal experiments to 
prevent fluctuations of the environmental temperatures by placing the calves in an enclosed room 
with good ventilation and stable temperature.
Chapter 6 demonstrated clearly that SAA is a highly responsive APP and, along with Hp, exhibits 
marked responses to R. multocida infection similar to those observed during a M. haemolytica 
pneumonic infection (Horadogoda et al., 1994). Statistically significant differences in APP
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responses were not found between control and infected animals because variation between the 
small groups of animals was large. Future experimental studies would require larger groups of 
animals for a significant effect to be documented. In man, SAA is a marker of inflammation, tissue 
trauma and acute disorders such as myocardial infarctions and acute pancreatitis (Mayer et al., 
2002). In domestic animals, SAA plays a role in the transport of bacterial endotoxins and lipid 
metabolism (Urieli-Shoval et al., 2000). Both SAA and Hp are detected early in the onset of 
disease, suggesting a possible release of these proteins from  local cells such as alveolar 
macrophages. An increase in Hp mRNA within the lung following a bacterial infection has been 
reported (Yang et al., 1995). It is conceivable that P. multocida LPS could stimulate alveolar 
macrophages to release proinflammatory mediators such as IL-6, IL-1 and T N F -a  which may 
stimulate pulmonary mucosal epithelial cells or alveolar macrophages to release APP in situ, 
instead of the cytokines stimulating the hepatocytes to release the APP into the systemic system. It 
would be of value to measure the levels of APP within BALF following experimental introduction 
of P. multocida into the lower respiratory tract and to identify the origin of their release by the 
development of a PCR assay, whereby mRNA could be extracted from an array of pulmonary cells 
and amplified against an APP primer. In addition, cytokine mRNA profiles could be examined to 
help try and understand the role of cytokine-mediated release of APP.
M easurement of lung phagocyte function in the presence of formalin-killed P. multocida in vivo 
and live P. multocida in vitro characterised possible mechanisms of host pathogen interactions 
(Chapter 6). The recovery of fresh cellular material from the lower respiratory tract by 
bronchoalveolar lavage and examination of this material through cytospin preparations made it 
possible to identify the stage of inflammation and differentiate between infected and normal 
animals. The recovery of lung fluid a few days before experimental challenge did provide a good 
indication of the clinical status of experimental animals. In this study, the percentage of mixed cells 
isolated were 25 % neutrophils, which was 15 % higher than normal bovine neutrophil levels 
(Allen et al., 1992b), and the remaining 75 % were macrophages. This may indicate that these 
particular animals had an underlying subclinical infection prior to the challenge.
The nasopharynx, where the bacterium often colonises, was swabbed on a weekly basis prior to 
challenge but during this period P. multocida was not detected (Barbour et al,, 1997; Brogden et al., 
1998). Additionally, bacteriological examination of the lung fluid prior to challenge may have 
indicated the presence of P. multocida, which if in the LRT, are often pathogenic. Evidence for the 
survival of M. haemolytica in tiacheobronchial washings has been shown, especially in bovine 
species where long-term survival was observed (Rowe et al., 2001), but no such studies have been 
conducted for P. multocida. Environmental differences between the URT and LRT may be 
responsible for the ability of P. multocida to cause disease in the LRT. It would be important for 
future in vitro studies to incubate bacteria in fluid extracted from nasopharynx and from lung, in the
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presence of both iron replete and iron deplete conditions for the pathogen, to assess the survival 
and proliferation potential o f P. multocida in the URT and LRT.
The presence of gross and microscopic pathological changes following formalin-killed R multocida 
challenge was thought, initially, to be due to the high degree of neutrophil recruitment, as 
uncontrolled neutrophil recruitment to the site o f tissue injury has been implicated in causing 
further damage (Soethout et a l ,  2002). However, similar high neutrophil recruitment was also 
observed following PBS challenge and it has been demonstrated in domestic animals that 
pulmonary lavage alone can stimulate neutrophil migration through endothelial cells (Cohen and 
Batra, 1980). The procedure of challenge and lung lavage, alongside bacterial infection, as 
indicated by the recovery of P. multocida from swabbing of the nasopharynx following challenge 
was therefore likely to be the cause of the increase in neutrophils.
At necropsy it was possible to recover bacteria from both infected (Group 2a, 10^ cfu formalin- 
killed R multocida 300ml PBS) and control (Group la, 300ml PBS) groups which were surprising 
considering neither of these groups were challenged with live P, multocida. A greater amount of 
bacteria recovered were from lungs in the formalin-killed P. multocida  group which correlated with 
the extent of lung damage, although the correlation was not statistically significant. Perhaps P. 
multocida resided before the start o f the experiment in the tonsillar crypts of those calves from 
which it was recovered at PM and the use of standard nasal swabs did not detect P. multocida, 
whereas tracheal swabs may have been more efficient. Alternatively, the bronchoscope could have 
introduced P. multocida from the URT into the LRT. It may have been better to use an alternative 
BAL technique such as transtracheal sampling that, although It requires surgical prepaiation of the 
ventral surface of the neck, ensures that samples are collected without contamination from the URT 
(Caldow, 2001). However, the nature of this technique is invasive and may not be suitable for 
routine examination of the lung for investigating bacterial diseases.
Interactions between cells comprising the first line of pulmonary defence and P. multocida have not 
been well characterised compared with other respiratory pathogens such as M. haemolytica and 
Haemophilus somnus (Richards and Renshaw, 1989 and Gomis et a l ,  1997). The work presented in 
this thesis has demonstrated the ability of alveolar macrophages to phagocytose P. multocida in 
vitro independent of an opsonin, as well as to demonstrate the survival of this pathogen in the 
hostile environment of the macrophage for up to 1 h. The latter finding suggests that as one of the 
pathogen's survival strategies to evade the bactericidal properties of the host, P. multocida may 
have prevented the fusion of the phagosome and lysosome, thereby disabling the initiation of the 
respiratory burst. The pathogen, H. somnus is able to survive and multiply within bovine 
phagocytes in vitro despite the activation of macrophage function through E. coli LPS and 
recombinant bovine cytokines. This demonstrates the ability of H. somnus to escape from the
203
Chapter 8__________________________________________________________________
bactericidal effects of the macrophage leading to dissemination of the pathogen in the body (Gomis 
et al., 1997 and Gomis et al., 1998). Furthermore, recent findings have confirmed the ability for E. 
coli K1 OmpA (+) to enter, survive and replicate intracellularly in monocytes and macrophages of 
newborn rats. Immunohistochemistry studies demonstrated the ability of E. coli to multiply rapidly 
within a single phagosome and burst the cell, leading to bacteremia (Sukumaran et al., 2003).
The LDCL assay confirmed the inactivity of the respiratory burst when macrophages were 
incubated with P. multocida when only a small CL response was observed, comparable to the 
control (McCoys medium). To investigate this further it would be of benefit to incubate cells 
simultaneously with bacteria and PMA, (Jian et al., 1995) and thus determine whether P. multocida 
in vitro had already disabled the respiratory burst. In vivo formalin-killed P. multocida neither 
enhanced nor disabled the respiratory burst of the lung phagocytes, as demonstrated by the similar 
large LDCL responses observed on the addition of PMA in vitro to bronchoalveolar cells recovered 
from calves challenged with PBS.
It would be of value for future work to examine different dose formulations of formalin-killed P. 
multocida and to investigate the optimal dose that would cause a significant clinical response from 
control animals. In Chapters 4 and 5 the bacteria were live and were thus likely to proliferate to a 
concentration higher than that in the administered bacterial suspension, therefore, a higher dose of 
bacterin than that used for live bacteria would be required to cause comparable disease.
Calves given formalin-killed P. multocida appeared to cope well with bacterin challenge, indicating 
a possible method for generating protection against exposure to a homologous challenge. Bacterin 
vaccines for M. haemolytica have demonstrated partial protection (Shewen and Wilkie, 1988; 
Gilmour et al., 1991) but to date no vaccine exists for P. multocida and so the generation of an 
adaptive response to a homologous challenge was investigated. It was expected that the 
pathophysiological responses in calves given only homologous challenge would be more severe 
than those calves given homologous challenge after exposure to the bacterin. However, 
surprisingly, a greater area of lung damage was observed in those calves treated with bacterin prior 
to homologous challenge, suggesting that the bacterin compromised the animals' defences to the 
homologous challenge rather than enhancing protection. If the bacterin was responsible for 
predisposing the animal to infection then one would expect the bronchoalveolar cells to have been 
disabled by formalin-killed P. multocida. However, this was clearly not the case, as mentioned 
previously. A more feasible explanation lay in the fact that calves given the bacterin had an 
underlying P. multocida infection, as demonstrated by the recovery of bacteria at PM, and this may 
have exacerbated the effects of the bacterin. Furthermore, the formalin-killed P. multocida 
challenge may have contained LPS that interacts with toll-like receptor-4 to stimulate the 
expression of cytokines or directly stimulate neutrophils to secrete reactive oxygen intermediates
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and granule contents such as elastase and proteolyic enzymes (Fittschen et aL, 1988). These toxic 
products are known to cause injury to adjacent cells and connective tissue structures, resulting in a 
more exacerbated pathological response in Group 2b calves than that observed for Group lb  calves. 
It would be interesting to measure the level of LPS potency in the formalin-killed P. multocida 
formulation. Localised IgG would have been produced by Group 2b calves following formalin- 
killed P. multocida to opsonise the homologous challenge, and promote phagocytosis. This thesis 
has provided evidence for the intracellular survival of P. multocida and future findings may support 
the lysis of the macrophage by the bacteria and in so doing release high levels of reactive oxygen 
intermediates causing host tissue damage. This mode of pathogenesis may provide an explanation 
as to why a more exacerbated pathological response was observed for Group 2b calves than that 
observed for Group lb  calves, as their immune system was not primed by formalin-killed R  
multocida prior to the homologous challenge. The measurement of localised antibody production 
following formalin-killed P. multocida challenge was beyond the scope of this thesis and would be 
considered for future studies.
A significant positive correlation was observed between lung damage and concentrations of Hp. 
This novel finding suggests that local cytokine production within the area of lung damage could 
have mediated the synthesis of Hp in situ.
The systemic IgG level o f all calves remained elevated, on a par with the high levels of serum 
neutralising antibody generated in calves infected with P. multocida A:3 prior to and during the 
experiment, probably residual from colostrum transfer. However there was no evidence of an 
increase or decrease in systemic IgG following exposure to formalin-killed P. multocida. It would 
be of interest for future work to assess the levels of IgG and IgA in lung fluid, as local antibody 
production following formalin-killed M. haemolytica has been observed in BALF recovered from 
goats (Zamri-Saad et al., 1999). One would expect the immune response to be highly localised and 
that the release of antibodies, primarily IgA, would be into the lung and not into the systemic 
system (Wilkie, 1982). It is important to stress that the primary aim of the work in Chapters 6 and 7 
was not to develop a bacterin vaccine but to provide a direct comparison between responses to dead 
and live ehallenge with P. multocida. The experiment would have been designed differently if the 
primary objective was vaccine development. For example, an adjuvant would have been used to 
complement the immune response, the vaccine would have been administered either intranasally or 
subcutaneously to stimulate the mucosal and systemic immune response, and repeat bacterin 
challenge would have been used to maximally stimulate an immune response. An obvious 
alternative for future work, associated with the production of a vaccine against P. multocida, would 
be to base the research on iron modulated bacterial protein expression technology, which has 
assisted successfully the development of a vaccine against M. haemolytica  A :2 infection in sheep
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and M. haemolytica A:1 infection in cattle at M RI (Gilmour et al., 1991; Donachie, unpublished 
observations).
It became apparent during the latter stages of the study that farms with calves free of P. multocida 
were becoming more difficult to find. When selecting calves for experimental work in Chapters 4 
and 5 at the early stage of the study, we were privileged to have a unique farm near M RI that reared 
calves consistently free of Pasteurella spp., a unique situation that was not appreciated fully until 
the farm closed down after the Foot and Mouth outbreak in 2001, when we were forced to search 
for a farm with Pasteurella spp. free calves within southern Scotland. This proved to be extremely 
difficult because it was common to recover P. multocida from approximately 50 % of calves within 
a few days of birth, indicating that transmission of P. multocida  was rapid and delayed the start of 
the final animal experiment (Chapter 6 and Chapter 7). Detection was carried out using nasal swabs 
smeared on vancomycin SB A  plates and in many cases P. multocida  was recovered, along with 
Proteus and E, coli. In light of this, it is of great importance for future studies that a large scale 
epidemiological study is conducted to assess accurately the extent and variety of serotypes present 
in Scottish herds. Ideally this study would be performed by swabbing the tonsillar crypts in 
addition to the nasopharynx, which should increase the probability of recovering P. multocida. 
Cultures testing positive for P. multocida would then be subjected to an array of serological, 
biochemical and genotypic tests to ascertain strain diversity or relatedness. This would improve our 
understanding of the epidemiology of pneumonic pasteurellosis caused by this bacterium and 
provide information on the most appropriate serotypes to be used for successful vaccination studies 
against P. multocida. Furthermore, the serotypes isolated would need to be correlated with health 
status and disease patterns of the animal, to provide more concise information needed when 
selecting potential vaccine candidates if a particular serotype could be associated consistently with 
either diseased or healthy animals. The potential for key bacterial surface structures, such as LPS 
that interact with the host system, to undergo antigenic variation may hinder vaccine development. 
An understanding therefore of the diversity o f such antigens will aid control strategies.
Official figures from VIDA, UK showed an increased incidence in pneumonic pasteurellosis 
caused by P. multocida as compared with M. haemolytica, from  1999 to 2001 (figures for 2002 are 
unavailable). This could be attributed to changes in farming practices brought about by changes in 
climatic conditions, as data retrieved from VIDA in 2001 showed a distinct seasonal pattern with 
the majority of pneumonic cases occurring in January, February and December. The low incidence 
in the autumn was likely due to relatively warm and dry conditions that allowed livestock to remain 
at pasture until much later in the year, with typical winter weather only occurring from December 
onwards (VIDA, UK).
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Changes in climatic conditions can alter plans for lambing or calving and often force the farmer to 
remove livestock from pasture and house them in small areas. Studies in ruminants at pasture have 
shown that pneumonic pasteurellosis tends to spread slowly and the mortality rate is lower than in 
feeder calves kept in confined quarters. This stems from the aetiology of the disease whereby 
animals become stressed due to overcrowding and poor ventilation, leading to suppression of the 
immune system, rendering the animals susceptible to R multocida infection. Risk factors to be 
considered include the mixing of calves of different ages, vaccination status, and movement of 
calves within and between farms, housing from pasture, weaning, dietary changes, decline in MDA 
status and other stresses such as castration (Gibbs, 2001). However, while any of the above factors 
may be associated with an outbreak of pneumonia in calves, it seems unlikely that alterations in 
farming practices alone are responsible for the increased prevalence of R multocida. Rather it is 
more than likely due to the evolution of virulent attributes of R multocida  that favour the survival 
o f the pathogen in a hostile host environment. P. multocida seems to differ from  M. haemolytica in 
the sense that it possesses an array of virulence factors that all contribute to the survival and 
proliferation of the organism, as opposed to M. haemolytica that perhaps has a smaller number of 
virulence factors. Leukotoxin of M. haemolytica Is the main recognised virulence factor 
(Jeyaseelan et al., 2002) but, more recently, LPS chemotype, specifically the rough form of M. 
haemolytica A:1 has been associated with the severity of ovine pneumonic pasteurellosis (Hodgson 
et al., 2003). P. multocida does not possess leukotoxin and this present study indicates that smooth 
LPS forms are rare. These differences between M. haemolytica and P. multocida emphasise the 
nature of the latter heterogeneous species that infects a broad spectrum of wild and domestic 
animals (Adler et al., 1999), which makes the development of a vaccine against P. multocida more 
of a challenge.
The work reported in this thesis led to a successful, progressive and reproducible animal model that 
has provided a detailed picture of the clinical and pathological responses typical o f BPP. This 
model of pneumonic pasteurellosis is currently being used by Intervet to assist with vaccine trials. 
In addition, the measurement of Hp and SAA has shown them to be useful markers for the disease. 
Phagocytic studies have demonstrated the ability of P. multocida A:3 to survive within the hostile 
environment of the alveolar macrophage for up to one hour in vitro, this novel finding may 
highlight a hitherto strategy unknown of P. multocida for evading the immune surveillance system 
in vivo. The challenge of conventional calves with formalin-killed R multocida seemed to 
predispose the animals to a homologous challenge instead of conferring protection which indicates 
that a bacterin challenge via the lung would not be the route to adopt for vaccination programmes. 
The LPS from R multocida A:3, a potentially important virulence factor, was characterised and 
found to be of the rough form, indicating loss of the 0-antigen which was thought previously to be 
responsible for variation amongst bacterial isolates. However this thesis has shown the potential for 
variation within the core region of LPS, denoted by 6 LPS core banding patterns amongst 30
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isolates. This novel discovery may hinder the development o f vaccines targeted against LPS. 
Pulsed-field gel electrophoresis of DNA cut by enzymes with infrequently predicted restriction 
sites revealed the potential for much genetic diversity. This study has provided a better 
understanding of the disease process and the host interaction with P. multocida  A:3. Despite an 
apparent increase in R multocida  virulence, the findings presented in this thesis, in conjunction 
with modern genetic tools and the recent sequencing of the entire genome of a turkey capsular 
serotype A strain (Pm 70) of P. multocida  (May et a l ,  2002) ensure that more informed approaches 
to studies of the host-pathogen interaction of value to vaccine development will be possible.
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Appendix 1. Solutions and Reagents
1.1. Carbohydrate media
1.1.1. Peptone water sugar base
Bacto peptone 10 g
NaCl 5g
Bromocresol purple solution (0.5% (w/v) in 95% ethanol 10 ml
Distilled water 1000 ml
Adjust pH to 6.8, autoclave at 121°C for 15 minutes.
1.1.2. Preparation of ONPG Broth
O N PG  solution:
0-nitro-phenyl-D-galactopyranoside (ONPG) 0.6 g
0.0 IM  Na2HP04 100 ml
Adjust pH to 7.5 and filter sterilise.
Peptone w ater:
Bacto peptone 10 g
NaCl 5 g
Distilled water 1000 ml
Autoclave at 121°C for 15 minutes.
Complete medium: ONPG solution, 25ml and Peptone water, 75 ml
Mix aseptically and dispense in 2.5 ml volumes (stable for one month at 4°C)
1.2. Blood Agar
1.2.1. 5 % Sheep blood agar plates
Blood agar base No.2 (Oxoid) 500 ml
Sterile sheep blood 25 ml
Melt the blood agar base completely in the microwave (reducing the power to 50 % after the first 5
m allows the entire agar to melt without boiling over). Allow to cool at 56°C for 30 m, and then
add aseptically sheep blood to 500 ml agar base. Swirl gently to mix and pour carefully avoiding
air bubbles, into sterile Petri dishes in approximately 20 ml amounts. If bubbles appear in the Petri
dish, pass a Bunsen flame over the agar to remove the bubbles prior to the agar setting. When
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plates are dry (within 15 min) incubate a test plate overnight to check sterility and store the rest in 
sealed bags at 4°C up to 4 weeks.
1.2.2. Vancomycin blood agar
Blood agar base No.2 (Oxoid) 500 ml
Vancomycin solution (Im g ml ' in DW, filter sterilised) 5ml
Prepare the blood agar as above. Add vancomycin solution (final concentration 10 jig ml '). Mix 
well and pour into sterile Petri dishes.
1.3. Pulsed-fiield gel electrophoresis reagents
1.3.1. Pett IV Buffer
Tris (pH 7.4) 10 ml of a 1 M  stock
Sodium chloride (MWt 58.44g) 58.44 g
dHjO 990 ml
Dissolve the above and store at RT
1.3.2. EC Lysis solution
Tris-HCl (pH 7.6) 6 ml of 1 M  stock
1 M Sodium chloride (MWt 58.44) 58.4 g
EDTA (pH 7.5) 100 ml of 0.5 M  stock
Deoxycholic Acid (Na) (MWt 392.6) 2 g
N-Lauroyl Sarcosine (MWt 293.4) 5 g
Polyoxyethylele 20 Cetyl Ether Brij 58 5 g
dHzO 894 ml
Dissolve the above. Autoclave at 121°C for 15 m. Store at RT.
Before use add fresh lysozyme at 1 mg ml"' and RNAse at 20 jil ml ' (add 2 jil of 10 mg ml ' stock 
solution ml ').
1.3.3. ESP buffer
EDTA (pH 9-9.5) 100 ml of 0.5 M  stock
N-Lauroyl Sarcosine (MWt 293.4) 1 g
Proteinase K 0.1 g
Incubate solution at 37°C for 2 h. Freeze in 1 ml aliquots at -20°C
1.3.4. TE Buffer
5 ml 1 M  Tris (pH 8) stock solutionr-giving a final concentration lOmM Tris 
1 ml 0.5 M EDTA (pH 8) stock solution:-giving a final concentration Im M  EDTA 
Add to 494 ml DW. Autoclave at 12 HC for 15 m and store at RT.
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1.3.5. O .IM PM SF
Resuspend 17.5 mg of PM SF (MWt 174.2) in 1 ml of isopropanol. M ake fresh each time.
1.3.6. 10 xT B E  Buffer
Tris (MWt 121.1) 108 g
Boric acid (MWt 61.83) 55 g
EDTA (pH 8) 40 ml 0.5 M  stock solution
Add to 800 ml DW. Mix and make up to 1 litre with DW. Autoclave at 121°C for 15 m and store at
RT.
1.3.7. 0.5 X TBE buffer
Mix 50 ml of 10 X TBE with 950 ml DW. Store at RT.
1.3.8. 0.5 M EDTA
Add 93.06 g EDTA (MWt 372.24) to 400 ml DW  and mix on a magnetic stirrer. Adjust the pH to 
8.0 with NaOH and make up to 500 ml with DW. Autoclave at 121°C for 15 m and store at RT. 
EDTA will not dissolve until pH is adjusted to 8.0
1.3.9. 1 M Tris
Add 121.1 g Tris to 800 ml DW. Adjust to desired pH with concentrated HCl. Make up to 1 litre 
with DW. Autoclave at 121°C for 15 m and store at RT. For 10 mM Tris (MW t 121.1) 5 ml of IM  
Tris pH 8.0 stock solution.
1.3.10. 2 % Low gelling agarose for plugs
Add 2 g of low gelling temperature agarose to 98 ml of D W  Dissolve in a microwave. Cool to 30- 
40°C in a waterbath for use or store at RT.
1.3.11. 1 % Agarose for PFGE gel
Add 3 g of agarose to 300 ml of 0.5 x TBE. Dissolve in a microwave. Cool to 50°C in a waterbath 
for use or store at RT.
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1.4. Immunoblotting solutions
1.4.1. Transfer buffer
25 m M Tris (MWt 121.1) 15 g
192 mM Glycine (MWt 75.07) 72.06 g
25 % (v/v) Methanol 1 250 ml
Mix and make up to 5 litres with DW. Store at RT.
1.4.2. High salt blocking buffer
0.5 M NaCl 29.22 g
0,5 % Tween-80 (v/v) 5 ml
PBS 1000 ml
Mix contents thoroughly and store at RT.
1.4.3. 0.1 M Tris (pH 7.6)
Add 12.1 g Tris (MWt 121.1) to 800 ml DW. Adjust to pH 7.6 with concentrated HCl. Make up to 1 
litre with DW. Store at RT.
1.4.4. 5 mg ml^ diaminobenzidine
3, 3 '-diaminobenzadine 100 mg
0.1 M  Tris (pH 7.6) 20 ml
Dissolve and immediately dispense into 1 ml and store at -20°C
1.4.5. DAB HRP substrate
5 mg ml ' diaminobenzidine 1 ml
0.1 M Tris (pH 7.6) 19 ml
0.15 % hydrogen peroxide (30 %, MW t 34.01) 100 p-1
Mix and use immediately.
1.5, ELISA reagents
1.5.1. Carbonate bi carbonate buffer
NazCOa (MWt 105,99) (15 mM) 0.795 g
NaHCOg (MWt 84.01) 1.465 g
Dissolve in 400 ml of D W  Adjust pH to 9.6 and make up to 500 ml with D W  Store at 4°C for up 
to one month.
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1.5.2. ELISA wash buffer
10 X PBS 1 litre
Tween 20 (0.05 %) 5 ml
DW  9 litres
Mix and store at RT.
1.5.3. 0.2 M Phosphate solution
Add 14.2 g Na2HP0 4  (MWt 141.96) to 500 ml DW. Store at RT.
1.5.4. Citric acid solution
Add 9.6 g Citric acid (MWt 210.14) to 500 ml DW. Store at RT.
1.5.5. OPD substrate solution
0.09 M  Citric acid solution 12.1 ml
0.2 M  Phosphate solution 12.9 ml
DW  25 ml
OPD (MW t 181.1) 40 mg
30 % H2O2 40 p.1
Mix citric acid and phosphate solutions together, then add DW  and OPD. Finally add hydrogen 
peroxide and mix well. Use immediately.
1.5.6. 2.5 M Sulphuric acid
Slowly add 136.25 ml concentrated H 2SO 4  to 863.75 ml DW. Important to add acid to water, not 
water to acid. Fume hood, eye protection and gloves. Mix and store at RT.
1.6. Viral ELISA Reagents
1.6.1. ELISA diluent (PBS/Tween-20/EDTA/0.5 % (v/v) ovalbumin)
1 X PBS / 0.05 % Tween-20 180 ml
0. IM  EDTA (MWT 372.2) 2 ml
Ovalbumin (5 % w/v) 1 g
Add ovalbumin to 20 ml of PBST and mix to dissolve, filter through a W hatman N o.l filter and 
Buchner funnel, make up fresh and discard remainder.
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1.6.2. ELISA substrate (Orthophenylenediamine)
O.IM Citric acid (MWT 210.4) 121.5 ml
0.2M Di-sodium hydrogen orthophosphate (MW T 141.96) 128.5 ml
DW  250 ml
pH 5.0 using either of the above reagents and store at 4°C. Before use add the following to 100 ml.
Orthophenylenediamine (OPD) tablets 
30 % Hydrogen peroxide (MW T 34.01)
80 mg 
80 111
1.7. Proteomic reagents
1.7.1. Rehydration buffer
8 M  Urea (MWt 60.06)
2% (w/v) CHAPS 
0.5% (v/v) IPG buffer 
(same pH range as the IPG strip) 
bromophenol blue 
DW
12 g
5 g
125 III
a few grains 
25 ml
1.7.2. Equilibration buffer
6 M Urea (MWt 60.06)
30 % (v/v) glycerol 
2 % (w/v) SDS (MWt 288.38)
50 mM Tris-HCl (pH 8.8)
Bromophenol blue 
DW
72.07 g 
69 ml 
4 g
6.7 ml
a few grains 
200 ml
1.8. Phagocytic reagents
1.8.1. Nigrosin
Stock solution: 1 % (w/v) nigrosin in DW
Diluting solution: 2 % (v/v) 0.4 ml PCS in 19.6 ml PBS
Working solution: 0.1 % nigrosin (1 pail stock solution to 9 parts diluting solution), filter, sterilise 
and store at -20°C in 90 |il aliquots.
1.8.2. Percoll reagent for the separation of bronchoalveolar cells
Percoll dilution to 1.075 g ml"': 53.2 ml Percoll stock solution, 10 ml of 10 x PBS and make up to 
100 ml final volume with DW.
Percoll dilution to 1.055 g ml"': 37.8 ml Percoll stock solution, 10 ml of 10 x PBS and make up to 
100 ml final volume with DW.
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1,8.3. Fluorescent dyes
Crystal violet: Stock solution is 1 % methyl violet stored at RT. The working solution is a 1/20 
dilution of the stock solution in PBS.
Acridine orange: Stock solution is 10 mg ml ' stored at 4°C and the working solution is 14.4 
mg/100ml of Gey’s balanced salt solution (GBSS).
1.8.4. RPMI (without antibiotics)
RPMÎ 1640 (without L-Glutamine) 40.65 ml
FBS (heat inactivated for 1 h at 56°C) 5 ml
1 % (v/v) Glutamine 1 ml
1 % (v/v) HEPES (2.5M) 600 jil
Mercaptoethanol 250 p.1
Mix the contents together using aseptic techniques in a sterile class II cabinet and adjust the pH to 
7.2 using 7.5 % Sodium bicarbonate. Store at 4'^C.
1.8.5. Freeze mixture for liquid nitrogen storage of lung cells
RPMI (10 % stock solution see appendix 1.8.4) 8 ml
DMSO 2 ml
FBS (heat inactivated) 10 ml
Mix the contents together using aseptic techniques in a sterile class II cabinet. Store at
- 20°C.
1.9. Sero logy  reagents
1.9.1. EDTA
Disodium EDTA 2 g
Sodium Chloride 0.8 g
Adjust to pH 7.4 with sodium hydroxide and make up the solution to a final volume of 100 ml with 
DW.
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2.11. Spot 120 Hypothetical protein precursor
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2.13. The fingerprint generated by mass spectrometry of 
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